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Summary 
 
1 
Summary 
During vertebrate development differentiation programmes unfold stepwise 
and involve a multitude of signals and responses that are spatially and temporally 
regulated. Transcriptional control, mediated by transcription factors, is a key feature 
of cell differentiation, but so is regulation on the post-transcriptional level, mediated 
by RNA-binding proteins (RBPs). Besides having general roles in the control of RNA 
metabolism, RBPs have been implicated in tissue-specific processes during 
embryonic development. The significance of such post-transcriptional events for the 
regulation of cell differentiation becomes more and more evident.  
Despite extensive studies in muscle differentiation, some aspects of the 
process are still largely unknown. This includes the signals and regulators involved in 
primary activation of the myogenic master regulator MyoD as well as the downstream 
mechanisms by which MyoD stabilizes the muscle cell fate. The discovery of our 
laboratory that the putative RBP Seb4 is an early MyoD target has raised the 
possibility that MyoD promotes muscle differentiation through post-transcriptional 
mechanisms. 
In this study, I investigated the biochemical properties and biological function 
of Seb4 during early development in Xenopus laevis. Seb4 is an evolutionary 
conserved small protein, containing a single RNA recognition motif (RRM). In 
contrast to most ubiquitously expressed RBPs, the expression pattern of Seb4 is 
regulated in a stage and tissue-specific fashion in ectodermal and mesodermal 
derivatives. My results provide evidence that Seb4 is essential for muscle and lens 
differentiation in Xenopus. In embryonic muscle cells Seb4 protein is unexpectedly 
highly abundant and located in both cytoplasmic and nuclear compartments in a 
distinct pattern. Consistent with this, RNA-coimmunoprecipitation assays have failed 
to identify selective RNA-targets. Furthermore, by immunoprecipitations no specific 
Seb4-associated proteins were identified, confirmed by the fact that Seb4 elutes as a 
monomer from gelfiltration columns. Taking all these evidences in consideration, this 
detailed analysis revealed Seb4 as a key regulator of various differentiation 
programmes and suggests Seb4 to have a more general role in the RNA metabolism 
of differentiating cells, rather than a selective function. 
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1 Introduction 
1.1 Xenopus laevis as a model organism of cell 
differentiation 
The development of an organism is based on the formation of complex 
structures from differentiated cell types from a fertilized egg. To investigate this 
complex process experimentally, it requires easily accessible model systems. 
The African clawed frog Xenopus laevis has been one of the most favored 
and best-studied model organisms for vertebrate embryology over the past decades. 
Major insights into early embryogenesis like signalling events important for body axis 
determination or germlayer formation were obtained from studies with Xenopus. 
1.1.1 The life cycle of Xenopus laevis 
Figure 1 illustrates an overview of the life cycle of Xenopus laevis. After 
fertilization, Xenopus embryos undergo cell cycles that have characteristic features 
(Niewkoop & Faber, 1967). During the first, 90-minute cell cycle, cortical cytoplasmic 
movements and male and female pronuclear fusion occur. The next eleven divisions 
occur at 20- to 30-minute intervals with no gap phases, while the embryo forms a 
blastula of 4000 cells, which encloses a fluid-filled blastocoel cavity. This mid-blastula 
embryo has three regions, the animal cap (which forms the roof of the blastocoel), 
the equatorial or marginal zone (the lateral walls and floor of the blastocoel) and the 
vegetal mass. Although all mid-blastula cells are pluripotent, explants of the animal 
cap form ectodermal derivatives in culture, while equatorial explants form mesoderm 
and vegetal explants form endoderm. At the end of the twelfth cycle, gap phases 
reappear, the cell cycle lengthens to 50min and zygotic transcription starts (this is 
called the mid-blastula transition, MBT; 5-6 hours post fertilization, hpf). In the 15th 
cycle, the dorsal lip of the blastopore forms at 9hpf, the cell movements of 
gastrulation begin and mitosis stops. Gastrulation converts the embryonic blastula 
into three layers, and establishes definitive anteroposterior and dorsoventral axes 
(Heasman, 2006). During neurogenesis starting 12hpf, the organs begin to form 
being fully developed by late tailbud stages. In regard to muscle formation, 
segregation of the first anterior somites begins at stage 17. Simultaneously with the 
segregation of an increasing number of somites from the somitic mesoderm, their 
cellular differentiation proceeds in a cranio-caudal direction. At stage 20 the 
myocoelic cavities begin to disappear. In the most anterior somites the myoblasts are 
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already spindle-shaped, while at stage 21 myofibrillae are formed. These myofibrillae 
become arranged in fusiform bundles at stage 23. At stage 24 initial motor actions 
can be observed. At stage 26 first spontaneous movements occur. The dorsal 
muscles derived from the myotomes and the ventral muscles develop further during 
the stages 37 and 39.  At stage 51 the first indications of the formation of secondary 
muscles originating from the group of primary muscles appear. After metamorphosis 
the adult frog has developed (Niewkoop & Faber, 1967). 
 
 
Figure 1: Life cycle of Xenopus laevis 
All stages shown are based on the normal table of Nieuwkoop and Faber 
(Nieuwkoop & Faber, 1967; Nieuwkoop & Faber, 1994) hr: hours post fertilization (hpf); 
(http://www.xenbase.org/xenbase/original/WWW/Marker_pages/Xenopus_stages/Xenopus_st
ages.html). 
 
1.1.2 Developmental concepts 
Development results from the coordinated behaviour of cells. The major 
processes involved in development are cell divisions, pattern formation, 
morphogenesis, cell differentiation, cell migration, cell death, and growth. Since the 
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somatic cells in the embryo generally contain the same genetic information, the 
changes that occur during development are controlled by the differential activity of 
selected genes and maternal determinants in different groups of cells. One way of 
changing cell fate and directing development is communication between cells 
mediated by signalling molecules, e.g. morphogens. Morphogens are small, secreted 
proteins, which diffuse over long distances, form concentration gradients, and give 
the cells positional information within the embryo, which is interpreted and causes a 
specific response. Pattern formation, in particular the early steps after fertilization of 
the egg, is also regulated by maternal determinants like localized mRNAs. But also 
later in development cytoplasmic RNA localization is a means to create polarity by 
restricting protein expression to a discrete subcellular location (Wolpert, 1998). 
1.1.3  Methodological advantages of Xenopus 
Among the many advantages, the major advantages of Xenopus laevis 
over other model organisms like mouse is the extra-uterine development, the 
enormous size of egg clutches (several hundred up to a few thousand eggs per day), 
and the hormone-inducible super ovulation of female frogs. Cohorts of eggs can be 
fertilized in vitro at the same time, which allows standardization and synchronous 
development. This provides sufficient material to perform biochemical experiments. 
The embryonic development is rapid, which offers the possibility to collect different 
developmental stages of one batch for comparative analyses. The embryos are 
relatively large with 1-2mm in diameter with only little pigmentation. Therefore, they 
are easy to manipulate (for example by nucleic acid injection) and provide the 
possibility of macroscopical analysis. Furthermore, the embryos can be simply 
cultured in semi-sterile conditions without external growth factors.  
Xenopus laevis has about the same DNA content in each of its cells as 
humans. It has 36 chromosomes, and the evolutionary history indicates that an 
ancestor of Xenopus laevis probably had 20 chromosomes, which were duplicated. 
The duplicate copies of each gene have subsequently diverged, complicating 
molecular analysis. For genetic analyses investigators focus their studies on a close 
relative of Xenopus laevis, Xenopus tropicalis, which offers the possibility of such 
genetic manipulations, because within the Xenopus genus, Xenopus tropicalis is the 
only diploid species. But the small size of the embryos limits macroscopical analyses. 
Another major advantage of Xenopus laevis with regard to understanding 
the basic biology of cell determination is the utility of the animal cap-explant assay. 
This assay provided a valuable means for identifying the first mesoderm-inducing 
factors (members of the transforming growth factor signalling class β; TGF-β) and 
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shed more light on endogenous signalling (Grunz et al, 1988; Rosa et al, 1988). 
Xenopus laevis became thereby the model organism with the best studied signalling 
pathways and the most clones isolated from it. 
 
1.2 Mesoderm specification and myogenesis 
During early vertebrate embryogenesis three germ layers, the ectoderm, 
mesoderm, and endoderm, are formed from pluripotent cells at the onset of 
gastrulation. The specification of these germlayers is substantially influenced by 
maternally deposited positional information. Along the animal-vegetal axis the 
ectoderm arises from the animal cap, the endoderm derives from the vegetal pole 
regions, while the mesoderm forms in the marginal zone.  
1.2.1 Mesoderm induction 
Mesoderm induction is one of the classical challenges in developmental 
biology. Various developmental biology approaches, particularly in Xenopus laevis, 
have identified many of the key factors that are involved in this process and have 
provided major insights into how these factors interact as part of a signalling and 
transcription-factor network.  
1.2.1.1 Forming the mesoderm and its derivates 
Besides creating the body cavity, one of the major tasks of gastrulation is 
to create mesoderm. In Xenopus, the mesoderm induction creates a zone of 
mesodermal cells at the equator of the embryo (the marginal zone). Complex 
morphogenetic movements bring these mesodermal cells into their correct position 
between the endoderm and the ectoderm within the post-gastrula embryo. The fate 
map in Figure 2 shows how the mesoderm becomes subdivided along the dorso-
ventral axis of the blastula and which tissues the mesodermal germlayer gives rise 
to. 
The mesoderm produces a wide range of tissues including the muscles, 
heart, vasculature, blood, kidney, gonads, dermis and cartilage. It also has a major 
role in the morphogenetic movements of gastrulation and patterning the embryo.  
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Figure 2: Fate map of the mesoderm in a Xenopus embryo 
The figure was modified from (Kimelman & Schier, 2002). 
 
 
1.2.1.2 Signalling factors involved in mesoderm induction 
Simplified, the Nodal family is involved in initiating mesoderm formation, 
fibroblast growth factors (FGFs) and Wnt protein family members (Wnts) are involved 
in maintaining the mesodermal state, and bone morphogenetic proteins (BMPs) are 
involved in patterning the mesoderm. These factors, however, can actually do much 
more. For example, in various experimental models, FGFs, BMPs and Wnts have 
been shown to be sufficient for initiating mesoderm formation (Slack et al, 1987); 
(Kimelman & Kirschner, 1987), and Nodal family members have been shown to be 
involved in patterning the mesoderm (Birsoy et al, 2006; Gritsman et al, 2000). These 
results indicate that extracellular signals do not necessarily have rigidly separated 
functions in mesoderm induction, and instead indicate that these signals might be 
networking while forming and patterning the mesoderm.  
In mesoderm specification the T-box transcription factor VegT (alias Brat, 
Xombi, or Antipodean) activates mesoderm induction by regulating the transcription 
of a large number of zygotic genes, none of which are expressed in animal cells. 
Additionally, VegT affects endodermal specification, dorsoventral axis formation, and 
convergence extension. 
 During oogenesis vegT is supplied maternally to the oocyte and is also 
expressed zygotically within the equatorial zone. The maternal mRNA is located 
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vegetally in mature oocytes and early embryos (Xanthos et al, 2001; Zhang et al, 
1998). At fertilization, vegT transcripts are released from the vegetal pole and slowly 
diffuse upwards. Because the third cleavage plane passes through the equator of the 
embryo before the transcripts leave the vegetal hemisphere, the vegT transcripts are 
trapped there, and therefore the subsequently translated VegT protein is restricted to 
the vegetal half.  
 
Figure 3: Early mesoderm induction in Xenopus 
 (Schohl & Fagotto, 2003) 
Both β-catenin and VegT induce Xnrs. FGF, Xnr and β-catenin signals cooperate 
to induce FGF3 and, perhaps, other FGFs along the marginal zone and thus activate MAPK. 
The combination of Xnr and FGF/MAPK signals then activates expression of mesodermal 
genes such as eomesodermin and Xbra (Schohl & Fagotto, 2003).  
 
In the 32-cell-stage Wnt11 mRNA and protein is enriched on the dorsal 
side, presumably due to the cortical cytoplasmic rotation triggered by the sperm 
entry. The result of this movement is the stabilization of β-catenin, an intracellular 
Wnt pathway component, on the future dorsal side of the embryo. This asymmetrical 
stabilization of β-catenin is essential for the formation of all dorsal and anterior 
structures (Heasman et al, 1994; McMahon & Moon, 1989). Among the major targets 
of the Wnt11/β-catenin/Tcf3 pathway are Xnr3 and siamois, and genes that have 
essential roles in head formation and convergent extension movements (Lemaire et 
al, 1995; Smith et al, 1995). 
At the start of zygotic transcription at MBT, VegT activates its targets. 
Many of its targets are transcription factors regulating endoderm formation, factors 
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that are involved in distinguishing between endodermal and mesodermal territories 
(mixer) (Kofron et al, 2004; Xanthos et al, 2001), Wnt antagonists (chordin, cerberus, 
noggin and dickkopf) (Xanthos et al, 2002). Another group of target genes that are 
directly regulated by VegT are the Xenopus nodal related (Xnr) genes (encoding 
TGF-β transcription factors) Xnr 1, 2, 4, 5, 6 and derriere. High levels of Xnrs induce 
the Spemann’s organizer in the prospective dorsal mesoderm – the main dorsalizing 
centre of the embryo. At gastrula stage the organizer, in turn, secretes another 
important group of molecules involved in mesoderm induction and patterning. These 
secreted molecules are antagonizing the growth factors of the BMP-, Wnt- and 
TGFβ- pathway by binding to the growth factors in the extracellular space and 
prevent them from binding to their cognate receptors.  
Generally, the Xenopus nodal related (Xnr) genes are required for the 
formation of bottle cells, normal gastrulation movements, and most importantly they 
are the inducers of mesoderm formation (Clements et al, 1999; Hyde & Old, 2000; 
Kofron et al, 1999).  
1.2.2 Myogenesis 
There are three major muscle types: cardiac, skeletal, and smooth. All of 
them are derived from the embryonic mesoderm during early embryogenesis. 
Cardiac precursor cells come from a population of cells in the anterior lateral plate 
mesoderm in early embryos. The heart is the first functioning organ to form during 
vertebrate development. Skeletal muscle arises from paraxial mesoderm that gives 
rise to the somites along the anteroposterior axis of the embryo. Somites become 
compartmentalized into the myotome, sclerotome, and dermatome, which give rise to 
skeletal muscle, axial skeleton, and dermis, respectively. In contrast to cardiac and 
skeletal muscle cells, which exit the cell cycle to undergo terminal differentiation, 
smooth muscle cells are highly plastic and can modulate their phenotypes between 
proliferative and differentiated states in response to extracellular cues. Much of our 
understanding of skeletal muscle gene expression regulation during development is 
at the level of transcription (Berkes &Tapscott, 2005). 
During early embryogenesis, after mesoderm induction, the myogenic 
determination factors MyoD and Myf5 are activated in pre-somitic mesoderm in 
response to mesoderm-inducing factors. After these first inductions of the myogenic 
programme, forming muscles in Xenopus can have different destinies, some of these 
resulting in cell death before adulthood. In particular, during metamorphosis, the 
primary myotomal myofibers completely die and are progressively replaced by 
secondary “adult” multinucleated myofibers (Chanoine & Hardy 2003). 
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1.2.2.1 Muscle formation 
During the development of most skeletal muscles, multinucleate myotubes 
are formed by fusion of many myoblasts (Youn & Malacinski, 1981). However, this 
does not occur during the myogenesis of the primary myotome muscle of Xenopus 
laevis. Here, myoblasts differentiate into uninucleate myocytes (Muntz, 1975; Youn & 
Malacinski, 1981) and later, at the onset of metamorphosis, develop into 
multinucleate muscle fibers. For a long time, the fate of the primary myotomal 
myofibers and the origin of the multinucleated secondary myotomal myofibers have 
been controversial (Muntz, 1975). In 1987, Boudjelida and Muntz strongly suggested 
that multinucleated primary myotomal fibers in Xenopus arise from amitotic division 
of the primary nuclei; hence, without cell fusion, the nuclei of the uninucleate 
myotomal myotubes would be polyploid up to octoploid in this species (Boudjelida & 
Muntz, 1987). This mechanism is mainly responsible for the multinucleation of the 
majority of the primary larval fibers, but it cannot be excluded that some secondary 
migrating myoblasts or some activated satellite cells could take part in the 
multinucleation process. On the other hand, some mononucleated fibers could fuse 
to form multinucleated secondary myotomal myofibers.  
The primary myotome derives from the somites, which in turn come from 
mesoderm tissue that invaginated during gastrulation. Somites are formed 
progressively at the rate of approximately 1.5 per hour from neurula stage 17 
onward. In Xenopus, by far the greatest part of the somite consists of myotome cells 
that will form muscle. A small dorsolateral part of each somite will form skin 
(dermatome) and only the smallest amount nearest the notochord forms the 
sclerotome (Nieuwkoop & Faber, 1967; Gurdon et al, 1998). In Xenopus, the somite 
cells initially orient perpendicular to the axis of the unsegmented paraxial mesoderm, 
then, rotate through 90 degrees to lie parallel to the axis with each primary myotome 
myofiber spanning the length of a single myotome (Hamilton, 1969; Youn & 
Malacinski, 1981). 
 During metamorphosis the primary myotomal myofibers die and are 
progressively replaced by secondary multinucleated myofibers arising from fusion of 
recently migrated adult-type myoblasts (Nishikawa & Hayashi, 1994). These authors 
reported programmed muscle cell death to be important in tail degeneration as well 
as in the larval-to-adult conversion of the dorsal body muscles of Xenopus 
(Nishikawa & Hayashi, 1994). As known so far, Xenopus is thus the only model 
system in which the primary body muscles die and are replaced by new adult 
muscles. The area of muscle cell death expands like a wave from the base of the tail 
to the anterior and posterior sides. 
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1.2.2.2 Signalling in myogenesis 
In Xenopus the activation of the myogenic programme is initiated by the 
members of the MyoD family in the muscle-forming region. Then initiation of 
myogenesis occurs in response to mesoderm-inducing factors. Different members of 
the FGF, TGF-β, and Wnt protein families have been implicated in this process.  
The members of the MyoD gene family, including MyoD, Myogenin, Myf5, 
and MRF4, encode basic helix-loop-helix (bHLH) transcription factors and contain 
one or two transactivation domains (at the N- and C-terminus). Remarkably, these 
factors are able to convert non-muscle cells to a muscle phenotype in culture. These 
myogenic regulatory factors (MRFs) stimulate muscle gene transcription by forming 
heterodimers with ubiquitous bHLH proteins, known as E proteins. These bind to E-
boxes, which are DNA elements of 6bp bearing the CANNTG consensus sequence, 
irrespectively of the nature of the center nucleotides (Arnold & Winter, 1998).  
At the initiation of myogenesis, members of the Wnt family of secreted 
glycoproteins are induced by BMP4 in the dorsal neural tube in mammals (Borello et 
al, 1999). Muscle specification during gastrulation also depends on the repression of 
BMP signalling, as triple depletions of Noggin, Chordin and Follistatin eliminate 
muscle precursor gene expression (Khokha et al, 2005). Shi et al. (2002) reported 
that the Wnt/β-catenin pathway is required for regulating myogenic gene expression 
in the presumptive mesoderm and may directly activate the expression of the myf5 
gene in the muscle precursor cells. These Wnt proteins, in combination with low 
concentrations of Sonic hedgehog (Shh) from the notochord and floor plate, induce 
the epaxial myotome, in which the expression of Pax3, Myf5, MRF4 and 
subsequently MyoD is promoted (see Figure 4 upper panel). Dosch et al. (1997) 
showed that Myf5 expression and muscle differentiation require a low dose of BMP4, 
resulting from superposition of antagonizing BMP4 and noggin proteins in vivo 
(Dosch et al, 1997; Hoppler et al, 1996). This result points out the crucial role of 
secreted molecules involved in mesoderm patterning on MRF regional expression in 
gastrula embryos.  
The ability to induce MyoD is under the control of linker histone proteins, 
which act as transcriptional inhibitors of MyoD induction (Steinbach et al, 1997). 
Indeed, maternal stores of the B4 linker Histone that are assembled into chromatin 
during the early cleavage divisions are replaced by somatic histone H1 during 
gastrulation. This transition in chromatin composition causes selective transcriptional 
silencing of regulatory genes required for mesodermal/muscle differentiation 
pathways (Vermaak et al, 1998). 
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Recent studies have established that induction is mediated by the cAMP-
activated protein kinase A through the activity of the transcription factor CREB. 
CREB phosphorylation enables recruitment of p300. It is of interest to note that mice 
lacking either CREB protein or the acetyltransferase activity of p300 have impaired 
expression of the myogenic bHLH transcription factors, suggesting the possibility that 
CREB and p300, perhaps through direct interaction, might be required for activation 
of the myogenic programme (Chen et al, 2005; Roth et al, 2003; Sartorelli & Caretti, 
2005). 
 
 
 
Figure 4: Models of major interactions in myogenesis  
(Gilbert, 2000;  Sartorelli & Caretti, 2005) 
 
Several pathways are involved in establishing muscle precursor fates. 
First, FGF signalling and Xbra expression are required and maintain each other’s 
expression. By mid-gastrulation the myogenic markers Mespo, Myf5 and MyoD are 
all expressed in an equatorial omega shaped domain similar to the ring domain of 
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xbra and fgf. Depletion of FGF4, FGFR1 or Xbra causes severe reduction in their 
expression (Conlon et al, 1996; Yokota et al, 2003). Myogenin and MRF4 are 
hierarchically downstream of MyoD and Myf5 and are involved in muscle 
differentiation and myofiber formation, respectively Myf5, MRF4 and MyoD can act 
as specification genes, whereas myogenin is required for differentiation of specified 
myoblasts into myotubes, and MRF4 is involved in myofiber formation. Additionally to 
the role of MRF4 in terminal differentiation it seems to act earlier during 
determination as well. Even in the absence of MyoD and Myf5, skeletal muscle is still 
formed as long as MRF4 expression is not perturbed (Kassar-Duchossoy et al, 
2004). Pax7 is required for satellite cell specification (Berkes & Tapscott, 2005; see 
Figure 4 lower panel). 
Myf5 and MyoD can both be detected in pre-somitic mesoderm at the 
transcript level and at the protein level for MyoD (Hopwood et al, 1989; Hopwood et 
al, 1991; Hopwood et al, 1992; Scales et al, 1990). Myogenin expression is found 
later than Myf5 and MyoD. Although Myogenin expression is always associated with 
muscle differentiation in mammals (co-incides with the initial appearance of 
transcripts of the cardiac α-actin gene, the first muscle structural gene to be 
expressed), Xenopus myogenesis displays the peculiar feature that Myogenin is not 
expressed in primary myotome, thus supporting the hypothesis that any other MRF 
(Myf5, MyoD, or MRF4) could play the role of myogenin during Xenopus primary 
myogenesis. In Xenopus, myogenin mRNA expression is restricted to secondary 
myogenesis, including the formation of new muscles in developing limbs, as well as 
in dorsal muscles during body remodeling occurring at metamorphosis (Nicolas et al, 
1998).  
Whereas extensive studies on the expression of Myf5 and MyoD during 
Xenopus myogenesis have been carried out, nothing was known about the spatio-
temporal accumulation of MRF4 transcripts and protein. Whole-mount in situ analysis 
revealed the first nuclear Xenopus MRF4 expression in the more differentiated 
anterior myocytes of the embryo. Mrf4 mRNA accumulation later extended 
posteriorly but was never detected in the posterior unsegmented mesoderm, in 
contrast to MyoD and Myf5 (Della Gaspera et al, 2006).  
 
Muscle determination and differentiation is not an all-or-none process but 
one that occurs gradually and may involve a multitude of signals and responses on 
the transcriptional as well as on the post-transcriptional level. Recent genetic studies 
have demonstrated that also miRNAs are required for both proper muscle 
development and function, with crucial roles for miRNAs being identified in regulating 
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muscle cell proliferation and differentiation. Several miRNA genes, like miRNAs miR-
1, miR-133, miR-206, and miR-208, are specifically expressed or highly enriched in 
skeletal and/or cardiac muscle (Callis et al, 2008). Beside transcription factors and 
miRNAs also RNA-binding proteins gain more and more importance in studying 
developmental processes, like myogenesis. 
 
1.3 RNA-binding proteins and their function 
In eukaryotes, transcription and translation occur in separate 
compartments, the nucleus and the cytoplasm, respectively. This allows eukaryotes 
to carry out extensive post-transcriptional processing of pre-mRNA that produces a 
more diverse assortment of mRNAs from its genome and provides an additional layer 
of gene regulation. Genome-wide studies revealed distinct programmes of RNA 
regulation, suggesting a complex and versatile post-transcriptional regulatory 
network. This network is controlled by specific RNA-binding proteins and/or non-
coding RNAs. Putative RNA-binding proteins comprise 3 – 11% of the proteomes in 
bacteria, archea and eukaryotes. The large number of RNA-binding proteins (RBPs) 
in all domains of life may merely reflect the ancient origin of RNA regulation, which is 
possibly the most evolutionary conserved part of cell physiology (Anantharaman et 
al, 2002). 
RBPs play key roles in post-transcriptional control of mRNAs, which, 
along with transcriptional regulation, is a major way to regulate patterns of gene 
expression during development and adulthood. Eukaryotic cells encode a large 
number of RBPs (thousands in vertebrates), each of which has unique RNA-binding 
activity and protein-protein interaction characteristics (Glisovic et al, 2008). RBPs 
regulate every aspect of RNA function. This activity is mediated by a relatively small 
number of RNA-binding scaffolds whose properties are further modulated by auxiliary 
domains. Recent findings demonstrate that multiple mRNAs that encode functionally 
related proteins are co-regulated by one or more sequence-specific RBPs as post-
transcriptional RNA operons or higher-order regulons (Keene, 2007). Ribonomic 
studies (systematic identification of RNAs associated with specific RBPs) have now 
been conducted for more than 30 specific RBPs. The results from these studies 
generally support and extend the proposed post-transcriptional operon model. Each 
of the analyzed RBPs has an unique RNA-binding spectrum comprised of 20 – 1000 
distinct transcripts that often share functionally related themes. The spectra of targets 
overlap with other RBPs, suggesting combinatorial binding of RBPs (Halbeisen et al, 
2008). 
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RBPs orchestrate and link the different steps of mRNA processing 
including polyadenylation, splicing, mRNA stability, mRNA export, localization, 
translation and finally degradation. In addition, RBP-RNA association is essential to 
recruit catalytic components to sites of RNA modification and to coordinate pre-
mRNA processing with other cellular pathways. 
RBPs have one or more known RNA-binding domains (RBD). 
Approximately one hundred types of RBDs have been described to date. Half of 
them are thought to have originated at early stages in evolution. Such is the K 
homology (KH) domain, SR domain (serin- and arginin-rich), RNA-binding Zinc finger 
(mainly C-x8-C-x5-C-x3-H type), RGG box, cold-shock domain (Y-box proteins), 
DEAD/DEAH box, Pumilio/FBF (PUF) domain, double-stranded RNA-binding domain 
(DS-RBD), Piwi/Argonaute/Zwille (PAZ) domain, Sm domain, etc. Others, such as 
the RNA recognition motif (RRM, also known as RBD or RNP domain) are mainly 
present in eukaryotes (Anantharaman et al, 2002; Glisovic et al, 2008).  
Many RBPs have one or more copies of the same RBD while others have 
two or more distinct domains. Individual RBDs are separated by linker sequences of 
highly variable length. These linkers provide a critical determinant of binding affinity 
and may modulate cis versus trans binding. In many cases, individual RBDs within 
the same protein have different binding specificities, which suggests they may allow 
a single protein to bridge multiple RNAs (trans) whereas in others, multiple RBDs 
interact with non-specific RNA lattice to increase binding affinity (cis) (Shamoo et al, 
1995).  
Several RBDs are suggestive of the molecular function of their RBP; 
DEAD/DEAH box for RNA helicase activity, PAZ domain for short single-stranded 
RNA-binding in RNAi or microRNAs (miRNA) processes, and Sm domain for snRNA-
binding in splicing and possibly in tRNA processing (Lee & Schedl, 2006). 
1.3.1 The RNA recognition motif RRM 
The RNA recognition motif (RRM), also known as the ribonucleoprotein 
domain (RNP) is found abundantly in all life kingdoms, although it exists at a lower 
abundance in prokaryotes and viruses. To date, only 85 proteins containing an RRM 
domain in bacteria (mostly cyano- bacteria), and six proteins in viruses have been 
identified (Maruyama et al, 1999). Prokaryotic RRM proteins are rather small (about 
100 amino acids) and have a single copy of the RRM domain. In eukaryotes, the 
RNA recognition motif is one of the most abundant protein domains. The most 
striking development is seen in vertebrates, which have at least 30 distinct RRM-
domain proteins with no orthologs in arthropods or nematodes and several 
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vertebrate-specific expansions within other ancient ortholog groups of RRM proteins. 
This diversity of RRM proteins correlates with and is probably functionally linked to 
the extensive utilization of alternative splicing as a means of generating protein 
diversity. A similar situation seems to exist in plants because over 50 plant-specific 
RRM proteins were detected in Arabidopsis (Anantharaman et al, 2002). To date, a 
total of 6056 RRM motifs have been identified in 3541 different proteins. In humans, 
497 proteins have been identified containing at least one RRM (Finn et al, 2006). 
Assuming the presence of about 20000 – 25000 protein-coding genes in the human 
genome, the RRM would therefore be present in about 2% of gene products. 
The RRM is an interaction domain, capable of association with RNA, 
homo-/hetero-dimerization with proteins, and rarely with DNA. This small domain is 
able to bind RNA with different affinities and specificities, to interact with RNA of 
different length and to contact several partners at the same time in a sequence 
and/or structure dependent manner.  
RRM proteins containing up to six RRMs have been found in eukaryotic 
proteins. RRMs are often found as multiple copies within a protein (44%, two to six 
RRMs) and/or together with other domains (21%) (Maris et al, 2005). In most 
instances, the RRMs have some basal level of non-sequence specific RNA-binding 
affinity. In addition, many also have a higher affinity for a specific structure or 
sequence of RNA. The most conserved RRM signature sequence is an eight-residue 
motif called ribonucleoprotein 1 (RNP1), which has the consensus [RK]-G-[FY]-[GA]-
[FY]-[ILV]-X-[FY]. A second six-residue region of homology, called ribonucleoprotein 
2 (RNP2), is typically located 30 residues N-terminal to RNP1, and has the 
consensus [ILV]-[FY]-[ILV]-X-N-L. Additional conserved amino acids define an 80-
residue domain that encompasses the RNA-binding function (Adam et al, 1986; 
Dreyfuss et al, 1988; Scherly et al, 1989). 
To date, more than 30 RRM structures have been determined either by 
NMR or X-ray crystallography and reveal unexpected variations. All of the structures 
present intrinsic common features and differences in RNA recognition reflecting the 
remarkable adaptability of this domain in order to achieve high affinity and specificity.  
The common structure of this domain is well characterized by the packing 
of two α-helices on a four-stranded β-sheet. However, the mode of protein and RNA 
recognition by RRMs is not clear owing to the high variability of these interactions. 
Different structural elements of the RRM are important for binding a multitude of RNA 
sequences and proteins. The β-sheet of an RRM remains the primary RNA-binding 
surface illustrated by the structures of U2AF65, 65-kDa subunit of U2 auxiliary 
splicing factor (three RRMs)(Kielkopf et al, 2001) and U2FA35, the small subunit 
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(one RRM) in Figure 5 (Kielkopf et al, 2001). Other examples for the RRM-RNA 
interaction via the β-sheet are the alternative-splicing factors PTB (polypyrimidine-
tract binding protein, four RRMs) (Simpson et al, 2004), and SRp20 (one RRM) 
(Hargous et al, 2006). Interestingly, despite using the same protein surface to bind 
RNA, each of these proteins achieves sequence-specificity in a slightly different 
manner. This structure of human SRp20 recognizes only one single cytosine 
nucleotide sequence-specifically via the β-sheet by Glu79 and Ser81. This specificity 
of the SRp20–RNA interaction allows the binding of this protein to more diverse RNA 
sequences making the evolutionary pressure on the bound RNA weaker (Hargous et 
al, 2006).  
 
 
Figure 5: The RRM structure of U2AF and PARN 
The U2AF35 β-sheet forms the RNA-binding surfaces of canonical RRM-
containing proteins. The PARN-RRM domain with bound m7GTP reveals an extended shape 
with the two C-terminal α-helices α2 and α3 protruding from the protein core. The m7GTP is 
bound on the surface of the N-terminal part of the RRM domain involving the loops 
connecting β2–β3 and β1–α1, respectively (Kielkopf et al, 2001; Monecke et al, 2008).  
 
Moreover, recent structural investigations showed that the interaction of 
RRM with RNA is not restricted to the β-sheet surface and that the loops (especially 
loops 1, 3 and 5) between the α-helices and β-strands appear to be as important as 
the β-sheet for RNA-binding. The β-sheet surface of an RRM appears to have an 
inherent preference for certain RNA sequences. It is possible that a role for the loops 
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of RRMs emerged later in evolution in order to expand the range of RNA target 
sequences that can be bound by an RRM.  
Fox-1 (feminizing locus on X) (Auweter et al, 2006), RBMY (RNA-binding 
motif gene on Y chromosome) (Skrisovska et al, 2007), and PARN (Poly(A)-specific 
ribonuclease) (Monecke et al, 2008) are examples for single RRM proteins in which 
the loops between the α-helices and β-strands are crucial for RNA interactions.  
Poly(A)-specific ribonuclease (PARN) is a processive 3′-exoribonuclease 
involved in the decay of eukaryotic mRNAs. Interestingly, PARN interacts not only 
with the 3′-end of the mRNA but also with its 5′-end. Still, PARN contains only one 
RRM domain that specifically binds both the poly(A) tail and the 7-methylguanosine 
(m7G) cap (Figure 5). The interaction of PARN with the 5′ cap of mRNAs stimulates 
the deadenylation activity and enhances the processivity of this reaction (Monecke et 
al, 2008). 
In many RRMs, a β-hairpin is present between the α2-helix and the β4-
strand. Involvement of this β-hairpin in RNA-binding has been strongly suggested for 
p14, a single RRM protein operating as a subunit of the essential splicing factor 3b 
(SF3b) (Spadaccini et al, 2006) by NMR titration. Other structural studies show that 
amino acids of the β-hairpin are directly hydrogen-bonded to bases of nucleic acid 
targets. 
In Fox-1, RBMY, U2AF35, and p14 the absence of a second RNA-binding 
RRM could explain the enhanced importance of the β-hairpin for interacting with 
RNA. 
 In contrast to the examples mentioned above, most RRM proteins contain 
multiple RRMs that are thought to help achieving higher affinity and specificity 
considering the weak binding affinity of most RRMs in isolation for their RNA targets. 
Indeed, biochemical data with the structure of several tandem RRMs bound to RNA 
(Sex-lethal (Handa et al, 1999), HuD (Wang & Tanaka Hall, 2001), PABP (Deo et al, 
1999)) or DNA (hnRNP A1; Ding et al, 1999) confirmed this initial hypothesis.  
The combination of two or more RRM domains allows the continuous 
recognition of a long nucleotide sequence (8–10 nucleotides), which often drastically 
increases the affinity. But the individual free energies of binding of the RRMs for RNA 
are not strictly additive. While the binding affinity of a multiple RRM containing 
protein might be expected to be the product of the affinities of its isolated RRMs, this 
is not the case with all RBDs, e.g. hnRNP A1 (Shamoo et al, 1994). The linker 
between the RRMs is an important determinant of binding affinity, with a longer 
length and distance decreasing the affinity immensely. Binding affinities between 104 
M-1 and 106 M-1 have been observed for RBDs representative of a typical RBD 
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(Shamoo et al, 1995). Assuming then that each isolated RRM of a hypothetical two 
RRM containing protein has an affinity of 105 M-1 for a nucleic acid ligand, the overall 
apparent affinity is calculated for the subsequent binding of the second RRM to the 
ligand that is already bound by the first RRM of the same protein as follows: if the 
linker length is 0 residues, with a distance of 30Å between both RRMs, the apparent 
affinity is calculated 2.9 x 108 M-1. However, if the linker is 120 residues long with a 
distance of 450Å, the affinity is decreased to 2.0 x 105 M-1 (Clery et al, 2008; Maris et 
al, 2005; Shamoo et al, 1995). 
Besides RRM-RNA associations, protein-RRM interactions have been 
found in several structures reinforcing the notion of an extreme structural versatility of 
this domain supporting the numerous biological functions of the RRM-containing 
proteins (Clery et al, 2008; Maris et al, 2005).  
The p14 subunit of the essential splicing factor 3b (SF3b) within the 
spliceosome contains a single RRM and stably interacts with the SF3b subunit 
SF3b155, which also binds U2AF65. A surprising observation is that the β-sheet 
surface, including residues in the RNP1 and RNP2 motifs, which mediates RNA-
binding in canonical RRMs, forms the binding interface with the SF3b155 peptide. 
Protein p14-RNA interactions are modulated by SF3b155 and the RNA-binding site 
of the p14-SF3b155 complex involves the non-canonical β-hairpin insertion of the 
p14 RRM (Spadaccini et al, 2006). 
 
1.3.2 Post-transcriptional regulation by RRM proteins 
As soon as RNA precursors are formed, RBPs associate with the nascent 
mRNA precursors, form ribonucleoprotein-particles (mRNPs), and mediate and 
couple diverse RNA processing reactions including 5'-end capping, 3'-end cleavage, 
polyadenylation, splicing, and editing. The transcripts are subsequently exported 
through nuclear pores to the cytoplasm where they may undergo localization to 
subcellular regions by complexes consisting of motor proteins and RBPs or by the 
signal recognition particle. The transcripts assemble with translation factors and 
ribosomes for protein synthesis, which is controlled by global or transcript-specific 
mechanisms (Gebauer & Hentze, 2004). Finally, mRNAs undergo exonuclease-
mediated degradation by diverse decay pathways.  
Surprisingly, the many different protein factors that guide mRNA 
modification pathways are composed of a limited number of conserved, modular 
RNA-binding domains. Of these, the RRM proteins with the RRM domain are by far 
the most abundant type of proteins. 
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In the following chapters some post-transcriptional events are described to 
illustrate the complex functions of the RRM-containing RNA-binding protein family. 
 
 
 
Figure 6: Control of gene expression at multiple steps  
(Halbeisen et al, 2008)  
 
1.3.2.1 Polyadenylation 
Polyadenylation occurs during post-transcriptional pre-mRNA processing. 
It is a two-step process: cleavage and poly(A) addition. Both cis-acting elements and 
trans-acting factors (multiprotein complex including cleavage-polyadenylation 
specificity factor, cleavage stimulation factor, cleavage factor, and poly(A) 
polymerase) are required for this process.  
The splicing factor SRp20, for example, (single RRM protein) affects 
recognition of an alternative 3′-terminal exon of a gene that codes for the peptides 
calcitonin and calcitonin gene-related peptide. SRp20 binds to splicing signals within 
the polyadenylation enhancer and increases exon 4 inclusion in vivo. This is the first 
indication that a canonical SR protein can influence polyadenylation and suggests 
that other SR proteins could play a general role in recognition of 3′-terminal exons, 
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thereby providing a link between the splicing and polyadenylation machineries (Lou 
et al, 1998). 
1.3.2.2 Splicing 
Pre-mRNA splicing is an essential step in gene expression that occurs co-
transcriptionally in the cell nucleus. Splicing in general (and alternative pre-mRNA 
splicing) includes or excludes (different) portions of a nascent transcript into the final 
protein-coding mRNA. Splicing is catalyzed by a large number of RNA-binding 
protein splicing factors, in addition to core spliceosome components.  
Splicing factors are localized to the nucleus in dynamic nuclear organelles 
(without a membrane) termed speckles. The presence of additional speckle-
associated proteins is required for the release of splicing complexes from speckles, 
thereby affecting pre-mRNA splicing and mRNA export. Speckle structure and 
function is controlled by phosphorylation, where serine phosphorylation of SR 
proteins controls both their association with the spliceosome and their recruitment 
from speckles to active sites of transcription (Handwerger & Gall, 2006). 
Some protein splicing factors, such as the U2 small nuclear RNP auxiliary 
factor (U2AF) associate with specific subsets of spliced mRNAs. U2AF is a highly 
conserved heterodimeric essential splicing factor, composed of a 65kDa (three 
RRMs) and a 35kDa (one RRM) subunit, with a well-characterized role during the 
early steps of spliceosome assembly. U2AF transient interaction with the pre-mRNA 
leads to the subsequent assembly of an active spliceosome complex. Genome-wide 
identification of cellular mRNAs associated to U2AF65 revealed around 5000 targets 
encoding transcription factors and cell cycle regulators (Berglund et al, 1998; Gama-
Carvalho et al, 2006; Wu et al, 1999; Zorio & Blumenthal, 1999). 
1.3.2.3 mRNAexport 
Compared to most nuclear trafficking pathways, mRNA export is unique in 
employing primarily the TAP:p15 heterodimer (transcription export; TREX). The 
TREX complex is recruited to the mRNAs by the splicing machinery (Reed & Cheng, 
2005; Stewart, 2007).  
SRp20 was found not only to bind to an mRNA export element from the 
intronless histone H2a gene, but also enhance the export of RNAs containing the 
element. Further, SRp20 associates with poly(A)+ RNA in both the nucleus and the 
cytoplasm of mammalian cells. Moreover, three shuttling SR proteins can provide 
adapter function by recruiting the general export receptor NXF1/TAP to mRNAs 
(Huang et al, 2003).  
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Mechanisms used to transport and anchor RNAs in the cytoplasm include 
vectorial transport out of the nucleus, directed cytoplasmic transport in association 
with the cytoskeleton, and local entrapment at particular cytoplasmic sites. The 
majority of localized RNAs are targeted to particular cytoplasmic regions by cis-
acting RNA elements; these are almost exclusively located in the 3'-untranslated 
region (UTR). Moreover, asymmetric distribution of RNA can also be established by 
the active transport of RNAs via RBP-motor protein complexes (Halbeisen et al, 
2008; St Johnston, 2005). 
1.3.2.4 mRNA stability/degradation 
The level of an mRNA in the cytoplasm represents a balance between the 
rate at which the mRNA precursor is synthesized in the nucleus and the rates of 
nuclear RNA processing, export and cytoplasmic mRNA degradation. In eukaryotic 
cells, degradation of bulk mRNA occurs by two alternative pathways, both of which 
are preceded by removal of the poly(A) tail by deadenylases. Following this first rate-
limiting step, mRNAs can undergo 3' to 5' exonucleolytic decay, which is catalysed 
by the exosome. The exosome activity is regulated by the SKI complex. Alternatively, 
after deadenylation, the cap structure is removed by the decapping enzyme DCP2, 
rendering the mRNA susceptible to 5' to 3' digestion by XRN1 (Houseley et al, 2006; 
Parker & Song, 2004). 
Strikingly, all proteins that function in the 5' to 3' mRNA-decay pathway 
have recently been shown to localize to P bodies. P-body components dynamically 
exchange with the cytoplasmic pool, which indicates that decay enzymes and co-
factors are not confined to P bodies. Also the exosome and SKI-complex 
components are not detected in P-bodies, indicating a degree of 
compartmentalization of mRNA-degradation pathways within the cytoplasm 
(Kedersha et al, 2005).  
The rate of mRNA decay is regulated by the interaction of cis-acting 
elements, like the AU-rich elements (ARE), in the transcripts and RBPs. AREs are 
conserved sequences found in the 3'-UTR of nearly 5% of all human genes. These 
sequences are targets of many ARE-binding proteins; some of which induce 
degradation whereas others promote stabilization of the mRNA, such as HuR 
(Barreau et al, 2005). 
The regulation of mRNA stability is the most well known molecular function 
of Hu proteins (four RRMs). Hu proteins bind to the 3'-UTRs of target mRNAs and 
prevent their degradation, thus indirectly enhancing protein production. Numerous Hu 
mRNA stabilization targets have been identified (Brennan & Steitz, 2001; Pascale et 
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al, 2008). Hu proteins appear to stabilize target mRNAs by antagonizing the actions 
of destabilizing proteins, such as TTP or AUF1 (Barreau et al, 2005). 
1.3.2.5 mRNA translation 
Translational regulation concerns the differential recruitment of mRNA 
species to the ribosome for protein synthesis, which results in a lack of correlation 
between the relative amounts of mRNA and the amount of the encoded protein. 
The 5'-cap and the poly(A) tail of the transcripts synergistically stimulate 
translation. The poly(A)-binding protein (PABP) contains four N-terminal RRMs and 
requires a minimum of 12 adenosine residues to bind RNA. PABP interacts with the 
translation initiation factor eIF4G. This PABP-eIF4G interaction results in the 
circularization of an mRNA and serves as a means to confirm the integrity of a mRNA 
and promotes the recruitment of the 40S ribosomal subunit (Cheng & Gallie, 2007).  
Stress granules, for example, are sites of translational regulation. They are 
specific structures in the cytoplasm that accumulate non-canonical 48S initiation 
complexes and contain mRNPs, 40S subunits and some initiation factors. It is 
proposed that TIA-1/TIAR (shuttling nucleocytoplasmic RBP containing three RRMs) 
forms aggregates used as a scaffold for other components of stress granules. Stress 
granules arise under stress conditions (e. g. heat shock, UV irradiation, energy 
depletion and oxidative stress) and appear as centers that sort, remodel and export 
specific mRNPs for re-initiation, decay or storage (Mollet et al, 2008). 
The cold-inducible RNA-binding protein CIRP (hnRNP A18) contains one 
RRM and several repeats of the RGG motif. In response to stress CIRP migrates to 
the cytoplasmic stress granules, where translation initiation is stalled, and acts as a 
translational repressor. This migration occurs in a TIA-1 independent manner but 
requires methylation-dependent nuclear export of CIRP (Aoki et al, 2003; De Leeuw 
et al, 2007).  
1.3.3 RRM proteins in differentiation 
Differentiation programmes must be continuously coordinated in the 
embryo and adult. The activity of genes involved in differentiation direct the initial 
assignment of cells into specific lineages during early stages of embryonic 
development. The determination of different cell types (cell fates) involves 
progressive restrictions in their developmental potentials. Tissue differentiation 
occurs at later stages after cellular determination, as the cell elaborates a cell-
specific developmental programme (e.g. muscle cells). 
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Differentiation should be able to simultaneously regulate the expression of 
many genes and on the other hand it should be sensitive and responsive to external 
cellular signals. Such requirements could be fulfilled by both transcriptional and post-
transcriptional regulation. Although, differentiation programmes relie on the 
hierarchical expression of specific transcription factors, parts of these processes are 
also dependent on regulation at the level of RNA, rather than DNA. In 
embryogenesis this is primarily because the zygotic genome is often quiescent 
during the early stages. Notably, regulation at the RNA level might be beneficial in 
terms of the ability to respond rapidly to signals and to modulate the levels of existing 
RNA populations in accordance with the temporal requirements within a given tissue. 
Such a mechanism could therefore contribute to the selective and regulated 
expression of gene products whose transcription has already been activated. RBPs 
that direct different steps of RNA metabolism during development are often similar to 
ubiquitously expressed RBPs that are involved in general mRNA processing.  
1.3.3.1 RNA-binding proteins as developmental regulators 
One example is the ELAV (embryonic lethal abnormal visual system)/Hu 
protein family in Drosophila, human, mouse, zebrafish and Xenopus. ELAVs possess 
three RRMs that mediate binding with high affinity and specificity to ARE-containing 
target mRNAs. They have been reported to target mRNAs encoding proteins 
important for neuronal differentiation. However, HuR regulates the stability of target 
myogenic mRNAs during muscle cell differentiation. HuR is initially transported to the 
nucleus in early myogenesis, but later accumulates in the cytoplasm where it 
enhances myogenin and myoD mRNA stability. The disruption of the transportin-2 
(TRN2)-HuR complex at late stages of myogenesis leads to its cytoplasmic 
accumulation, as well as to the stabilization of myoD and myogenin messages, 
resulting in higher efficiency of muscle differentiation (Figueroa et al, 2003; van der 
Giessen & Gallouzi, 2007). An interesting feature is that without RRM3, HuR proteins 
cannot oligomerize on their target mRNAs, weakening their ability to prevent mRNA 
decay (Anderson et al, 2000; Fan & Steitz, 1998). 
ElrA, a member of the ELAV family, and the Xenopus homologue of HuR, 
functions in polyadenylation and stabilization. ElrA is present at all times during 
Xenopus development and was previously shown to bind to two different maternal 
mRNAs in Xenopus embryos, polypeptide chain release factor Cl2 and the activin 
receptor actR mRNAs, in a manner dependent on the presence of their embryonic-
specific consensus sequences. In contrast, new findings show that ElrA binds 
specifically to the cyclin E1 3′-UTR independently of its adenylation state. ElrA has 
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been shown to protect the deadenylated mRNA from degradation in vitro, in 
association with the Xenopus cold-inducible RNA-binding protein CIRP (Aoki et al, 
2003). Consistent with a role for ElrA in regulating cyclin E1 mRNA, it was recently 
shown that its human homologue HuR binds to and stabilizes the mRNA encoding 
human cyclin E1 (Guo & Hartley, 2006; Slevin et al, 2007).  
Another example is the single RRM protein ePABP2 (embryonic poly(A) 
binding protein) in Xenopus. ePABP2 is involved in poly(A) elongation, which 
functions as a translational switch to control the synthesis of key regulatory proteins 
that drive the cell cycle and promote cell-fate decisions in early embryos, such as c-
mos, the cyclins and wee1. ePABP2 contains a central RRM with significant amino 
acid sequence identity (72%) with the RRMs of nuclear PABP2 proteins (ubiquitously 
nuclear expressed) from human, mouse, and Xenopus. Nevertheless, ePABP2 
differs from the previously described nPABP2 in that it is located primarily in the 
cytoplasm of Xenopus oocytes. Both ePABP2 protein and its mRNA are detected 
predominantly during oogenesis and during the earliest stages of development.  
They decline after the onset of zygotic transcription and are later expressed in adult 
ovarian tissue (Good et al, 2004). 
1.3.3.2 Regulation of localized RNAs in pattern formation 
In Xenopus, only five hours after fertilization zygotic transcription 
commences at MBT. This means that the first patterning events occur exclusively 
without transcription, depending on other regulatory mechanisms, such as maternal 
mRNA localization. 
RNA localization generally refers to the transport or enrichment of subsets 
of mRNAs to specific subcellular regions generating cell polarity through the spatial 
restriction of gene expression. Cytoplasmic RNA localization is an evolutionary 
ancient mechanism for producing cellular asymmetries. The maternal contribution of 
RNA is a special feature of RNA localization and is crucial to patterning early 
development; initially silent in the oocyte, these transcripts are translated after 
fertilization and guide the early steps of development, like germ layer formation. RNA 
localization can be achieved passively by local protection from degradation or 
through the trapping/anchoring at specific cellular locations.   
RNAs are localized to the vegetal pole of Xenopus oocyte by three 
different pathways. First, the early or METRO pathway uses the mitochondrial cloud 
(Balbiani body) to deliver RNAs, and germinal granules (collectively called the germ 
plasm) to the vegetal pole in early oogenesis. Second, the late pathway operates in 
late oogenesis and uses microtubules and molecular motors. Third, the intermediate 
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pathway uses a combination of early and late pathways to deliver RNAs to the 
vegetal pole of the oocyte (Kloc & Etkin, 2005).  
Localization of selected maternal mRNAs has been observed in other 
species as well. In Drosophila melanogaster e.g. bicoid, gurken, nanos, and oskar 
mRNAs are all targets of Vg1RBP/Vera and determine the body axes. Vg1RBP/Vera 
belongs to the VICKZ proteins, a highly conserved family of RBPs containing two 
RRMs and four KH domains (Yisraeli, 2005). Bicoid and oskar are also targets of 
Staufen (RBP with double-stranded RNA binding motif), and Bruno (a single RRM 
protein). Bruno also interacts with oskar mRNA (Yisraeli, 2005). In zebrafish vasa, 
nanos1, and dazl co-localize with the mitochondrial cloud in the germ plasm and are 
transported to the vegetal cortex during early oogenesis (Kim-Ha et al, 1995; Kosaka 
et al, 2007). 
A growing number of spatially localized mRNAs in Xenopus oocytes have 
been shown to be required for normal embryonic patterning, including VegT, Vg1, 
and Wnt11. Wnt11, for example, is localized to the vegetal pole by the early pathway. 
No mouse or human orthologs for VegT have been identified, but a VegT ortholog 
has been reported in the tunicate C. intestinalis (Showell et al, 2004).  
In Xenopus, Vg1 was the first mRNA reported to be localized at the oocyte 
vegetal cortex (Melton, 1987). In the late pathway of RNA localization Vg1 is 
specifically recognized by Vg1RBP/Vera forming an RNP complex in the nucleus 
followed by export and localization (Deshler et al, 1997; Schwartz et al, 1992). 
Today, many different RNAs are known to be localized at the vegetal cortex such as 
Vg1; the Xenopus homologue of Bicaudal-C (Wessely & De Robertis, 2000), and the 
T-box family member VegT (Xanthos et al, 2001; Zhang et al, 1998) are involved in 
mesoderm and/or endoderm formation (see chapter 1.2.1.2.). 
ElrB, another Xenopus ELAV family member, closely related to ElrA, binds 
to and translationally represses the maternal vg1 mRNA during Xenopus oocyte 
maturation by binding to the VTE element in the 3′-UTR of vg1 (Colegrove-Otero et 
al, 2005). 
1.3.4 Seb4 subfamily members in Xenopus 
In Xenopus several RRM proteins have been identified though in most 
cases their function and mechanism are still unknown. Most of these RBPs contain 
more than one RRM (e.g. Elav/Hu family, etc.). But there are also few proteins, that 
contain only a single RRM, like mentioned above, e.g. ePABP2, three homologues of 
CIRP, and a small evolutionary conserved subclass including Hermes, Seb4R, and 
Seb4 (Figure 6). 
Introduction  
 
 
26
Hermes (heart RRM expressed sequence) was originally identified as a 
mRNA encoding a single RRM protein expressed in the developing heart, kidney, 
eye, and epiphysis in Xenopus embryos. It was demonstrated, that myc-tagged 
Hermes protein was able to associate to poly(A)+ RNA in oocytes. When deletion 
constructs of Hermes were tested, only the full-length Hermes protein could 
associate with poly(A) RNA in vivo, neither the N-terminal RRM nor the C-terminal 
half of the protein were sufficient enough to bind to RNA (Gerber et al, 2002; Gerber 
et al, 1999). In situ analysis revealed that embryos overexpressing Hermes show 
greatly reduced expression of the precardiac marker nkx2-5 and myocardial 
differentiation markers, including troponin (TnIc) and cardiac α-actin, whereas muscle 
gene expression in the somites, and overall somite morphology, was left unaffected. 
Overexpression of Hermes also led to a strong down-regulation of the kidney pre-
differentiation marker, Xpax-2 (Gerber et al, 2002). 
Hermes is found, sometimes as multiple spliced forms, in many different 
species such as frog, fish, chicken, mouse, and human (Gerber et al, 1999; Wilmore 
et al, 2005), but its function remains unknown. During Xenopus oogenesis hermes 
mRNA and Hermes protein localize in the vegetal cortex of the oocyte. A 
subpopulation of Hermes protein is concentrated in a specific structure in the vegetal 
cortex, the germplasm, where Hermes protein co-localizes with Xcat2 and 
RINGO/spy mRNAs. The overall level of Hermes protein decreases during meiotic 
maturation and is barely detected in embryos until the tailbud stage. Injection of 
Hermes antisense morpholino oligonucleotides accelerates the process of oocyte 
maturation and results in cleavage defects in vegetal blastomeres of the embryo 
(Zearfoss et al, 2004). RNA-immunoprecipitation (RIP) studies showed that myc-
tagged Hermes protein functionally, and/or physically interacts with RINGO/spy, mos, 
and Xcat2 mRNAs in vivo. The translation of RINGO/spy, mos, and Xcat2 mRNAs is 
repressed in oocytes, an event critical to normal development. Hermes negatively 
regulates the translation of these mRNAs and therefore, plays an important 
regulatory role during maturation, cleavage and germ cell development (Song et al, 
2007). 
In 1998, Heinrich Jasper from our laboratory identified a cDNA coding for the 
Xenopus orthologue of mouse SEB4 (named after the Staphylococcal aureus 
enterotoxin B) as a direct target of MyoD in a suppression PCR-screen for novel 
MyoD targets (Jasper, 1998). Overexpression studies revealed that Seb4 induced 
efficiently ectopic skeletal muscle gene expression in uninduced animal cap explants. 
In 2000, seb4b the non-allelic gene copy of seb4a was cloned and characterized by 
Ingrid Fetka (Fetka et al, 2000). The seb4a and seb4b gene copies encode each a 
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single RRM-containing protein with the Seb4a protein encompassing 225 and the 
Seb4b protein encompassing 227 amino acid residues. Xenopus Seb4 shares 65% 
identity with mouse Seb4 and 62% with its human counterpart (RNPC1) and 43% 
identity with C. elegans T22B2.4. Xenopus Seb4 transcripts are present at all stages 
from the oocyte to the late tadpole. By RT-PCR it was shown that before zygotic 
transcription is initiated, seb4 mRNA is maternally contributed to the early embryo. In 
the early gastrula embryo Seb4 is expressed in the paraxial mesoderm that is fated 
to give rise to the somites. Seb4 mRNA expression is also found in the heart, the 
lens and the otic vesicle (Fetka et al, 2000).  
 
 
 
Figure 7: Seb4 subfamily 
(A) Model of the Seb4 closest related single RRM proteins illustrating the 
conserved motifs and their suggested function. (B-D) In situ hybridization in Xenopus embryo 
against (B) seb4 (Fetka et al, 2000), (C) seb4R (Boy et al, 2004), and (D) hermes (Gerber et 
al, 1999). 
 
 
In 2004, a Seb4-related protein Seb4R was characterized in Xenopus as a 
putative RBP with a single RRM. Seb4R exists as a maternal protein, as well as a 
zygotic protein. Seb4R transcripts are present at all stages from the oocyte to the 
late tadpole. Maternal Seb4R is localized to the vegetal pole. Recently, it was found 
that ectopic Seb4R acts as a positive regulator of vegT mRNA stability and 
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translation leading to a role for maternal Seb4R in endoderm and mesoderm 
formation (Souopgui et al, 2008).  
At gastrula stage (st. 10.5), zygotic Seb4R expression is exclusively 
restricted to the mesoderm. At stage 20, Seb4R expression clearly follows the 
formation of the central nervous system, including the expression in the area 
designated to form the eye, olfactory placodes, forebrain, midbrain, hindbrain and 
spinal cord. In stage 32 embryos, Seb4R is strongly expressed in the central nervous 
system, and particularly in the subventricular zone of the neural tube, an area 
containing specified neuroblasts (Boy et al, 2004). Overexpression experiments of 
ectopic Seb4R demonstrated a pro-neural effect of Seb4R on all neuronal tissues 
promoting early neural differentiation. Blocking Seb4R function using Morpholino 
oligonucleotides leads to the opposite effect. Seb4R is found to be upregulated by 
the pro-neural marker Neurogenin and the differentiated marker NeuroD, but 
inhibited by the Notch/Delta signal transcription cascade (Boy et al, 2004).  
 
Seb4 and Seb4R contain a single RRM in the N-terminal part and two 
additional conserved domains in the C-terminal part of the protein. Seb4 shows an 
overall amino acid sequence similarity to Seb4R of 73% and an RRM similarity of 
98%. Despite the high degree of similarity of Seb4 to Seb4R on the sequence level, 
Seb4 is clearly distinct from Seb4R in its expression pattern. Yet, when Seb4 was 
ectopically overexpressed in the retina, it was even found to cause the same effects 
in the retina as Seb4R did (Boy et al, 2004). 
The functions of Seb4, in particular in muscle, still remain elusive. 
 
1.4 Objectives 
Global coordination of gene expression not only depends on 
transcriptional regulation, but also to a large extent on post-transcriptional events. 
Besides general roles in the control of RNA metabolism RRM-containing proteins 
have been implicated in different tissue-specific processes during embryonic 
development and the significance of post-transcriptional mechanisms for the 
regulation of cell differentiation becomes more and more evident.  
Despite extensive studies in muscle formation, some aspects of the 
myogenic specification process are still largely unknown. This includes the signals 
and regulators involved in primary activation of the myogenic master regulators 
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MyoD and Myf5, as well as the downstream mechanisms by which MyoD and Myf5 
stabilize the muscle cell fate. 
The discovery, from our laboratory, that the RNA-binding protein Seb4 is 
an early MyoD target raises the possibility that MyoD promotes muscle differentiation 
through post-transcriptional mechanisms. This view has also been substantiated by 
the finding that Seb4 is capable of inducing ectopic skeletal muscle. 
 The main goal of this work was to analyze Seb4 in Xenopus embryos 
biochemically and biologically in the context of myogenesis. A biochemical 
characterization of Seb4 has not been shown to date and should be supported by the 
generation and use of specific antibodies against Seb4 for protein detection 
supporting many different experimental approaches. The search of interacting 
proteins and RNA targets could also shed more light on its biological function. 
Another important issue that should be investigated was protein expression pattern 
and the cellular localization of Seb4. 
The biological characterization included the generation of Seb4 mutant 
phenotypes by depletion of endogenous Seb4 protein levels in the embryo and the 
analysis of affected marker genes to find out more about Seb4 and its role in muscle 
differentiation. 
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2  Material and Methods 
2.1 Laboratory Equipment 
The subsequent laboratory equipments were used. The companies are put 
in brackets. 
 
CCD camera: ProGres C14 (Zeiss) 
Centrifuges: Eppendorf centrifuge 5417C (Eppendorf); Omnifuge 2.0 RS (Haereus); 
Sorvall RC-5B (Du Pont), Micro 22R (Hettich Zentrifugen), Optima MAX-E 
Ultracentrifuge (Beckman), PicoFuge (Stratagene) 
Developer: Curix-60 (Agfa) 
Glass injection needles: Glass 1BBL W/FIL 1.0 mm (World Precision Instrument). 
Injector: Pli-100 (Digitimer Ltd.) 
Incubator: Driblock DB1 and DB20 (Teche) 
Microneedle Puller: P-87 (Sutter Instrument). 
Micromanipulator: Mm-33 (Science Products) 
Microscopes: Stereomicroscopes Stemi SV6, Stemi SV11 (Zeiss), MZFCIII (Leica), 
Axiophot (Zeiss), Axiovert 200M (Zeiss) 
Nylon membrane: Hybond™ N (Amersham) 
pH-Meter: pH-Meter 761 Calimatic (Knick) 
Pipetes: Pipetman, Gilson (2µl, 20µl, 200µl, 1000µl) 
Software: Photoshop CS2 (Adobe); Illustrator CS2 (Adobe); MacVector 7.1 (Oxford 
Molecular Group); Office 2004 for Mac (Microsoft), Endnote 9.0 (Thomson), 
QCapture Imaging (Zeiss/Axiophot), BASreader and Aida Image analyser415 
Software (Phospho-Imager) 
Sonicator: Bioruptor™ (Diagenode), Branson Sonifier 
Spectrophotometer: GeneQuant II (Pharmacia Biotech), Nanodrop ND-1000 
(PeqLab) 
Thermocycler: Primus 96 plus (MWG), Gene Amp PCR System 9700 (Applied 
Biosystems) 
UV-crosslinker: (Stratagene) 
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2.2 Reagents 
2.2.1 Chemicals 
 Agar (Difco); Agarose (Gibco/BRL); Ampicillin, Streptomycin, Bacto trypton, 
Yeast extract (Difco); Chicken serum, lamb serum (Gibco/BRL); Human chorionic 
gonadotropin (Sigma); Levamisol (Vector Laboratories); QIAzol (QIAgen). 
The fine- and bio-chemicals were ordered at the following companies: Fluka, 
Merck, Sigma-Aldrich, Roth, Biomol. 
2.2.2 Proteins and enzymes 
The following proteins/enzymes were ordered at the companies put in 
brackets:  
 
Alkaline phosphatase (Roche); BSA fraction V, Chymostatin, Leupeptin, Pepstatin 
(Sigma); DNase I (Stratagene); Klenow enzyme (Roche); RevertAid™ M-MuLV 
Reverse Transcriptase (Fermentas); Restriction endonucleases with 10x restriction 
buffer system (NEB, Roche, Fermentas); RNaseA (Sigma); RNasin (Promega); T3, 
T7 and SP6 RNA polymerase with 5x incubation buffer (Promega); Taq DNA 
polymerase with 10x PCR buffer (NEB); Proteinase K (Sigma); RNase free DNase I 
(Promega); Precision Plus Protein Prestained Standard (Biorad). 
 
2.3 Antibodies 
2.3.1 Primary antibodies 
The rat monoclonal antibodies were generated in collaboration with Dr. 
Elisabeth Kremmer, GSF München. The polyclonal rabbit antibodies against Seb4 
were generated at BioGenes GmbH, Berlin. 
The SF3b155, X DRSP, X NO-66, X NO-38 and X AND-1 antibodies were 
kind gifts from Prof. Marion Schmidt-Zachmann, deutsches Krebsforschungszentrum 
dkfz, Heidelberg. 
 
antibody host species, subclass marker for application, dilution 
X Seb4 6E5 mono rat serum, IgG2a striated muscle, lens, 
heart 
ICC: 1:1000, WB: 1:10,  
IF: undiluted, IP 
X Seb4 8B3 mono rat serum, IgG2a   
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X MyoD 7F11 mono rat serum, IgG2a striated muscle WB: 1:10, IP 
X PGDS 7D12 mono rat serum, IgG2a β-Catenin WB: 1:10, IP 
hu Serin 2  mono rat serum RNA Polymerase II 
(active) 
IF: 1:10 
X Seb4 7600 poly rabbit serum striated muscle, lens, 
heart 
ICC: 1:1000, WB: 
1:8000 
X Seb4 7601 poly rabbit serum   
SF3b155 guinea pig splicing speckles IF: 1:100-200 
X DRSP guinea pig splicing speckles IF: 1:500 
X NO-66 mono mouse ascytes nucleolus IF: 1:500 
X NO-38 mono mouse ascytes nucleolus IF: 1:3000-5000 
X AND-1 mono mouse ascytes nuclearplasm IF: 1:500 
X Lamin mono mouse ascytes inner nuclear envelope IF: 1:1000 
α-Tubulin mono mouse ascytes, 
sigma 
microtubuli, cytoplasm IF: 1:100, WB: 1:1000 
hu WG16 mono mouse serum RNA Polymerase II 
(active and inactive) 
IF: 1:10, WB: 1:50 
Histone H3  rabbit, Abcam H3 core region WB: 1: 1000 
 
2.3.2  Secondary antibodies 
antibody conjugate company dilution 
sheep anti-digoxygenin fab alkaline phosphatase Roche ISH: 1:2500 
sheep anti-mouse IgG alkaline phosphatase Chemicon ICC: 1:1000 
anti-rabbit IgG Fc alkaline phosphatase Promega ICC: 1:1000 
goat anti-rat IgG + IgM alkaline phosphatase Dianova ICC: 1:1000 
goat anti-mouse IgG peroxidase Dianova WB: 1:10000 
goat anti-rat IgG + IgM peroxidase Dianova WB: 1:5000 
goat anti-rabbit IgG peroxidase Dianova WB: 1:10000 
rabbit anti-rat IgG Alexa-fluor 488 Invitrogen IF: 1:100 
goat anti-mouse IgG Alexa-fluor 594 Invitrogen IF: 1:200 
donkey anti-guinea pig IgG Cy-2 Dianova IF: 1:200 
donkey anti-rat IgG Rhodamin red X Dianova IF: 1:100 
donkey anti-mouse IgG Cy-2 Dianova IF: 1:200 
donkey anti-mouse IgG Rhodamin red X Dianova IF: 1:200 
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2.4 Oligonucleotides 
Primers were synthesized by Biomers (http://www.biomers.net/de) and 
Morpholino oligonucleotides were ordered from Gene Tools (http://www.gene-
tools.com/vivomorpholinos). 
2.4.1 Primers for Seb4 cloning  
Seb4 full length: HJ37 + HJ40 
HJ37 for; EcoRI, XhoI, start 
5'-CGAATTCACTCGAGGGCAAGATGCACACCA-3' 
 
HJ40 rev; XbaI, stop 
5’-GGTCTAGACTAAGCGCTATTGCATGCGGT-3’ 
 
Seb4 subcloning: 
RR175 for; XhoI, start 
5’-CCGCTCGAGGGCAAGATGGCAAATGTGAATCTTHGCATA-5’ 
RR176 rev; stop, XbaI  
5'-GGTCTAGACTATGCTCCCAGGTATGCAAG-3'  
SO3 rev, stop, XbaI 
5'-AGATCTCTACTTCCTGAGGCTGGA-3'  
SO4 for; EcoRI  
5'-GAATTCATCCAGCCTCAGGAAG-3'  
SO5 rev; stop, XbaI 
5'-AGATCTCTAAGCTCTGTCTGCCAT-3 
SO6 for; EcoRI 
5'-GAATTCAATGGCAGACAGAGCT-3'  
 
construct 12: HJ37 + SO3; product size 93bp 
construct 34: SO4 + SO5; product size 117bp 
construct 56: SO6 + RR176; product size 96bp 
construct 14: HJ37 + SO5; product size 206bp 
construct 36: SO4 + RR176; product size 197bp 
delta C: HJ37 + RR176; product size 290bp 
delta N: RR175 + HJ40; product size 446bp 
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2.4.2 Primers for RT-PCR 
Random Hexamer: 
RR13: 5' - NNNNNC -3 ' (N = G, A, T or C) 
 
Oligo (dT)18: 
5’-TTTTTTTTTTTTTTTTTT-3’ 
 
XHistone H4; annealing temperature 55°C, 23 cycles 
for 5' - CGGGATAACATTCAGGGTATCACT -3 ' 
rev 5 ' - ATCCATGGCGGTAACTGTCTTCCT -3  
 
XGAPDHb; annealing temperature 55°C, 23 cycles 
for 5’- TGAGCGGTAAAGTTCAAGTCGTC -3’ 
rev 5’- CACTACATACTCGGCACCAGCATC -3’ 
 
XSeb4R; annealing temperature 58°C, 28 cycles 
for 5'-GGAACCTGCAGAGCGCATTTACTA-3',  
rev 5'-GTCAGGCTGGAGCTGTTGAGGCTG-3', 
 
XSeb4 HJ 26/27; annealing temperature 58°C, 28 cycles 
for 5’-GGGCTATGGCTTTGTCACAATGGCAGAC- 3’ 
rev 5’-GCTGAACACCAAATGCAAAACCTGGCTG -3’ 
 
2.4.3 Morpholino oligonucleotides 
Seb4 MO: 5’-AAGATGCACACCACACAGAAGGACA-3’ 
Standard control MO: 5’-CCTCTTACCTCAGTTACAATTTATA-3’ 
 
2.5 Plasmids 
pBS (Stratagene) 
pCS2+ (Rupp et al, 1994) 
pCS2+MT6 (Rupp et al, 1994) 
pCS2+ FLAG (Cabot, R.) 
pET-M30 (Novagen) 
pGEX 4T3 (Pharmacia) 
pGEM-T (Promega) 
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pCS2+XSeb4 (Jasper, H.) 
pCS2+mut-XSeb4 (Cabot, R.): seven nucleotide substitions downstream of 
ATG start codon; position 4-10 WT sequence of CACACCA is deleted 
and substituted by GCAGGAG  
pCS2+XSeb4-flag (Cabot, R.) 
pCS2+mut-XSeb4-flag (Cabot, R.) 
pGEXGst-XSeb4 (Mansperger, K.) 
pCS2+MT6-Seb4 construct 12 (Oberleitner, S.) 
pCS2+MT6-Seb4 construct 34 (Oberleitner, S.) 
pCS2+MT6-Seb4 construct 56 (Oberleitner, S.) 
pCS2+MT6-Seb4 construct 14 (Oberleitner, S.) 
pCS2+MT6-Seb4 construct 36 (Oberleitner, S.) 
pCS2+MT6-Seb4-delta C (Authaler, A.) 
pCS2+MT6-Seb4-delta N (Authaler, A.) 
pCS2+XSeb4R (Boy et al, 2004) 
pCS2+XMyoDb (Rupp et al, 1994) 
pCS2+TCF1-flag (Mansperger, K.) 
pBluescript-KS-XMLC35 (Theze et al, 1995) 
pBluescript-Nrp1 (Richter et al, 1990) 
pGEM-T-α-crystallin (Winkler, M.) 
pBluescript-SK-Troponin (Drysdale et al, 1994). 
EF1α (Frydenberg et al, 1991) 
 
2.6 Biological material 
E. coli strains: 
BL21(DE3): B F- dcm ompT hsdS(rB- mB-) gal (DE3); (Novagen) 
XL1Blue: F'::TN10 proA+B+laclq Δ(lacZ)M15/recA1 end A1 gyrA96(NalR) thi hadR17 
(rK-mK-) glnV44 relA1 lac; (Stratagene) 
 
Xenopus laevis (Nasco, Xenopus Express): 
Adult wild-type Xenopus laevis frogs were used. The frogs were kept in tap 
water with a temperature of 17-19°C and a population density of one frog per 5l 
water. The animals were fed three times per week with Pondsticks Premium brittle 
(Interquell GmbH, Wehringen). 
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XTC and A6 culture cells (ATCC, LGC-Promochem): 
Cells were cultured in DMEM medium, 15% ddH2O, 15% fetal bovine 
serum, at 26°C in 26mm Petri dishes. A6 cells were subcultured with 0.25% trypsin 
and 0.03% EDTA for cell detachment. Medium was renewed twice per week, when 
cells were split in a dilution 1: 1 or 1: 2 according to their confluency.  
 
2.7 Molecular biological methods 
2.7.1 Solutions 
Antibody solution: 80% TBSX, 15% heat-inactivated lamb serum, 5% Xenopus egg 
extract 
 
Staining solution: BM-Purple solution (Boehringer) ready to use;  
BCIP 5-Bromo-4-Chloro-Indolylphosphate, (Biomol) 
NBT Nitroblue Tetrazoliumchloride (Biomol) 
3.5µl BCIP (in 100% Dimethylformamide, stored at -20°C) and 4.5µl NBT (in 70% 
Dimethylformamide, stored at -20°C) added to 1ml AP-Buffer 
 
Egg extract: Homogenate of equal volumes of dejellied Xenopus eggs and PBS, 
centrifuge twice for 10min at 4°C at 10000rpm in HB4 or SS34 rotor until extract is 
clear, aliquots of 0.75ml stored at -20°C  
 
AP-Buffer: 100mM trichlorethane Tris/HCl 9.5; 100mM NaCl; 50mM MgCl2 
 
Bleaching solution: 1% H2O2; 5% Formamid; 0.5x SSC 
 
DEPC-H2O: ddH2O with 0.1% Diethylpyrocarbonat (DEPC) agitated at 23°C o/n and 
autoclaved afterwards. 
 
10mM digoxygenin labelled NTP mixture: 10mM CTP, GTP, ATP, 6.5mM UTP and 
3.5mM dig-11-UTP (Roche). 
 
Hybridization solution: 5x SSC, 50% formamide, 1% Boehringer block, 
0.1% Torula RNA, 0.01% Heparin, 0.1% Tween-20, 0.1% CHAPS, 5mM EDTA. 
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Lamb Serum: Heat-inactivated lamb serum (30min with 56°C), stored at -20°C 
 
MEMFA: 0.1M 3-(N-Morpholino)-propanesulfonic acid (MOPS), 2mM EGTA, 1mM 
MgSO4, 3.7% formaldehyde (pH 7.4 at 23°C)  
 
Paraformaldehyde: 4% paraformaldehyde in PBSw (pH 7.5 at 23°C), stored at -20°C 
 
PBS: 137mM NaCl, 2.7mM KCl, 8mM Na2HPO4, 1.7mM KH2PO4 (pH 7.2 at 23°C) 
 
PBSw: 1xPBS, 0.1% Tween-20  
 
Proteinase K: 10µg/ml Proteinase K in PBSw 
 
20xSSC: 3M NaCl, 0.3M sodium citrate (pH 7.0 at 23°C) 
 
TBS: 50mM trichloroethylene (Tris)/HCl, 150mM of NaCl (pH 7.5 at 23°C) 
 
TBSX: 1xTBS, 0.1% Triton X-100 (pH 7.5 at 23°C) 
 
TE: 1mM EDTA, 10mM of Tris/HCl (pH 8.0 at 23°C) 
 
TBE: 100mM Tris/HCl, 83mM borate, 0.1mM EDTA (pH 8.6 at 23°C) 
2.7.2 Isolation of nucleic acids 
2.7.2.1 Preparation of DNA 
Plasmid DNA preparations were carried out using mini-, midi- or maxi 
preparation kits (QIAgen): QIAprep Spin Miniprep Kit (250), Cat. No. 27106; QIAprep 
Plasmid Midiprep Kit (25), Cat. No. 12143; QIAprep Plasmid Maxiprep Kit (25), Cat. 
No. 12163. 
2.7.2.2  Isolation of RNA 
Embryos were collected at the required developmental stage according to 
the normal table of Nieuwkoop and Faber (Nieuwkoop & Faber, 1967), (5 embryos 
per tube). Buffer was removed and QIAzol (QIAgen) was added (600µl per 5 
embryos per tube; for RIP experiments: 50 embryos per 30µl sepharose beads / 
300µl QIAzol). Samples were stored at -80°C, or if used immediately they were 
shock frozen with liquid nitrogen, then thawed on ice, and vortexed for 30sec at rt. 
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Cell debris was removed by centrifugation for 10min at 12000xg at 4°C. 0.2 vol 
chloroform was added to the supernatent, shaken by hand, incubated for 3min at rt 
and finally centrifuged for 15min at 12000xg at 4°C. Supernatent was mixed with 0.5 
vol (of starting volume) of isopropanol, incubated for 10min at rt followed by 
centrifugation at 12000xg for 10min at 4°C. RNA pellets were then washed twice with 
70% ethanol and air-dried for about 10min at rt. The RNA was dissolved in DEPC-
treated H2O (15µl for RIP-material, and 30µl for other material) on ice, 10min at 
56°C, and then stored at -80°C.  
2.7.3 Manipulation and analysis of nucleic acids 
2.7.3.1 Cloning methods 
The desired DNA fragments were amplified by PCR with appropriate 
primers containing specific restriction sites. The PCR products were subcloned into 
pcR2-TOPOII-vector (Invitrogen) and sequenced by MWG. Further, the constructs 
were digested with the appropiate endonucleases, separated on an agarose gel and 
purified. Subsequently, the DNA fragment was ligated into the desired 
(dephosphorylated) vector. 
2.7.3.2 Gel electrophoresis of nucleic acids 
DNA was isolated in horizontal agarose gels. Depending upon fragment 
size, 1-2% TBE agarose gels were used. After electrophoresis the gels were 
photographed. 1kb or 100bp DNA ladder (Fermentas) was used as size standard. 
RNA was separated in 1.5% denaturating formaldehyde agarose gels (1x MOPS). 
2.7.3.3 Isolation of DNA fragments from agarose gel 
In order to isolate DNA fragments after electrophoresis from agarose gel, 
the appropriate bands were cut out under long-wave UV light. The DNA was 
extracted from the gel with QIAquick Gel Extraction Kit (250), Cat. No. 28706 
(QIAgen). 
2.7.4 Polymerase chain reaction (PCR)  
2.7.4.1 PCR amplification of DNA fragments for cloning 
The reaction was carried out in a total volume of 50µl. The reaction mixture 
contained 100ng template DNA, 25pmol each primer, 0.5mM dNTPs, 1U Advantage 
Taq Polymerase (Invitrogen) or Taq polymerase (NEB) and 1x of the supplied buffer. 
The programme was 95ºC 30 sec, 58ºC (for all Seb4 constructs) 30sec, 72ºC 1min, 
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30 cycles. The PCR products were subcloned into pcR2-TOPOII-vector (Invitrogen) 
and sequenced by MWG.  
2.7.4.2 RT-PCR assay  
In the RT-PCR assay, 0.5-1µg total cellular RNA was reverse-transcribed 
in a volume of 20µl with RevertAid™ M-MuLV Reverse Transcriptase (Fermentas) 
and random hexamer primer under RNA-preserving conditions (by adding RNasin) 
according to the manufacturer’s protocol to generate cDNA. The cDNA templates 
were amplified by Taq DNA polymerase standard (NEB). The cDNA samples were 
mixed with polymerase, 1x buffer and H2O in one tube that was split before adding 
the different primer pairs used. The samples were normalized by PCR amplification 
of housekeeping genes, such as H4 (Histone H4) or GAPDH, and the desired target 
cDNA species were amplified using specific primers. The PCRs were carried out in 
the exponential phase of amplification. This was pre-tested by determining the 
specific cycle number (from three different cycle rounds), at which an unsaturated 
product signal was generated (detected by agarose gel electrophoresis). Last, the 
PCR samples were loaded side by side in an agarose gel to compare their intensity. 
2.7.5 In vitro transcription 
2.7.5.1 In vitro transcription for microinjection 
For microinjection capped mRNAs were in vitro transcribed with DNA 
dependent RNA polymerase (Promega). Reactions were set up as following: in a 
total volume of 50µl, 2µg linearized plasmid DNA, 1x of the supplied transcription 
buffer, 0.5mM dNTPs, 2.5mM G(ppp)G RNA Cap Structure Analogue (NEB), 10mM 
DTT, 20U RNAsin and 40U Sp6 or 60U T3 or T7 RNA Polymerase. The reaction was 
incubated for 4 hours at 37°C. Subsequently, the template DNA was digested with 
10U RNase free DNaseI for 30min at 37°C. The RNA was purified with the RNeasy 
Kit, Cat. No. 74104 (QIAgen). The concentration of the RNA was determined with a 
NanoDrop ND-1000 spectrophotometer (Peqlab) and the quality was controlled by 
electrophoretic gel analysis. 
2.7.5.2 In vitro transcription of digoxygenin labelled RNA probes 
Plasmids were linearized and antisense RNA was generated by in vitro 
transcription with a DNA dependent RNA polymerase (Promega). The reactions were 
set up in a total volume of 50µl as following: 2µg linearized plasmid DNA, 1x of the 
supplied transcription buffer, 0.35mM digoxygenin labelled UTPs (DIG-11-UTP; 
Roche), 0.65mM UTP, and 1mM each ATP, GTP and CTs, 20U RNAsin and 20U 
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SP6, T3 or T7 RNA Polymerase. The reactions were incubated at 37°C for 4h and 
purified with the RNeasy Kit (Qiagen). The quality was controlled by electrophoretic 
gel analysis. 
2.7.6 RNA in situ hybridization 
The embryos were fixed in fresh MEMFA for 1.5-2 hours at rt under 
rotation and washed afterwards with PBS 3x5min. The dehydration of the embryos 
was performed over a period of one hour by replacing the PBS with 100% ethanol. 
The lipid membranes were dissolved by storing the embryos at -20°C in 100% 
ethanol at least for 16h. The embryos were rehydrated through a 75, 50, 25% 
ethanol series in PBSw. Each ethanol step was incubated for 5min at rt.  Afterwards 
3 washes for 5min with PBSw were performed. The solution was then changed to 
Proteinase K in PBSw (10µg/ml) and incubated for 20min at 17°C, followed by a 
short rinse with PBSw. Again two washes for 5min were performed with PBSw. After 
the Proteinase K digest the embryos were refixed with 4% paraformaldehyde for 
20min. A short rinse with PBSw was performed followed by five subsequent washes 
in PBSw for 5min. The PBSw was replaced with hybridization solution (50% PBSw: 
50% hybridization solution; 100% hybridization 3min each step). 0.5ml of fresh 
hybridization solution was added to each vial and incubated at 65°C for 1h to 
inactivate endogenous phosphatases. The embryos were then prehybridized at 60°C 
for 2-6h. To 100µl of hybridization solution 30-50ng of RNA probe was added and 
incubated at 95°C for 2-5min, cooled immediately afterward on ice and added to the 
embryos in prehybridization solution. The RNA probe was hybridized to the mRNA 
over night at 60°C. To remove excess of non-hybridized RNA probe, the embryos 
were washed after the hybridization as follows:  2xSSC; 0.1% CHAPS short rinse; 
2xSSC; 0.1% CHAPS for 20min; short rinse with 0.2xSSC; 0.1% CHAPS; twice for 
30min at 60°C in 0.2xSSC; 0.1% CHAPS. Prior to the binding of the antibodies the 
embryos were transferred into TBSX (short Rinse in 50% TBS: 50% 0.2xSSC; 0.1% 
CHAPS), washed in TBS for 5min and rinsed in TBSX. To block unspecific antibody 
binding sites, the embryos were incubated in antibody buffer (0.5ml per vial) for 2h at 
4°C. In parallel, AP-conjugated anti-DIG antibody (1/5000 diluted in antibody buffer) 
was preabsorbed against Xenopus proteins present in antibody solution. 0.5ml of 
preabsorbed antibody solution was added to the embryos and incubated o/n at 4°C. 
After antibody binding, the embryos were briefly rinsed with TBSx and washed six 
times for 1h in TBSX. Embryos were shortly rinsed in AP buffer and equilibrated for 
15min. AP-buffer was replaced with 0.5ml staining solution and incubated o/n at 
17°C in the dark. The staining reaction was stopped when the specific stain 
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appeared saturated by washing twice in PBS for 10min. Unspecific staining 
background of the embryos (if occurred) was removed by washing the embryos in 
75% ethanol in PBS for 20min. The stain was fixed in MEMFA o/n. The embryos 
were bleached in bleaching solution on a light box for roughly 2h. The bleach solution 
was washed out with PBS three times for 5min. For long-term storage, the embryos 
were transferred to PBSw containing 0.2% Na-azide and stored at 4°C. 
2.7.7 RNA-co-immunoprecipitation 
All experimental steps were performed under RNA preserving conditions. 
This includes: Sterile, disposable plasticware is generally free of RNase activity. 
Glassware was either treated by baking at 200° C o/n or was washed with 
RNaseAway (Roth); always wearing gloves; all experiments were performed on ice 
or by 4°C; clean bench using RNaseAway (Roth). 
2.7.7.1 Solutions 
DEPC-H2O: ddH2O with 0.1% Diethylpyrocarbonat (DEPC) agitated at 23°C o/n and 
autoclaved afterwards 
 
10x MOPS: 41.8 g 3-[N-morpholino] propanesulfonic acid (MOPS), 6.8 g Sodium 
acetate, 20ml 0.5 M EDTA, add H2O to 1000 ml, store at 4°C in the dark, no 
autoclavation 
 
20xSSC: 3M NaCl, 0.3M sodium citrate (pH 7.0 at 23°C) 
 
RIP- buffer: 50mM Tris/HCL, 100mM NaCl, 1.5mM MgCl2, 100mM sucrose, 0,1% 
NP-40, 0.5mM DTT, 10mM Vanadyl complex (NEB), 50U/ml Superasin, protease 
inhibitors (pH 7.5 at 4°C) 
 
NB hybridization solution: 1xDenhardts, 2xSSC, 2% 5.2mg/ml salmon DNA 
2.7.7.2 Coupling of antibody to ProteinG Sepharose-beads 
Specific antibodies used for RIP were coupled to ProteinG-Sepharose 
beads by incubating 100µl beads with 10ml antibody containing tissue culture 
supernatent o/n at 4°C under rotation. Beads with bound antibodies were centrifuged 
at 110rcf at 4°C, tissue culture supernatent was collected, and beads were washed 
twice with 0.2M sodium borate (pH 9.0 at 23°C). The coupling reaction (+5mg/ml 
dimethylpimelimidat; 20mM) was incubated for 30min at rt under rotation. The 
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reaction was stopped by washing with 0.2M ethanolamin (pH 8.0 at 23°C), and then 
by incubating with 0.2M ethanolamine for 2h. Beads were stored in PBS at 4°C. 
2.7.7.3 Blocking of beads 
The blocking precedure was tested (IP with embryo extract, on Coomassie 
gel) with several blocking conditions (time and temperature) and components (in 
different concentrations), like E.coli t-RNA, yeast RNA type III, 10-20% BSA, and 
salmon sperm DNA leading to the final protocol: 100µl antibody-coupled or 
uncoupled ProteinG-Sepaharose beads were blocked by adding 1ml 20% BSA + 
25µl Salmon sperm (5.2mg/ml) DNA for 2h at rt under rotation. 
2.7.7.4 Embryo extracts for RIP- reaction 
For the RIP-reaction I established a RIP protocol. Per experimental condition 
ca. 50 neurulae were collected in a 15ml falcon tube and homogenized with 3ml RIP-
buffer by pipetting with a 1000µl tip and sonication with the Bioruptor 3x30sec at high 
level. Cell debris was removed by 3300rcf centrifugation at 4°C for 10min. 
The embryo lysate was precleared with 20µl blocked (uncoupled) beads for 
1h at 4°C. Beads were centrifuged for 1min at 4°C at 110rcf and discarded. 
Subsequently, the precleared lysate was incubated with 40µl blocked and antibody-
coupled beads for 2h at 4°C (RIP-reaction).  
After binding of the desired protein to the antibody-coupled beads, the beads 
were washed several times with increasing salt concentrations (2x RIP-buffer with 
100mM NaCl, 2x RIP-buffer with 200mMNaCl, 1x RIP-buffer with 300mMNaCl) each 
step 5min long with 2 min centrifugation at 110rcf at 4°C. 
Bound protein material was eluted by RIP-buffer containing 0.2% sarcosyl 
(without NP-40 or MgCl2) for Western blotting. Associated RNA material was 
precipitated by RNA isolation with QIAzol. 
2.7.7.5 Radioactive labelling via reverse transcription 
The reaction mixture of template RNA (0.5µg RNA; 2µl RNA from RIP 
experiments, after QIAzol-RNA preparation), 1µl oligo(dT)18 primer (0.5µg/l) or 1.5µl 
random hexamer primer (0.2µg/µl) were filled up with DEPC-treated H2O to 8µl, 
mixed gently and spun down in a microcentrifuge for 3 sec. The mixture was then 
incubated at 70°C for 5min, chilled on ice and briefly centrifuged. The following 
components were added: 4µl 5xreaction buffer, 1µl RNasin (20u/µl), 1µl mix of 10mM 
dGTP, dATP, dTTP. After incubation at 37°C for 5min (if oligo(dT) primer was used), 
or at 25°C for 5min (if random hexamer primer was used), finally 1µl [α32p]dCTP 
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(10mCi/ml) and 1µl RevertAid M-MuLV Reverse Transcriptase (200u/µl) were added. 
The RevertAid™ M-MuLV Reverse Transcriptase (RT) possesses an RNA-
dependent and DNA-dependent polymerase activity and a ribonuclease H activity 
specific to RNA in RNA-DNA hybrids. The DNA polymerase activity of the RT lacks a 
3’ - 5’ exonuclease activity. The mixture was incubated at 42°C for 60min (if random 
hexamer primer was used, 10min incubation at 25°C additionally and before the 
42°C step). The reaction was stopped by adding 5µl of 0.5M EDTA. 25µl of 0.6N 
NaOH were added and incubated at 70°C for 30min (final hydrolysis of RNA from the 
RNA-cDNA hybrid). Unincorporated dNTPs were removed by purification with G-50 
quick spin columns (Roche), according to the manufacturer’s protocol. 
2.7.7.6 RNA detection with autoradiography 
Radioactively labelled cDNA derived from RIP-RNA-material, was loaded 
on vertical 6% PAA TBE gels, and separated by gel eletrophoresis. Gels were dried 
on Whatman paper at 80°C for 1h and exposed to a phospho-imager screen. 
Screens were analyzed with a phospho-imager apparatus FujiFilm Fla-3000 and the 
according software (BASreader control software for FujiFilm BAS and FLA scanners 
and Aida Image Analyser415). 
2.7.7.7 Northern blot analysis 
For the purpose of hybridizing radioactively labelled cDNA probes (derived 
from the RIP-material) to total Xenopus RNA, I adapted the procedure based on the 
basic protocol for Northern blot hybridization of current protocols in molecular biology 
as follows (Terry Brown et al., 2004). Equal amounts (20µg RNA/lane) of total RNA 
(isolated from neurula embryos) were loaded on a horizontal 1.5% denaturing 
formaldehyde agarose gel (1xMOPS) and were size-separated by electrophoresis 
(3h, 80-100V). Blotting the size-separated RNA to a nylon membrane was 
accomplished by capillary force in a 10xSSC buffer bath o/n at 4°C. After blotting, the 
membrane was washed twice briefly with 2xSSC, backed for 15min at 80°C, and UV 
crosslinked with1200 Joule. The membrane then was cut into single lane stripes, and 
put into 15ml falcon tubes and washed with 6xSSC for 5min, followed by 
prehybridization at 68°C for 2h with 5ml hybridization solution per tube under 
rotation. The radioactivity of the labelled cDNA probes was monitored by measuring 
the counts per minute (cpm) via scintillation. (e.g., n=1; RIP-Seb4: 14070cpm, RIP-
beads: 23309cpm, RIP-βCat: 7410cpm, EF1-α cDNA: 187827cpm, neurulae cDNA: 
31373cpm, -cDNA: 5001cpm, mock: 27cpm). To hybridize the radioactively labelled 
cDNA probes to total Xenopus RNA, 100µl probe was incubated for 5min at 95°C, 
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added to 1ml hybridization solution and applied on to the membrane strips. After 
hybridization o/n at 68°C under rotation, the membrane strips were washed twice for 
5 min at rt with 2xSSC; 0.1% SDS, and twice for 20min at 42°C with 0.5xSSC; 
0.1%SDS, and once briefly with 2xSSC. The membrane was exposed to a phospho-
imager screen and subsequently analyzed. 
 
2.8 Protein analysis 
2.8.1 Solutions 
3x Lämmli buffer: 150mM Tris/HCl (pH6.8 at 23°C), 300mM DTT, 4% SDS, 30% 
glycerol 
 
Embryo lysis buffer for WB: 20mM Tris/HCl (pH7.5 at 23°C), 100mM NaCl, 1mM 
EDTA, 1% Triton X-100, 10% glycerol, 3mM CaCl2, 3mM MgCl2, β-mercaptoethanol 
1:1000, protease inhibitors 
 
E1-buffer: 110mM KCl, 50mM Tris/HCl (pH7.4 at 23°C), 5mM MgCl2, 0.1mM 
spermine, 0.1mM EDTA, 2mM DTT, 0.4mM PMSF 
 
Nuclear-buffer: 25% glycerol, 25mM Tris/HCl (pH7.4 at 23°C), 70mM KCl, 5mM 
MgCl2, 0.2mM EDTA, 2mM DTT, 0.4mM PMSF 
 
Embryo-lysis-buffer for gelfiltration: 20mM Tris/HCl (pH7.5 at 23°C), 100mM NaCl, 
1mM EDTA, 10% glycerol, 3mM CaCl2, 3mM MgCl2, protease inhibitors 
 
BC-100 column buffer (gelfiltration): 100mM Nacl, 25mM Hepes (pH 7.6 at 23°C), 
1mM MgCl2, 0.5 EGTA, 0.1mM EDTA, 10% glycerol, protease inhibitors 
 
BC-200 column buffer (gelfiltration): 200mM Nacl, 25mM Hepes (pH 7.6 at 23°C), 
1mM MgCl2, 0.5 EGTA, 0,1mM EDTA, 10% glycerol, protease inhibitors 
 
Chemiluminescence reagents (ECL): 
Luminol solution: 0.44g luminol in 10ml DMSO, frozen in 1ml aliquots, stored at 
-20°C; p-coumaric acid: 0.15g in 10ml of DMSO, frozen in 0.44ml aliquots, stored at 
-20°C; 
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solution 1 (100ml): 10ml 1M Tris/HCl (pH 8.5 at 23°C), 1ml luminol, 0.44ml 
p-coumaric acid;  
solution 2 (100ml): 10ml 1M HTris/Cl (pH 8.5 at 23°C), 60µl 30% ddH2O2 
 
HEG buffer: 50mM Hepes pH7.6, 10% glycerol, 1mM EDTA, 1mM DTT, 1% TritionX-
100, 1mM PMSF, 2.5µg/ml Leupeptin, 10µg/ml Aproptinin, 0.7µg/ml Pepstatin 
 
HEG150: HEG buffer with 150mM NaCl 
 
HEG300: HEG buffer with 300mM NaCl 
 
1x HEMG: 25mM Hepes pH7.6, 0.1mM EDTA pH8, 12.5mM MgCl2, 10% glycerol 
 
GST-lysis-buffer: 1xHEMG, 0,5M NaCl, 0.1% NP-40, 1mM PMSF, 
2.5µg/ml Leupeptin, 10µg/ml Aproptinin, 0.7µg/ml Pepstatin 
 
GST-washbuffer I: 1xHEMG, 0.7M NaCl, 0.1% NP-40, 1mM PMSF, 
2.5µg/ml Leupeptin, 10µg/ml Aproptinin, 0.7µg/ml Pepstatin  
 
GST-washbuffer II: 1xHEMG, 0.7M NaCl, 0.01% NP-40, 1mM PMSF, 
2.5µg/ml Leupeptin, 10µg/ml Aproptinin, 0.7µg/ml Pepstatin 
 
GST- urea-elutionbuffer: 1xHEMG, 8M Urea 
 
Lysozyme solution: 0.5g/10ml GST-lysis-buffer 
 
Developer solution (silverstaining): 7.5g Na2CO3 in 250ml ddH2O, add 125µl 37% 
formaldehyde 
2.8.2 Coupled in vitro transcription and translation 
In vitro translations of proteins were performed with the TNT® SP6 Quick 
Coupled Transcription/Translation System (Promega) according to the 
manufacturer’s protocol. 
2.8.3 Protein extraction from Xenopus laevis embryos (embryo extracts) 
Embryos were collected at the required developmental stage according to 
the normal table of Nieuwkoop and Faber (Nieuwkoop & Faber, 1967) (5 embryos 
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each tube). 50µl embryo-lysis-buffer for Western blot analysis was added to each 
embryo (250µl starting volume/ tube/ 5 embryos). Embryos were lysed and 
homogenized by pipetting (with a 200µl tip) and sonication, using the Bioruptor 
3x30sec at high level. Cell debris was removed by 10min centrifugation at 4°C at full 
speed. 250µl 1,1,2-Trichlortrifluorethane were added to the supernatent, vortexed 
and centrifuged for 10min at 4°C at full speed. After separating the organic from the 
aequous phase, the upper phase containing the proteins was kept and precipitated 
by Wessel-Flügge-precipitation. The samples were mixed with 1 vol ddH2O, 2 vol 
methanol, 1 vol CHCl3, vortexed and centrifuged for 5min at full speed at 4°C. After 
removing the upper phase subsequently 3vol of methanol were added to the 
interphase and vortexed. After centrifugation the white protein pellet was air-dried 
and resolved in 3x Lämmli buffer, incubated for 10min at 95°C, shock frozen with 
liquid nitrogen and stored at -80°C. 
2.8.4 Nuclear preparation of Xenopus laevis embryos 
Around 100 embryos were collected at the required developmental stage 
according to the normal table of Nieuwkoop and Faber (Nieuwkoop & Faber, 1994) in 
15ml falcon tubes and washed 3x with 1ml E-1 buffer containing 0.2% NP-40 and 
0.25M sucrose. Embryos were lysed and homogenized by pipetting in E-1/0.25M 
sucrose (20µl per 5 embryos). Additional E-1/0.25M sucrose buffer was added to a 
volume of 40µl per 5 embryos, followed by vortexing with another 200µl E-1 with 
0.05% NP-40 and 2.2M sucrose. The homogenate was layered on a 10µl cushion of 
E-1/2.2M sucrose in a 5x20mm centrifuge tube (Beckman) and spun at 130000xg for 
2h at 4°C in an Beckman ultra-centrifuge Optima MAX-E (TLA-55 rotor). Yolk and 
lipid supernatent were separated from the cytoplasmic fraction. The nuclear pellet 
was resuspended in 250µl nuclear buffer. Then the nuclei were spun down on a 10µl 
cushion of 80% glycerol for 10min at 4000rcf in a microfuge at 4°C. The supernatent 
was removed and the nuclear proteins were extracted with the protein extraction 
protocol (see 2.8.3). 
2.8.5 SDS-PAGE 
SDS-PAGE (SDS-polyacrylamide gel electrophoresis) was carried out 
according to standard protocols (Sambrook et al, 1989), with 10%, 12% or 15% PAA 
gels according to the size of the protein of interest. 
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2.8.5.1 Western blot analysis 
Western blot analysis was carried out according to standard protocols 
(Sambrook et al, 1989), and signals were detected by enhanced chemiluminescence 
solution in a relation of 1:1. The signals were exposed to a Super-RX Fuji medical X-
ray film and developed according to the manufacturer’s protocol. 
2.8.5.2 Coomassie-staining 
SDS-PAA gels were incubated o/n at rt in 0.4g of Coomassie blue R350 
dissolved in 200ml of 40% (v/v) methanol in water, and destained in 60% ddH2O, 
30% methanol and 10% acetic acid for roughly 4h, and exchanging the destain-
solution 2-4 times. 
2.8.5.3 Silver-staining 
The silver-staining reaction is based on the use of silver nitrate to bind 
proteins at a weakly acidic pH and subsequent reduction of silver ions to metallic 
silver by formaldehyde at an alkaline pH. This procedure is >100 times more 
sensitive than traditional Coomassie Brilliant Blue staining and allows for superior 
detection of low abundance proteins (> 100pg) and nanogram quantities of DNA and 
RNA. There are several disadvantages of this method including a lack of linearity, 
non-stoichiometric staining of proteins, a lack of compatibility with the microchemical 
preparation of proteins for identification by mass spectrometric techniques, and a 
highly subjective assessment of the staining endpoint. 
SDS-PAA gels were washed twice for 10min in 50% methanol, once 
10min in 5% methanol, once 15min in 33µm DTT in ddH2O, and once 15min in 0.1% 
AgNO3. Afterwards the gels were flushed 3x with ddH2O, then briefly washed in 
developer solution and then developed in fresh solution for about 5min. When protein 
bands became visible the developer solution was poured off and the gels were 
washed twice with ddH2O. Finally, the reaction was stopped by adding solid citric 
acid.  
2.8.6 Protein-immunoprecipitation (IP) 
ProteinG-Sepharose beads were coupled with specific antibodies of 
interest and blocked as decribed in 2.7.6.2 and 2.7.6.3. The embryos were lysed in 
50-100µl HEG500 per embryo with a 200µl Pipetman tip and incubated on ice for 
20min. The lysate was cleared via centrifugation at 4°C for 10min at full speed. The 
supernatant was transferred into a new siliconized tube. One sample equivalent was 
put aside as the input sample. 25µl of blocked and antibody incubated 
ProteinG-Sepharose beads-slurry was added to the samples and incubated o/n 
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under rotation at 4°C. The sepharose was pelleted by centrifugation at 100xg for 
about 10sec. The supernatant was carefully removed and discarded. The beads 
were washed under rotation lasting 15min at 4°C with the following buffers: 
2xHEG150, 2xHEG300. After the last step, as much washing buffer as possible was 
removed. The beads were incubated in 20µl 3xLämmli buffer for 5min at 95°C. The 
IP samples including input dilutions were loaded on a SDS-PAGE. 
2.8.7 Gelfiltration 
Gelfiltration chromatography was performed at 4°C using a Superose6 
column with an Amersham Biosciences UPC-900 monitor and pump system, 
equilibrated with BC-200 buffer. The system was monitored and controlled by 
methods run by the UNICORN control system (Version 5.01). The Superose6 column 
was calibrated with blue dextran (2 MDa), thyroglobulin (669 kDa), apoferritin (443 
kDa), β-amylase (200 kDa), alocohol dehydrogenase (150 kDa), albumin (66 kDa), 
and carbonic anhydrase (29 kDA; Sigma MWGF 1000 molecular weights kit). Three 
different methods for protein extraction were performed and compared. (A) 100 
embryos at st. 24 were collected and lysed in 1.5ml and (B) 200 embroys at st. 24 
were collected and lysed in 12ml embryo lysis buffer, which was adapted to the 
requirements for gelfiltration (no detergents, no denaturing reagents). Both extracts 
were sonicated 3x30sec in the Bioruptor at high level and cleared by centrifugation. 
Extract (B) was precipitated with 0.3g ammoniumsulfate per ml lysate, dialysed and 
resuspended in BC-100. Extract (C) is a modified extract (A), using a douncer 
instead of the Bioruptor for homogenization. Protein concentrations from all extracts 
were measured with the Bradford reagent (Biorad). Embryo extracts (about 1.3mg 
protein) were applied to the column in a volume of 500µl and eluted at a flow rate of 
0.150 ml/minute. Fractions (500µl) were collected, precipitated (after Wessel-Flügge) 
and analyzed by Western blotting. 
 
2.8.8 Purification of Gst-tagged recombinant Seb4 protein 
The expression vectors were transformed into Escherichia coli strain 
BL21. A starter culture was grown over night at 37°C. The starter culture was diluted 
1:100 and grown at 37°C to an OD595 of 0.6. Optimal Gst-Seb4 expression was 
observed upon induction with 0.4mM IPTG for 2h at 30°C (standard conditions of 
1mM IPTG, 2h at 37°C were optimized for Gst-Seb4). The cells were harvested at 
4000xg for 20min and the supernatant was discarded. The pellet was resuspended in 
15ml GST-lysis-buffer per 1l culture volume. 200µl lysozyme solution were added per 
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1l culture volume and rotated for 30min at 4°C. Afterwards the lysate was frozen in 
liquid nitrogen and thawn at 37°C for three times. To shear the genomic DNA, the 
lysate was sonicated 3x30sec with an amplitude of 50% with a microtip (Branson 
sonifier). Warming up was avoided by putting the tube on ice. The lysate was cleared 
via centrifugation for 30min at 15.000rpm, 4°C. Prior to the GST purification, the 
glutathione sepharose beads-slurry was washed with 5-10 vol of GST-lysis-buffer. 
300µl beads-slurry were added to 20ml of crude lysate and rotated for 1h at 4°C to 
allow binding of GST-fusion protein to glutathione beads. Afterwards the beads were 
washed three times with 5ml GST-washbuffer I and three times with 
5ml GST-washbuffer II for 15min at 4°C. The GST-fusion protein was eluted off the 
beads with GST-urea-elutionbuffer for 2h at rt. A second elution was performed o/n 
at rt. Both eluates were compared by SDS PAGE and Coomasssie staining, whereby 
the first eluate made up the majority, of approximately 90%, as expected. Afterwards 
both eluates were combined and dialysed in PBS o/n. Aliquots of all steps were 
analyzed by SDS-PAGE.  
2.8.8.1 Dotblot 
In vitro translations of the deletion constructs were performed with the TNT® 
SP6 Quick Coupled Transcription/Translation System (Promega) according to the 
manufacturer’s protocol. 5µl of of the TNT lysates containing the translated myc-
tagged Seb4 deletion proteins were pipetted directly onto a nitrocellulose membrane 
and analyzed by Western blotting and autoradiography. The autoradiograph served 
as a protein expression control. The TNT protein amounts were represented by 
comparable protein signals, because they were subcloned into the pCS2+myc-tag 
vector. Every construct contained six methionin residues derived from the six aligned 
myc-tags, while the remaining portions os Seb4 protein contein either none or one 
additional methionin or cystein residue. Thus, the theoretical labelling efficiencies 
differ by less than 15%, while the actual specific activity reflects also the efficiency of 
translation of each of the clones. 
 
2.9 Histological methods 
2.9.1 Solutions 
AP buffer: 100mM Tris/HCl (pH 9.5 at 23°C), 50mM MgCl2, 100mM NaCl, 
0.1% Tween 20, 5mM Levamisole 
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AP staining solution: 3.5µl 5-Bromo-4-Chloro-Indolylphosphate (Biomol) (in 100% 
Dimethylformamide, stored at -20°C) and 4.5µl Nitroblue Tetrazoliumchloride (in 70% 
Dimethylformamide, stored at -20°C) added to 1ml AP-Buffer  
 
A-PBS: 103mM NaCl, 2.7mM KCL, 0.15mM KH2PO4, 0.7mM NaH2PO4 pH7.5 
 
A-PBS-T: APBS with 0.1% Tween20 
 
Blocking buffer: PBT plus 10% heat inactivated serum 
 
Citrate buffer: Stock A: 0.1M citrate monohydrate (10.5g for 500ml solution) 
Stock B: 0.1M Trisodiumcitrate-dihydrate (14.7g for 500ml solution) 
Working Sol.: 9ml A with 41ml B to 450 ml ddH2O 
 
DAPI: Hoechst dye (1mg/ml) 1:1000 in APBS-T  
 
Dent’s Fixative: 80% methanol, 20% dimethyl sulfoxide (DMSO) 
 
Elvanol: 2.4g of MOWIOL 4-88, 6 g of glycerol, 6ml of H2O, 12ml of 0.2M Tris 
(pH8.5), 2.5% w/v DABCO (1,4,-diazobicycli-(2.2.2)-octane) 
2.9.2 Immunocytochemistry (ICC) 
The vitelline membrane was manually removed with forceps Dumont No.5 
from the embryos. Subsequently, the embryos were fixed in MEMFA for 1-2h at rt 
under rotation and rinsed afterwards with PBS. PBS was gradually replaced with 
methanol. The embryos were incubated in methanol at -20°C for at least 16h. They 
were rehydrated by 80%, 50%, 0% methanol in PBS for 5min each, followed by a  
1x5min rinse with PBS and one washing step in PBT for 15min. The embryos were 
incubated in PBT plus 10% heat inactivated goat serum, blocking unspecific antibody 
binding sites at rt for 1h. The primary antibody was diluted in the blocking buffer and 
incubated over night at 4°C. Afterwards the embryos were washed six times with 
PBT for 1h. The secondary antibody coupled with alkaline phosphatase was diluted 
1:1000 in blocking buffer. The embryos were incubated in secondary antibody 
solution over night at 4°C. Subsequently, the embryos were washed six times with 
PBT for on hour. Prior to staining, the embryos were equilibrated twice in AP buffer 
for 30min. The endogenous alkaline phosphatases were inactivated by addition of 
Levamisol to the AP buffer. The embryos were stained in 1ml staining solution in the 
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dark for 30 to 120min at rt, until the specific stain appeared saturated. The staining 
reaction was stopped by rinsing the embryos in PBS. The stain was fixed in MEMFA 
o/n. The embryos were bleached with bleaching solution (1% H2O2; 5% Formamid; 
0.5x SSC) for 2h on a light box.  
2.9.3 Immunofluorescence (IF) 
Both, the embryonic tissue and the single cells were fixed (not live), either 
by crosslinking and/or precipitating fixatives, formaldehyde and methanol or acetone 
and methanol respectively. Crosslinking fixatives, e.g. formaldehyde, act by creating 
covalent chemical bonds between proteins in tissue. Precipitating (or denaturing) 
fixatives (e.g. methanol, acetone) act by reducing the solubility of the proteins and by 
disrupting the hydrophobic interactions which give many proteins their tertiary 
structure. The proteins of these samples are therefore denatured but preserved from 
decay and mechanically stabilized for the IF procedure. 
The fluorophores chosen for the immunofluroscence experiments were 
excited by light of one wavelength, and emitted light of a different wavelength in the 
visible spectrum, shining green or red. Alexa Fluor 488 (absorption at 488nm and 
emission at 540nm), and Cyanine Cy2 (absorption at 492nm and emission at 
510nm), fluoresce green, and Alexa Fluor 594 (absorption at 594nm and emission at 
640nm), and Rhodamine Red-X RRX (absorption at 570nm and emission at 590nm), 
fluoresce red. For nuclear detection DAPI staining was performed. DAPI was excited 
with ultraviolet light. When bound to the minor groove of double-stranded DNA its 
absorption maximum is at 358 nm and its emission maximum is at 461 nm. This 
emission is fairly broad and appears blue. DAPI also binds to RNA (around 500 nm), 
though it is not as strongly fluorescent.  
The Alexa Fluor dyes (Molecular Probes by Invitrogen) were synthesized 
through sulfonation of rhodamine and cyanine dyes. Sulfonation makes Alexa Fluor 
dyes negatively charged and hydrophilic. Alexa Fluor dyes are very photostable, 
bright, and less pH-sensitive than common dyes of comparable excitation and 
emission. Rhodamine Red-X conjugates also contain a spacer arm (from 
aminohexanoic acid), which extends the dye out from the surface of the protein. 
Consequently, proteins conjugated with Rhodamine Red-X are significantly brighter 
than others and are particularly recommended from the producing company 
(Dianaova) for double labelling along with Cy2 (Dianova). All secondary antibodies 
used were affinity purified and guaranteed to have minimal cross reaction with other 
species. 
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2.9.3.1 Immunofluorescence on embryo sections 
The following protocol is based on Kunz et al. (2004) with modification for 
paraffin sections. The embryos were fixed under rotation in MEMFA for 1h at rt. 
Afterwards they were transferred into ice-cold Dent’s Fixative o/n at -20°C. Prior to 
embedding, the embryos were rehydrated for 30min in 100mM NaCl, 
100mM Tris/HCl pH7.4. Embryos were again dehydrated with an ascending ethanol 
series of 50%, 70%, 80%, 96% and 100% for 2h each. The ethanol was replaced by 
incubating the embryos twice for two hours in Xylene. Then they were soaked in 
paraffin at 55°C twice for two hours. The embryos were placed in paraffin and the 
blocks of paraffin were hardened on a cooling plate. The embryos were sectioned 
with an electrical microtome to slices of 4µm and dried for 2h at 37°C. The paraffin 
was removed by the following steps: 2x10min Rotihistol (Roth), 2min 100% Ethanol, 
2min 96% Ethanol, 2min 80% Ethanol, 1min 70% Ethanol, 1min 50% Ethanol, briefly 
in ddH2O. After a short rinse with citrate buffer, the antigen was renatured by boiling 
the slides in citrate buffer in the microwave twice for seven minutes with a 2min 
break. The sections were cooled down to rt for at least 20min. A short rinse with 
ddH2O followed. Prior to immunostaining, unspecific antibody binding sites were 
blocked by incubation for one hour at rt in APBS-T with 20% heat inactivated lamb 
serum. The slides were incubated with the primary antibody o/n at 4°C in APBS-T 
with 10% heat inactivated lamb serum. Subsequently, the slides were washed the 
following: 2x5min in APBS-T, 5min in APBS-T with 0.3M NaCl, 2x5min in APBS-T. 
The secondary antibody was again incubated over night at 4°C in APBS-T with 
10% heat-inactivated lamb serum. Since the secondary antibody was labelled with a 
fluorescent dye the sections were kept in the dark from this step on. Afterwards the 
slides were washed the following: 2x5min in APBS-T, 5min in APBS-T with 0.3M 
NaCl. The DNA was stained for 10min with DAPI. The slides were washed for the 
last time for 5min in APBS-T. Afterwards they were dried and embedded in Elvanol. 
The cover slipedges were sealed with colorless nail polish. The sections were 
analyzed with fluorescence microscopy. 
2.9.3.2 Immunofluorescence on A6 culture cells 
The protocol used for IF on A6 cells is based on the protocol of Prof. 
Schmidt-Zachmann. A6 cells were cultured on cover slips in 12-well plates o/n until 
confluency was reached (an adherent epithelium). Culture medium was removed, 
cells were washed once briefly with ice-cold PBS and fixed by washing 7min in -20°C 
methanol, followed by 30sec -20°C acetone. After 15min air-drying, the cells were 
rehydrated in PBS. The cells were then incubated for 25min in the primary antibody 
Material and Methods  
 
 
53
solution (in APBS-T with 10% heat inactivated lamb serum). Subsequently, the cells 
were washed twice 5min with PBS, followed by incubation for 25min with the 
secondary antibody in APBS-T with 10% heat inactivated lamb serum, and two 
repeated washing steps (2x5min PBS). The DNA was stained with DAPI for 10min 
with one washing step afterwards. The cover slips were dried and placed upside 
down on slides with one drop of Elvanol. The cover slips were fixed with colorless 
nail polish. The sections were analyzed with fluorescence microscopy. 
2.9.3.3 Image acquisition 
Images were obtained using a Zeiss Axiophot or Leica MZFCIII 
microscope fitted with 5x, 10x, 20x, 40x and 60x objectives and AxioCam or ProGres 
Zeiss digital cameras. For digital image acquisition and processing, Qcapture (Zeiss) 
or ProGres C14 (Zeiss) were used. All image acquisition settings of one experiment 
were adapted to the according background control. Final arrangement of all images 
was performed using Adobe Photoshop and Adobe Illustrator, adjusting the levels of 
one image in the linear range. 
 
2.10  Embryological methods 
2.10.1 Solutions 
Cystein: 2% L-Cystein in 0.1xMBS (pH7.8 at 23°C, adjusted with 5M NaOH) 
 
Human Chorionic Gonadotropin (HCG): 1000 I.U./ml HCG in ddH2O 
 
MEMFA: 0,1M 3-(N-Morpholino)-propanesulfonic acid (MOPS), 2mM EGTA, 
1mM MgSO4; 3.7% formaldehyde (pH 7.4 at 23°C) 
 
1x Modified Barth’s Saline (MBS): 5mM HEPES, 88mM NaCl, 1mM KCl, 0.7mM 
CaCl2 (before use), 1mM MgSO4, 2,5mM NaHCO3 (pH 7.6 at 23°C) 
  
MBS/high salt: 1xMBS with 50mM NaCl 
 
0.1xMBS/Gentamycin: 0.1xMBS, 10µg/ml Gentamycin 
 
MBS/CS: 0.8xMBS high salt with 20% chicken serum, 200U Penicillin/ml, 200µg/ml 
streptomycin stored at -20°C 
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2.10.2 Superovulation of female Xenopus laevis 
Xenopus laevis females were stimulated to lay eggs by injection of 500-
800 units of human chorionic gonadotropin (Sigma) into the dorsal lymph sac and 
incubation at 18-20°C over night. Egg laying started about 12-18h later. 
2.10.3 Preparation of testis 
A male frog was anaesthethized in 0.1% 3-Aminobenzoeacid-ethyl-ester in 
ddH2O for 30min, cooled down in ice-cold water, and killed by decapitation. The two 
testes were taken from the abdominal cavity by pulling out the yellow fat body, with 
which they are connected by connective tissues. Until use, the testes were stored in 
MBS/CS for maximal 7 days. 
2.10.4 In vitro fertilization of eggs and culture of the embryos 
For in vitro fertilization a piece of testis was minced in 1xMBS and mixed 
with freshly laid eggs. Afterwards the embryos were cultured in 0.1xMBS at 16-23°C 
in 110mm Petri dishes. 
2.10.5 Removal of the egg jelly coat 
One hour after fertilization or later, the egg jelly coat was removed in 2% 
cysteine solution pH 7.8 for about 5min with gentle agitation in a conical glass flask. 
Embryos were washed three times with 0.1xMBS and cultured further in 
0.1xMBS+10µg/ml gentamycin at 16-23°C.  
2.10.6 Injection of embryos 
Injection needles were pulled from glass capillaries (World Precision 
Instrument, Inc.; glass thin wall W/Fil 1.0mm, 4IN) with the Microneedle Puller 
(setting: heat: 800; pull: 35; vel: 140; time: 139; Sutter Instrument, model P-87). It 
was placed into the holder of the injection equipment (Medical System, model Pi-
100). The tip of the injection needle was broken with Dumont tweezers (No 5); the 
opening was calibrated until an injection pressure of 30psi produced an injection 
volume of 5nl in a defined injection duration (30ms-1s). The needle was filled with 
1-2µl antisense Morpholino oligonucleotide containing solution shortly before the 
injection. 10nl nucleotide solution was injected into each embryo. Embryos were 
injected at the two-cell stage unilaterally twice in one blastomere or once/twice in 
both blastomeres. After injection, the embryos were incubated in 0.1xMBS containing 
gentamycin at 16-23°C until the desired developmental stages in a 60mm Petri dish 
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covered with 1% agarose in 0.1xMBS. The saline was changed every day to 
increase the survival rates of the embryos. 
2.10.7 Protein knock-down in embryos by antisense Morpholino 
oligonucleotide 
Antisense Morpholino oligonucleotides are nonionic DNA analogs 
available from Gene Tools. The optimal target is a 25-base sequence that lies within 
the region from the 5' cap through the first 25-bases of coding sequence, has a 
~50% GC content for high target affinity and has little or no secondary structure. The 
Morpholino oligonucleotide should not have stretches of four or more contiguous G 
so that it remains water-soluble (see Genetools; http://www.gene-
tools.com//vivomorpholinos). 
Due to complementary binding of the antisense Morpholino oligonucleotide 
to its target RNA, translation of this protein is efficiently blocked (Heasman, 2002; 
Heasman et al, 2000). Depending on the turnover of Seb4 protein, after a certain 
time the pool of existing protein is degraded and the knock-down of Seb4 becomes 
effective, because de novo translation is inhibited.  
Embryos were injected with 10nl antisense Morpholino oligonucleotide at 
the two-cell stage. After injection, the embryos were incubated in 0.1xMBS 
containing gentamycin at 16-23°C until tadpole stage. 
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3  Results 
Besides the general role of RNA-binding proteins (RBPs) in cellular 
processes, RBPs can play major roles in development by operating at different steps 
of differentiation or in concert with tissue-specific regulators controlling gene 
expression on the post-transcriptional level. The putative RNA-binding protein Seb4 
is a novel factor that might mediate its suggested role in muscle differentiation by 
post-transcriptional regulation.  
The experiments presented here aimed to investigate the biochemical 
characterization and biological role of Seb4 during Xenopus development.  
 
3.1 Generation of antibodies against Seb4  
Specific antibodies are a major tool to analyze protein characteristics in 
vitro and in vivo. For broader application options we chose to generate both specific 
monoclonal and polyclonal antibodies against Seb4 protein. For this purpose a 
glutathione-S-transferase (Gst)-Seb4-fusion construct was cloned and recombinant 
Seb4 was expressed in E.coli cells. After purification of the Gst-Seb4-fusion protein 
with glutathione-Sepharose, the eluted full-length protein and in a small percentage 
its degradation products were analyzed by SDS-PAGE with subsequent Coomassie 
staining and were evaluated against a BSA standard (Figure 8A). As often reported 
in the literature, the E.coli host protein DnaK (Hsp70; molecular chaperone 
homologue migrating at 70kDa) was co-purified along with Gst-Seb4 (migrating at 
50kDa) (Baneyx, 1999). The monoclonal antibodies were raised in cooperation with 
the laboratory of Elisabeth Kremmer (GSF München) using rats for immunization. 
Positive primary hybridoma cell supernatants were pre-screened by the Kremmer 
laboratory concerning their specificity to bind the Seb4-antigen, but not to the GST-
fusion part (or DnaK). Two additional sera of polyclonal antibodies were generated 
by BioGenes, by immunizing rabbits with the Gst-Seb4-fusion protein. Two 
monoclonal antibodies Seb4 8B3 and Seb4 6E5 and the two polyclonal sera 7601 
and 7600 were then further analyzed by Western blotting to test their antigen 
specificity and to evaluate their signal/noise ratio (Figure 8B and C). 6E5 specifically 
recognizes in vitro translated Seb4, whereas 8B3 does not (Figure 8B). After the 
second boost of immunization the specificity against in vitro translated and 
endogenous Seb4 (migrating at 25kDa) increases in the polyclonal serum 7600, 
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accompanied with unspecific binding in the higher molecular range. The polyclonal 
serum 7601 does not recognize endogenous Seb4 in embryo extracts. 
 
Figure 8: Generation of Seb4 monoclonal and polyclonal antibodies 
 (A) Quantitation of bacterially expressed and purified Gst-Seb4 against BSA 
protein. (B) Western blot analysis testing the rat monoclonal 6E5 and 8B3 antibody against in 
vitro translated (TNT) Seb4 and TCF1 as an unspecific protein control (antibody dilution 1:10; 
5min exposure time). (C) Western blot analysis testing the rabbit polyclonal sera 7600 and 
7601 against in vitro translated (TNT) Seb4 and embryo protein extracts (from st. 16 
embryos) comparing 1st and 2nd boost of immunization (antibody dilution 1:1000; 10sec 
exposure time).  
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3.1.1 Specificity of antibodies raised against Seb4 
Seb4a protein (Jasper, 1998) and its non-allelic gene copy encoding 
Seb4b (Fetka et al, 2000) have a very high sequence similarity and are of 
approximately similar molecular weight due to their amino acid sequence of 225 
amino acids (aa) and 227aa, respectively (Figure 9). Seb4R protein is smaller in size 
with 215aa and has less sequence similarity, but is still closely related (Boy et al, 
2004). The N-terminus which contains the RRM domain is highly conserved in all 
three proteins, whereas the C-termini are more diverse, as one can see in the 
sequence alignment in Figure 9.  
Since both the monoclonal and polyclonal antibodies were raised against 
the full-length Seb4a protein the antigenic regions could be present in a conserved 
region on all three proteins mentioned above. In order to use the generated 
antibodies as a reliable tool for Seb4a characterization, first of all their specificity had 
to be tested and furthermore the appropriate dilution factor had to be titrated.  
In the Western blot analyses shown in Figure 9B, C and D the polyclonal 
(7600) and the monoclonal (6E5) antibodies with the highest antigen specificity 
(Figure 8) are tested against endogenous protein extracts from embryo lysates of 
tadpole stage 26 or 37, respectively, and in vitro translated proteins (Seb4a and 
Seb4R). The different embryo stages used here exhibit no protein differences in 
quantity of endogenous Seb4. In vitro translated Seb4a protein (Seb4 TNT) migrates 
at 25kDa, which correlates with the estimated molecular weight of 24,750Da (lane 1 
in B and C). Interestingly, when endogenous protein from embryo lysates is 
analyzed, both antibodies detect a double band (lane 2 in B and C) at around 25kDa. 
As illustrated by the schematic representation of the banding patterns in panel B and 
D, the lower band (lane 2 in B and C) migrates at the same size as the in vitro 
translated Seb4 protein (lane 1 in B and C), at the expected molecular weight of 
25kDa.  
 Interestingly, in vitro translated Seb4R (Seb4R TNT; lane 4 in B and C) is 
also recognized by both polyclonal and monoclonal antibodies, but shows decreased 
mobility compared to its theoretical molecular weight of 23,650Da. Seb4R is detected 
at a size of around 25,5kDa, and therefore migrates slower than Seb4. The 
endogenous protein detected as the upper band (around 26kDa; lane 2 in B and C), 
however, does not correlate with the same size of the in vitro translated Seb4R 
protein (lane 4 in B and C). Side by side comparison of in vitro translated Seb4 and 
Seb4R protein (lane 3 in B and C) demonstrates the different migration behaviour 
between the TNT and the endogenous proteins detected by the antibodies. The 
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molecular nature of endogenous protein represented by the upper band (lane 2 in B 
and C), is currently unclear. 
 
Figure 9: Comparative analysis of specific polyclonal (7600) and 
monoclonal (6E5) antibodies against Seb4. (A) Sequence alignment of Seb4 gene 
copies and Seb4R. (B), (C), (D) Endogenous (from st. 26 embryos) and in vitro translated 
(TNT 35S-cys+met labelled) Seb4 and Seb4R in Western blots (B and C on one film, exposure 
time 3min; D exposure time 1min) with Seb4 antibodies in different concentrations, as 
indicated. Black bars depict protein migration pattern. 
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In regard to the specificity, both antibody sera detect endogenous and in 
vitro translated Seb4 and in vitro translated Seb4R. The polyclonal antibody serum 
7600 also recognizes multiple unspecific proteins in the embryo extract and in the 
reticulocyte lysate after in vitro translation (lane 2 and 3 in B), but with lower signal 
intensity than the specific Seb4 signal. With an optimal dilution of 1:10, the 
monoclonal antibody 6E5 (Figure 9C) detects exclusively specific signal. Using a 
higher dilution (1:8000) of the polyclonal antibody serum a comparable (to the 
monoclonal antibody) selectivity for Seb4 can be achieved (Figure 9D). In vitro 
translated Seb4 protein serves as a reference, which co-migrates with the lower 
endogenous band. The relative intensities varied from experiment to experiment and 
can be neglected. 
3.1.2 Defining the Seb4 antibodies 
Seb4 and Seb4R are highly similar in their amino acid sequence. Both 
proteins are expressed tissue and stage-specifically, whereby Seb4R is mainly 
expressed in the nervous system, and in contrast, Seb4 mainly in striated muscle. As 
shown in 3.1.1 both the polyclonal as well as the monoclonal antibodies recognize 
endogenous Seb4 but also in vitro translated Seb4R.  
To define the properties of the antibodies in more detail, the location of the 
epitopes were mapped. For this reason several deletion constructs of Seb4 were 
cloned, which are schematically shown in Figure 10A. The new constructs and the 
proteins, which they encode, are named after the numbered PCR primer pairs used 
to generate them. In an initial experiment the constructs delta C (containing the 
RRM) and delta N (the C-terminal half) were in vitro translated and tested for 6E5 
antibody recognition by Western blot analysis, with the result that only delta C was 
detected (data not shown). Subsequently, I generated new constructs 12, 34, 56, 14 
and 36 representing different portions of the RRM domain. In a dotblot, duplicates of 
native, in vitro translated and 35S-methionin/cystein labelled protein constructs (from 
Figure 10A) were spotted on a membrane and tested for 6E5 antibody recognition. 
Due to the subcloning into the pCS2+myc-tag vector, every construct contains six 
methionin residues upstream of every myc-tag and either none or one additional 
methionin or cystein residue. Thus, the specific labelling activities differ less than 
15% from each other. Therefore, the autoradiograph serves as a protein expression 
control. As a control for specificity I used a monoclonal antibody against β-Catenin, 
(PGDS) which is of the same subclass (IgG2a) as the monoclonal Seb4 antibody 
6E5. 
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Figure 10: Epitope characterization of antibodies raised against Seb4 
(A) Overview of Seb4 deletion constructs, cloned with numbered primer sets 
(arrows) shown underneath. Construct names (numbers) derive from primer numbers. 
Shaded boxes show different protein domains, as marked in Figure 7A. (B) Right panel; 
dotblot of in vitro translated Seb4 deletion constructs (35S-cys+met labelled), as depicted in 
(A) on a nitrocellulose membrane, detected with antibodies against proteins as indicated 
(PGDS, poly-7600, mono-6E5). Left panel; autoradiograph. 
 
 
The signals show clearly that the monoclonal Seb4 antibody 6E5 
recognizes only the native Seb4R (lane 1) and Seb4 (lane 2) full-length proteins and, 
unexpectedly, none of the native deletion mutants. Interestingly, endogenous Seb4R 
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is not recognized but as an in vitro translated protein, native or denatured, it is. 
Furthermore, the delta C deletion protein is recognized in its denatured form, but not 
as a native peptide. As expected, the polyclonal antibody serum against Seb4 
recognizes many epitopes located in many different regions spanning the whole 
protein length. Except for construct 34 (lane 6), all mutant proteins are recognized by 
the 7600 serum.  
The experiments to define the 6E5 antibody revealed that the epitope is 
located in the highly conserved N-terminus (mainly the RRM). This observation 
explains why both sequence-homologues, Seb4 and Seb4R, are recognized. 
Unfortunately, the exact location of the epitope could not be mapped. The epitopes of 
the polyclonal serum are distributed all over the protein from the N- to the C-
terminus, as expected. The polyclonal serum may be useful when used at higher 
dilutions (1:8000; compare Figure 10B to D). 
Taking all antibodies’ characteristics in consideration, the monoclonal 6E5 
antibody against Seb4 provides a powerful tool, because its high specificity results in 
minimal background. Additionally, it may be useful to have two specific antibodies 
with diverse properties, a monoclonal and a polyclonal serum, recognizing epitopes 
in different locations, and having different host specificities. 
 
3.2 Spatial and temporal expression of Seb4 
Characterization of gene expression patterns is a crucial part of 
understanding the molecular determinants of development. Gene expression in a 
developing embryo occurs in a time-specific manner (temporal patterns) with subsets 
of differentially expressed genes in spatial patterns, which leads to the differentiation 
of cell fates. The expression pattern per se at a specific time point or developmental 
stage and in a specific tissue gives a lot of information about the character and 
function of a gene or protein and is mostly the fundamental step on which further 
experiments are built on.  
3.2.1 Developmental expression of Seb4 protein in vivo 
To date, no protein data of Seb4 is available. Seb4 mRNA is present 
continously from the unfertilized egg until at least late tadpole stages with a low point 
during gastrulation (Jasper, 1998; Fetka et al, 2000). Our newly generated Seb4 
antibodies were used to assess the corresponding protein expression pattern of 
endogenous Seb4 during embryonic development. 
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Protein extracts from different developmental stages between the 
unfertilized egg and tadpole stages were analyzed by Western blot analysis. In the 
unfertilized egg Seb4 protein is already present and remains at the same level until 
early neurula stage (Figure 11A lane 1 to 5). During neurogenesis (between stage 13 
and 19) protein expression increases strongly (compare lane 5 and 6). Strikingly, in 
all stages Seb4 migrates as a double band at 25kDa (see Figure 9) of comparable 
abundance, and Seb4 protein never disappears or decreases. 
 
Figure 11: Endogenous Seb4 protein expression in vivo 
(A), (B) Western blots against Seb4 using the monoclonal antibody 6E5 diluted 
1:10. Equivalents of 2 embryos loaded per lane in A, or as indicated in B (1e: one embryo; 
1/4e: one quarter of an embryo). (A) Endogenous Seb4 protein levels in different 
developmental stages. Lower panel: Coomassie stained SDS-gel serves as loading control. 
(B) Seb4 protein quantitation comparing different amounts of recombinant Gst-Seb4 fusion 
protein with endogenous Seb4 protein levels of embryo extracts.  
 
To determine the abundance of Seb4 protein in the embryo, Western blot 
signals from lysates were compared to the signals from a titration series of 
recombinant Seb4 protein (Figure 11B). This results in the conservative estimate that 
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one embryo stage 26 contains approximately 1ng soluable Seb4 protein. (One 
quarter of an embryo is approximately equivalent to 100pg of recombinant Gst-Seb4, 
and the Seb4 signal of one embryo equals the signal of 1ng recombinant Seb4). 
Assuming that such an embryo consists of approximately 106 cells (Mohun et al, 
1984), of which up to 10% express Seb4 mRNA/protein, Seb4 protein is present at 
105 copies per cell. According to this estimation, Seb4 belongs to the class of very 
abundant proteins in the cell expressed throughout early larval development. 
3.2.2 Two specific Seb4 proteins  
Since Seb4a/b and Seb4R are very similar in sequence, but expressed in 
different tissues, it was essential to rule out that endogenous Seb4R was also 
detected by the Seb4-specific antibodies. As described in chapter 3.1.1 and 3.2.2 the 
antibodies raised against Seb4 detect a double band at the estimated molecular 
weight of Seb4 at 25kDa. It was of interest to identify the proteins represented by 
these two bands and to distinguish between the putative candidates Seb4a, Seb4b 
and Seb4R proteins. In embryo extracts, the lower protein band correlates with Seb4, 
whereas the upper band could not be attributed to any of the proteins mentioned 
above. Additionally to Seb4, the antibodies recognize in vitro translated Seb4R, as 
shown above (3.1.1), which migrates slower than expected from its theoretical 
molecular weight. One explanation for the discrepancy in migration behaviour may 
be a post-translational modification.  
Subsequently, the Seb4 protein expression was investigated further in 
vivo. First, knock-down experiments using specific Morpholino oligonucleotides 
against Seb4 were performed (Figure 12A, B). Due to complementary binding of the 
Morpholino to the seb4 target mRNA, translation of Seb4 protein is efficiently blocked 
(see below, chapter 3.3.1). The Morpholino oligonucleotide (target region shown in 
Figure 12A; position -3 until +22) was designed against the seb4b clone instead of 
the seb4a clone, because of better solubility characteristics (compare seb4b position 
11 to 13 CAC, and Seb4a position 11 to 13 CCC; see 2.10.7). In spite of one 
mismatch at position 12, the Seb4 antisense Morpholino oligonucleotide (MO) targets 
both mRNAs, seb4a and seb4b. The corresponding region of seb4R, however, 
contains seven mismatches in the stretch of 25 nucleotides and should not be 
targeted by the Seb4 MO (Figure 12A).  
 Next, the Seb4 MO was injected into 2-cell stage embryos, lysed at early 
neurula stage 14 and analyzed for the endogenous Seb4 protein levels by Western 
blot analysis (Figure 12B). With increasing amounts of injected MO against Seb4, the 
Seb4 protein represented by the double band signal decreases (in comparison to the 
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uninjected control signal) and has almost disappeared with the highest dose of 40ng 
MO per embryo (Figure 12B lane 3). 
 
Figure 12: Seb4a/b protein is not phosphorylated 
(A) Sequence of Morpholino oligonucleotide aligned with Seb4 gene copies and 
Seb4R. (B) Seb4 Morpholino injected embryos lysed at stage 27, Western blot against Seb4 
with 6E5 antibody, diluted 1:10. (C) Embryo extracts stage 27 treated with shrimp alkaline 
phosphatase (SAP) for different time periods, as indicated; Western blot against Seb4 with 
6E5 antibody, diluted 1:10. 
 
The second question concerning the unexpected migration behaviour 
potentially as a result of a post-translational modification was addressed next. Since 
phosphorylation is one of the most common post-translational modifications, Seb4a/b 
were tested for phosphorylation to be the cause of the slower migrating protein 
(represented by the upper band). For this reason, embryo extracts from stage 27 
embryos were treated with shrimp alkaline phosphatase (SAP) for several time points 
(10min, 30min, 2h), as indicated in Figure 12C, and analyzed by Western blot 
analysis against Seb4. Both signal bands were still detectable after 2h of SAP 
treatment; the protein pattern has not changed. 
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These results indicate that the monoclonal antibody 6E5 recognizes 
endogenous Seb4 but not Seb4R in vivo, although in vitro translated Seb4R can be 
detected by 6E5. The Seb4a/b protein migrates as a double band at 25kDa. 
Phosphorylation as a post-translational modification of Seb4a/b can be excluded. 
3.2.3 Seb4 is expressed in mesodermal and ectodermal derivatives 
Analysis of the spatial and temporal in situ expression pattern of a factor 
can shed light on its biological function in many ways. For example overlapping 
expression domains can give information about potential interaction partners, or 
upstream/downstream regulation.  
Seb4 was shown to be a direct target of MyoD (see 1.3.4; (Jasper, 1998)), 
so, first of all the RNA expression pattern of both factors were compared by RNA in 
situ hybridization (ISH; Figure 13A). 
In blastula stage embryos (st. 9), zygotic myoD expression is not 
significantly induced yet, but a basal, maternal, ubiquitous myoD expression exists. 
The same is true for seb4, low, maternal RNA expression is detectable by RT-PCR 
(Fetka et al, 2000), but not by ISH yet. The myoD expression is induced in 
prospective myoblasts in the gastrula stage (st. 11) in an omega-shaped pattern 
around the blastopore, excluding the organizer region above the dorsal lip. Zygotic 
seb4 is induced in two small regions within the myoD expression domain flanking the 
dorsal lip/organizer. Neurula stage embryos (st. 18) show an identical myoD and 
seb4 expression pattern in the unsegmented, paraxial mesoderm consisting of 
presumptive myoblasts. In tailbud stage embryos (st. 30), myoD is expressed in the 
myotome and begins to be down-regulated in postmitotic, differentiating myocytes. 
Seb4 is likewise expressed in the myocytes of the myotome, but also in the 
myocardium and in ectodermal derivatives like the lens, the ventral part of the otic 
vesicle, some cranial placodes and developing lateral line primordia (Schlosser & 
Northcutt, 2000).  
In the next experiment, the developmental Seb4 expression was followed 
in situ on the RNA level (ISH; 1-8) as well as on the protein level by 
immunocytochemistry (ICC; 1’-8’) in comparable embryonic stages (Figure 13B). In 
the early blastula (st. 7; Figure 13B1) the maternal RNA contribution of seb4 is 
located in the animal hemisphere. Seb4 protein is also localized in low amounts in 
the animal half of an early blastula embryo (B1’).  
In the gastrula stage embryo (B2), zygotic seb4 transcription is induced in 
two small domains flanking the organizer region around the blastopore.  
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Figure 13: In situ expression pattern of Seb4 in Xenopus laevis 
embryos analysing the RNA and protein level. (A) Seb4 and myoD RNA in situ 
hybridization in blastula, gastrula, neurula and tailbud stages. (B) Comparative analysis 
between Seb4 RNA (1-8) and protein (1’-8’) expression/localization in several stages by ISH 
(1-8) and ICC (1’-8’), respectively. Panels B1, 2’, 4-8’ lateral view; 1’ animal view; 2 posterior 
view; 3, 3’ dorsal view. Inlay in panel 3: crosssection perpendicular to A-P axis as indicated 
by white dashed line. Arrows in 5, 5’ point at the retina and lens, respectively. White squares 
in 7, 7’ are shown as enlargements in 8, 8’. 
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At this stage the protein is still distributed over the animal half; no distinct 
protein domains are visible yet (B2’).   
In neurula stage embryos (B3, 3’) the RNA and protein expression 
domains are located in the paraxial mesoderm and correlate with each other. In early 
tailbud stages, seb4 RNA expression is induced in the retina and in the otic vesicle 
(auditory vesicle; ear), whereas Seb4 protein cannot be detected yet in these 
ectodermal derivatives (B4, 4’).  
Seb4 expression in the myoblasts correlates on the RNA and protein level. 
In later tailbud stages (B5, 5’) seb4 mRNA is expressed strongly in the retina (arrow) 
as well as in the myocardium. Seb4 protein is now also found in the eye, where it is 
expressed in the lens (arrow) and absent from the retina. The same is true for the 
proctodeum, where Seb4 protein is present, but Seb4 mRNA cannot be detected. 
Heart muscle and skeletal muscle in the somites show both Seb4 RNA and protein 
expression. In even later stages, after 2d of development (st. 34; 6 and 6’), the 
expression pattern of seb4 RNA and protein correlate in all tissues: striated muscle, 
heart muscle, lens and otic vesicle. Seb4 protein that was earlier (and later; see 
below) found in the anal region, has disappeared at stage 34. After 3d (st. 42; 7 and 
7’) seb4 RNA expression begins to be down-regulated in the dorsal myocytes, 
whereas the protein is still detectable. At this time Seb4 is strongly expressed in the 
differentiated ventral body wall muscle. The ventral muscles have migrated ventrally 
and retain segmental identity, by the lack of fusion between the adjacent myotubules 
(Martin & Harland, 2001). Here, Seb4 protein appeared again in the anal region, 
whereby Seb4 mRNA seems absent. 
 Seb4 expression is also induced in the head in some cranial and facial 
placodes, in cells around the eye belonging the developing lateral line primordia, 
epibranchial placodes and trigeminal placodes (Schlosser & Northcutt, 2000). Most 
strikingly, seb4 RNA expression in the eye is still restricted to the lens, whereas Seb4 
protein is clearly localized to the retina, and excluded from the lens (8 and 8’). 
Altogether, Seb4 is expressed in a distinct tissue specific pattern in 
mesodermal and ectodermal derivatives. Including the neurula stages, its 
mesodermal expression domain mainly overlaps with the expression domain of 
myoD. At tailbud stages Seb4 is expressed not only in the somites like MyoD but is 
also found in the lens, the ear, and the heart. Seb4 expression correlates on the RNA 
and protein level in the myoblasts. Exceptions to this rule occur in the anal region 
and during eye differentiation in early tailbud and late tadpole stages.  
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3.3 Seb4 depletion leads to reduced muscle and lens 
To find out more about the function of a protein a major method of a biologist 
is to create mutant embryos and to analyze their phenotypes. In contrast to gain-of 
function (G-o-F) experiments, only loss-of-function (L-o-F) studies can reveal the 
essential functions of a protein. For the L-o-F approach antisense Morpholino 
oligonucleotides were utilized as a means to investigate gene function in vivo in the 
embryo — a method well established in Xenopus (Heasman et al, 2000). 
Additionally, the specificity of the endogenous Seb4 expression pattern analyzed in 
3.2.3 can be confirmed by the lack of Seb4 protein upon Seb4 knock-down. Analysis 
of Seb4 mutant phenotypes can also lead to conclusions about the requirement of 
Seb4 for a specific tissue. Nevertheless, the technique applied here in this study (see 
2.10.7) only targets the zygotic, and not the maternal Seb4 protein. 
For the L-o-F experiments I generated a Seb4 knock-down by injecting 
antisense Morpholino oligonucleotides (MO) directed against seb4 and thereby 
blocking seb4 translation. After protein ablation, the morphology of the developing 
mutants can be described and further investigated by marker analysis. 
3.3.1 Seb4 Morpholino efficiently depletes Seb4 in vitro and in vivo  
Before the generation of Seb4 knock-down mutant embryos, the specificity 
of the exogenous flag-tagged Seb4 MO and the efficiency to block translation had to 
be initially tested. In several experiments this was successfully accomplished. First of 
all, the MO was tested in reticulocytes lysate assays, next it was confirmed in vivo by 
blocking the translation of Seb4 protein (data not shown). Finally the MO was used in 
vivo to efficiently deplete endogenous Seb4 protein. 
In the in vitro approach, first of all, the MO specificity and dose-
dependency was tested by comparison of the Xenopus Seb4 MO to a human 
standard control MO. Secondly, the Seb4 MO was tested for its target specificity for 
wildtype seb4 but not for a mutant seb4, which contains seven nucleotide 
substitutions downstream of the ATG start codon. 
The reaction was performed in reticulocytes lysates, which provide every 
component needed for protein synthesis (SP6 RNA-polymerases, nucleotides, 
ribosomes, amino acids, etc.) from plasmid DNA. The inhibition of translation was 
controlled by applying the MOs in two doses (with 10x fold difference) to the reaction 
expressing either wildtype or mutant seb4 cDNA plasmids. The samples were loaded 
on a SDS-PAGE and analyzed by Western blotting against Seb4 (Figure 14). As 
expected, in presence of the unrelated control MO neither the mutant nor the 
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wildtype Seb4 protein synthesis is altered (compare lane 1, 5 and 2, 6). If adding the 
specific Seb4 MO, the mutant Seb4 protein is still expressed, whereas the wildtype 
Seb4 translation is strongly reduced (compare lane 3, 7 to 4, 8). With a 10x higher 
dose of the Seb4 MO the wildtype Seb4 expression can be blocked almost 
completely (lane 8) proving that the Seb4 MO works in a specific and efficient 
manner. 
In the next step the blocking efficiency and specificity was tested in vivo. 
Therefore embryos were injected in the 2-cell-stage into both blastomeres with a total 
of 20ng MO per embryo. The embryos were collected at the time points indicated 
past the injection procedure (e.g. at 6h, 30h and 54h). The total protein of the 
embryos was extracted and Seb4 was analyzed by SDS-PAGE and Western blotting 
(Figure 14B). The lanes were equally loaded, as judged by Ponceau S staining (data 
not shown). The uninjected control group of embryos (lane 1, 4 and 7) as well as the 
standard MO injected group (lane 2, 5 and 8) show ascending Seb4 protein levels as 
development proceeds. In contrast, Seb4 MO injected embryos show descending 
Seb4 protein levels at the given times (lane 3, 6 and 9) and Seb4 protein expression 
is decreased to a large extent after 54h (compare lane 7, 8 and 9). 
After the specificity and the efficiency of the Seb4 MO had been 
confirmed, the Seb4 expression pattern was investigated in situ upon Seb4 MO 
knock-down and the mutant phenotypes and their penetrance was analyzed.  
Unilateral injections offer several advantages. The uninjected body half 
serves as an internal control to the mutant body side. Another advantage is that 
higher doses of a specific MO can be tested in unilaterally injected embryos, 
because the wildtype side can compensate the phenotypic perturbation effect to 
some extent.  
In Figure 14C, both sides, the uninjected (4, 5, 6) and the MO-injected (4’, 
5’, 6’) side of Seb4 depleted embryos are shown. Excitingly, the typical striated 
muscle structure of the aligned myocytes is lost in the injected body half. Only very 
few cells still express Seb4 protein after injection of 20ng/e MO (4-4’’). Injection of 
30ng/e of MO (5-5’’) results in an even stronger decrease of Seb4 expression. A total 
lack of Seb4 protein can be observed in the embryo in panel 5’’ in the trunk region of 
the skeletal muscle. Only low amounts of Seb4 protein are still present in the muscle 
of the tailbudtip (5’). 
With an increase of the injected dose of Seb4 MO, the body is increasingly 
reduced in length, with malformations of the head (microcephaly) and a shortened 
tailbud tip. These developmental defects on the mutant side consequently lead to the 
curvature of the embryo towards the injected side. 
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Figure 14: In vivo knock-down of endogenous Seb4 protein reduces 
muscle tissue (A) Western blot against Seb4 using 6E5 (1:10); TNT reticulolysate assay. 
(B) Western blot against Seb4 using 6E5 (1:10); depletion of endogenous Seb4 protein in 
embryos by injection of 20ng MO per embryo in the 2-cell-stage into both blastomeres. (C) 
Unilateral Seb4-MO injected embryos were analyzed at stage 36 by ICC with the 6E5 
antibody diluted 1:1000. (C1-3) controls; (1) uninjected WT embryo; (2) 40ng/e standard MO 
injected twice into both blastomeres; (3) ICC control uninjected WT embryo without 6E5 ab; 
(4), (5), (6) uninjected control side, (’) double unilateral injected side of same embryo, 
concentrations are as indicated; (’’) Somites of both embryo sides in detail. 
 
Results  
 
 
72
The highest dose of injected MO (40ng/e; 6-6’’) causes a very severe 
phenotype. Under this condition Seb4 protein is not detectable anymore in the 
myotome, heart and eye. The body size is reduced to 50%, the axis is shortened, 
and the head/eyes and tailbud/fin are reduced drastically (6’). Also the uninjected 
side is affected in its Seb4 expression. The myocytes do not align in their proper 
manner anymore; the myotome appears compressed and unstructured leading to the 
suggestion of Seb4 being involved in myogenesis as a factor regulating structure, 
alignment and adhesion of myocytes. 
The L-o-F experiments strikingly show that injections of increasing 
concentrations of Morpholino against Seb4 lead to a loss of Seb4 expression, which 
causes reduced muscle tissue, diffuse and unstructured myocytes, reduced body 
size, head and tailbud ablations and a loss of tissue on the mutant side causing a 
bend in the body axis towards the injected side.  
3.3.1.1 Depletion of Seb4 causes ablation of muscle and lens specific gene 
expression 
The characterization of the mutant Seb4 phenotype was completed by 
substantiated marker analysis in situ, which identified the altered tissues and 
pathways involved (Figure 15). According to the Seb4 expression pattern supported 
by the pattern of the mutants lacking Seb4, several marker genes were selected for 
RNA in situ hybridization (ISH) to reveal the phenotypic consequences of Seb4 
ablation. Since Seb4 is mainly expressed in the somites, the first tissue analyzed 
was paraxial mesoderm and skeletal muscle. As described in chapter 3.2.3, the seb4 
expression domain in the neurula embryo matches completely with the expression 
pattern of myoD. Therefore, the gene expression of myoD was investigated as an 
early master regulator of skeletal muscle (Hopwood et al, 1989). As a late muscle 
marker, myosin light chain mlc35 (alias MLC1f/3f) was analyzed, designating 
differentiated myocytes in the somitic muscle (Theze et al, 1995). 
To test whether neural tissue was affected by Seb4 depletion, nrp1 
(nervous system-specific RNP protein-1) gene expression was investigated, Nrp1 is 
specifically expressed in the nervous system, including brain, spinal cord and eye, 
beginning at the stage of neural plate formation, where cell proliferation takes place 
(Richter et al, 1990). Furthermore, markers for heart and lens were tested, due to 
Seb4 expression in both tissues in late tailbud stages (see Figure 13B). Troponin 
(cardiac troponin Ic) expression is restricted to the heart at all stages of Xenopus 
development (Drysdale et al, 1994). α-crystallin belongs to the family of crystallins, 
which are very abundant structural components of the lens. The antisense probe 
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against α-crystallin serves as a molecular indicator of lens differentiation (Brunekreef 
et al, 1997).  
 
 
Figure 15: Seb4 protein depletion reduces skeletal muscle and lens 
specific gene expression. Injection of 20 ng/e Seb4 MO into two blastomeres at the 2-
cell-stage. Embryos were analyzed at the neurula (st. 15) and tailbud stage (st. 34) by ISH 
(digoxigenin labelled antisense probes against myosin light chain 35, nrp1, α-crystallin, 
myoD, troponin). (A-E) Uninjected control embryos; (A’-E’) 20ng/e standard MO injected 
control embryos; (A’’-E’’) 20ng/e Seb4 MO injected embryos. 
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The experiment was carried out by injecting 20ng/e of Seb4 MO into both 
blastomeres in the 2-cell-stage and following analysis of the manipulated embryos in 
the stage according to the optimal expression of the marker gene (Figure 15). 
Consistent with the morphological perturbation of the larval musculature (described 
in chapter 3.3.1), mlc35 is completely abolished upon Seb4 depletion (15A’’). The 
lack of mlc35 expression (15A’’) implies that no differentiated myocytes are formed 
anymore. Nrp1 expression, in contrast, appears only weakly impaired by Seb4 
depletion (15B’’). Nrp1 is still strongly expressed in the eye, brain and spinal chord. 
The little reduction in global nrp1 expression is possibly due to a secondary effect 
caused by the ablation of muscle tissue. In panel 7C-C’’ is shown that the expression 
of α-crystallin in the lens is strongly down-regulated after Seb4 knock-down indicating 
that Seb4 is required for proper lens differentiation. By contrast, the absence of Seb4 
protein in the myocardium does not influence troponin expression (15E’’). Thus, 
Seb4 expression is not essential for heart development. Intriguingly, the expression 
of myoD, one of the direct upstream regulators of Seb4, is decreased immensely 
upon Seb4 depletion (15D’’).  
Concluding from the results illustrated in Figure 15, Seb4 ablation leads to 
reduced expression of skeletal muscle and lens specific genes implying an important 
regulatory role for Seb4 in the differentiation programmes of these tissues. However, 
Seb4 appears to be dispensable for heart muscle differentiation, despite strong 
expression of Seb4 in the heart. Seb4 depletion also leads to an extensive reduction 
of myoD expression, one of the key regulators of the myogenic lineage, suggesting a 
regulatory feedback loop between Seb4 and MyoD. 
 
3.4 Interaction partners of Seb4 
Most proteins act in concert with others. Protein-protein and protein-RNA 
interactions are of central importance for virtually every process in a living cell. 
Information about these interactions improves our understanding of the coordination 
of biochemistry, signal transduction networks and can provide the basis for 
understanding the function of a protein. 
After analysis of the Seb4 expression in vivo and in situ the next aim was 
to identify any associated factors to Seb4. Due to its protein sequence and domain 
composition Seb4 has the potential to bind to protein and RNA. First of all, I 
searched by general means for an interacting protein partner of Seb4 and secondly, I 
adapted an RNA-immunoprecipitation assay to find associated target RNAs. 
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3.4.1 Proteins interacting with Seb4 
3.4.1.1 Co-immunoprecipiation 
Co-immunoprecipitation (co-IP) is considered to be a major assay to 
detect protein-protein interactions, especially when it is performed with endogenous 
(not overexpressed and not tagged) proteins. The protein of interest is isolated with a 
specific antibody. One way is to separate the antibody-antigen complex from the 
other proteins and cellular components by using sepharose beads coupled to 
antibodies, which bind the complex.  
To adapt the method of co-IP to Seb4 protein, the individual steps of the 
co-IP were optimized to meet the necessary requirements for optimal specificity and 
efficiency. The specific antibody (6E5) was covalently coupled to proteinA sepharose 
beads before blocking the unoccupied positions. This offered several technical 
advantages. The antibody can be easily removed from the coimmunoprecipitated 
material after “pulling-down” Seb4 with its associated factors. More stringent washing 
conditions can be applied to the sample without losing material but gaining a higher 
specificity. Higher and more stable beads-occupancy also led to reduced background 
and higher efficiency.  The co-immunoprecipitated proteins were subsequently 
visualized by silver staining (Figure 16).  
In an initial experiment, the IP conditions concerning the antibody-beads 
association (before and after the coupling process) were tested and compared in a 
Coomassie stained SDS gel (Figure 16A lane 3, 5 and 4, 7). When the antibody is 
not covalently coupled to the beads, the antibody is dissolved in the Lämmli buffer or 
IP-eluate, respectively, resulting in two extra protein signals of the heavy and light 
chain after Commassie-staining (the light chain migrates at 25kDa, and the heavy 
chain at 55kDa) (16A lane 3, 7). The strong signals of the heavy and light chain are 
very dominant (the light chain migrates at the same size as Seb4), superimposing 
the faint IP-signals (16A lane 7). After coupling the antibody covalently to the beads, 
the antibody remains stably associated and can be removed (lane 4). In the IP-
eluate, subsequently no antibody proteins are found (16A lane 5, 6) and, thus, the 
antibody signals are not disturbing the detection of proteins of similar molecular 
weight. The IP-efficiency is analyzed by Western blotting (Figure 16B). Seb4 is not 
unspecifically bound to the beads (16B lane3). Antibody dependent, Seb4 protein is 
immunoprecipitated with high efficiency (far above 10%), because after a 5sec 
exposure of the IP-band the same signal intensity is reached as the 10% input band 
after 3min).  
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Figure 16: Efficient co-immunoprecipitation of Seb4 detects no 
interacting proteins. (A) and (B) were accomplished under „normal“ (not RNA-preserving) 
conditions, whereas (C) and (D) were performed under RNA-preserving conditions. (A), (C), 
(D) Coomassie- or silverstained SDS-PAGE. (B) IP efficiency shown by a Western blot 
against Seb4 with 6E5 diluted 1:10. Exposure times are indicated. (D) Elution of 
immunoprecipitated material with 0.2% sarcosyl. Percentage of the input or 
immunoprecipitated material loaded per lane is indicated. Antibodies used, are either 
covalently coupled or not coupled to the beads, as indicated. 
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Both antibodies, the monoclonal 6E5 (coupled to the beads, 16B lane 2) 
and the polyclonal 7600 (uncoupled to the beads, 16B lane 4), have the potential to 
immunoprecipitate Seb4 with equal high efficiencies.  
Since the polyclonal Seb4 antibody recognizes many epitopes, most likely 
also some on other proteins, I preferred the monoclonal 6E5 antibody for the IP 
experiments in order to reduce unselective background. In regard to the putative role 
of Seb4 to bind RNA, the IPs were performed under RNA-preserving conditions. In 
case Seb4-RNA interaction serves as a platform for protein-protein interaction, the 
RNA-preserving conditions supported the chance of detecting interacting proteins 
dependent on Seb4-RNA association.  
In the following experiments, the IP samples were either directly dissolved 
in Lämmli buffer or eluted with sarcosyl detergent and then resolved by SDS-PAGE 
(16C, D). The gels were subsequently stained with silver, because this procedure is 
compatible with mass spectrometry analysis of proteins. The Seb4-
immunoprecipitated material (16C lane 2, 3) shows the same protein band pattern 
than the control reaction without an antibody control (beads alone; 16C lane 4), 
which leads to the conclusion that the protein bands visualized by silver-staining are 
actually not immunoprecipitated, but unspecific background. Interestingly, one 
protein detected at 70kDa (asterisks; 16C lane 2 and 3) is specifically enriched after 
Seb4-IP.  
In the next experiment, the immunoprecipitated material is recovered from 
the beads-ab-complex by elution with 0.2% sarcosyl (Figure 16D). Unfortunately the 
protein of approximately 70kDA deteced before (16C lane 2, 3) cannot be 
reproduced with this method. The eluate and the removed beads of the control IPs 
(lane 3, 4) and the Seb4-IPs (lane 5, 6) show no Seb4-specific enrichment.  
Despite the high sensitivity of the method applied here (silver-staining 
detects low abundance proteins > 100pg), no protein interaction partners of Seb4 
were detected. 
3.4.1.2 Seb4 is not bound in a complex 
Another option to investigate if Seb4 is bound in a complex of protein 
interaction partners is size exclusion chromatography. Gelfiltration is a 
chromatographic method in which particles in an aqueous solution (BC-200 buffer) 
are transported through a stationary phase (superose6) in a column and are 
separated based on their hydrodynamic volume. This results in the separation of a 
solution of proteins based on size. The filtered solution (eluate) was collected in 
different fractions, precipitated and analyzed.  
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 Protein extracts from embryo lysates of neurula stage embryos, were 
homogenized under different conditions and analyzed by Western blotting against 
Seb4 (Figure 17A). The embryos were either homogenized with a glass douncer 
(extract 1, lane 1’ and 1 in 17A) or by Bioruptor-lysis (ultrasonic waterbath; extract 2, 
3 in 17A).  
 
Figure 17: Seb4 elutes as a monomer by gelfiltration.  
(A), (C) Western blots against Seb4 with 6E5, diluted 1:10. (B) UV absorbance of 
extract 2 used for gelfiltration. (B) Comparison of different extract conditions. Extract 1: 
douncer, no detergent, 1’= ¼ of 1; extract 2: bioruptor, no detergent; extract 3: bioruptor, + 1 
% triton. (C) Collected fractions after gelfiltration. 
 
Extract 3 (17A lane3) was additionally treated with 1% Triton X-100. 
Although the buffer conditions of extract 3 provided the best Seb4 precipitation 
efficiency, the detergent is not compatible with the gelfiltration column. Hence, the 
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buffer and method of extract 2 (lane 2) offered the optimal conditions (Bioruptor, no 
detergent) for gelfiltration – a compromise between the precipitation efficiency 
(Bioruptor-lysis) and the buffer conditions compatible with gelfiltration (no detergent).  
For the gelfiltration experiments the method was further modified at several steps. 
The samples (bioruptor or douncer homogenized lysates) applied to the column were 
either crude lysates of neurula embryos in a small volume, or lysates in a larger 
starting volume with subsequent ammoniumsulfate precipitation (and dialysis). The 
standard method of assessing the resolution of a chromatographic separation is to 
monitor the elution profile with a UV detector for absorbance at 280nm, which 
provides a rough measurement of total protein eluting in a given fraction (Figure 17B; 
extract 2). According to the absorbance curve in Figure 17B, the fractions containing 
total protein above threshold were fraction A14 to C8. The fractions from A14 up to 
C8 were analyzed by SDS-PAGE and Western blotting against Seb4 (Figure 17C). 
All different generated protein extracts delivered the same results, represented in 
Figure 17C. Seb4 is found in the fractions between C4 and C7 (around 29kDa) with a 
peak in C5 and C6 (< 29kDa), which shows that Seb4 elutes with proteins of a size 
just below 29kDa. Thus, Seb4 behaves largely as a monomer and is not bound 
within a complex of higher molecular weight under all tested conditions. 
3.4.2 Seb4 – an RNA-binding protein?  
Gene regulatory networks require many levels of coordination, one also 
that links transcriptional and post-transcriptional processes. RNA-binding proteins 
(RBPs) act on the post-transcriptional level, which could be pre- or post-translational. 
Due to the amino acid sequence of Seb4, harbouring an RRM domain, we assume 
an RNA-binding function for Seb4. 
With the aim of finding associated RNA targets of Seb4, I developed a 
technology for purifying endogenously formed RBP–mRNA complexes from embryo 
extracts, by modifying and optimizing existent protocols for RNP investigations.  
To identify Seb4 associated RNAs several approaches were applied 
(Figure 18). RNA-Co-Immunoprecipitation (RIP) attempted to reveal endogenous 
Seb4-RNA complexes (red+blue) from lysates of Xenopus embryos. In a first step 
the protein-IP efficiency was controlled by Western blot analysis (18A). Next, putative 
RNA-target candidates were tested by RT-PCR (18B; data not shown). Finally, 
targets were screened by hybridizing Xenopus laevis total RNA with radioactively 
labelled cDNA derived from RNA extracted from the co-immunoprecipitated material 
under RNA-preserving conditions (18C). 
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Figure 18: Flowchart of RNA-co-immunoprecipitation (RIP) 
experiments to identify Seb4 associated RNA targets.  RIP: Immunoprecipitation of 
endogenous Seb4 from embryo extracts with the 6E5 antibody coupled to protein G 
sepharose beads under RNA preserving conditions, followed by (A) an „efficiency-check“ WB 
after elution of immunoprecipitated Seb4 by 0.2% sarcosyl; (B) „candidate approach“ by RT-
PCR to visualize putative candidates; (C) „fishing approach“ by hybridizing labelled cDNA 
deriving from co-immunoprecipitated transcripts after RNA preparation with Trizol, to total 
RNA. 
 
3.4.2.1 RNA-preserving-conditions ensure high protein-IP efficiency 
Despite the challenge lacking a positive control for the RNP-preserving 
conditions (see 2.7.7), it is even of greater importance to control the other steps of 
the procedure. The main reaction on which every following step depends on is the 
protein-immunoprecipitation. Hence, it was absolutely necessary to optimize the IP-
conditions and to control the efficiency by Western blot analysis (Figure 19). After 
elution of the beads-antibody complex, more than 25% of total (input) Seb4 could be 
immunoprecipitated (compare Figure 19 lane 2 and 7). In the contrary, neither the 
beads control nor the antibody 7F11 against MyoD serving as a negative ab control 
of type IgG2a (19 lane 3, 4, 1) could bind or precipitate any Seb4 protein. Further 
evidence for successful Seb4 precipitation was provided by Seb4 immunodepletion 
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effect observed in the embryo extract after Seb4-IP (19 lane 6). After Seb4-RIP, the 
Seb4 protein content in the embryo extract is strongly decreased compared to the 
MyoD-RIP (19 lane 5) and the input (19 lane 7). The high amounts of precipitated 
Seb4 under RNP-preserving conditions suggest that also Seb4 associated RNAs are 
precipitated.  
 
 
Figure 19: High Seb4 protein precipitation efficiency in RIPs. RIPs with 
antibodies (coupled to beads) against Seb4 (6E5) and MyoD (7F11), and beads alone. 
Western blot against Seb4 (6E5, 1:10). 
 
3.4.2.2 Northern blot total RNA screen 
The most promising option to screen for unknown RNA targets is a global 
approach. To identify targets, Seb4 co-immunoprecipitated material was hybridized 
against total RNA extracted from Xenopus. Instead of labelling the cDNA generated 
from total RNA from embryos an alternative and potentionally more sensitive method 
was carried out. Labelled cDNA probes were generated from the Seb4-co-
immunoprecipitated material and were hybridized against total RNA prepared from 
embryos at the according developmental stage (Figure 20). This method allows 
detection of rare transcripts, because the signal/noise ratio is much higher by 
selectively labelling the Seb4 co-immunoprecipitated RNA during the reverse 
transcription, rather than the total RNA.  
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Figure 20: RIP – „Fishing approach“ by hybridization against total 
neurula RNA. (A), (B) 32p autoradiograph of 6 % PAA gel; loaded samples: 32p dCTP 
labelled cDNAs, after reverse transcription; 100bp DNA ladder, ethidium bromide stained. (A) 
Optimizing RT- labelling conditions using total RNA, oligo d(T)-priming. (B) Random hexamer 
primed cDNA, + and – reverse transcriptase (RT). (C) 1,5% denaturating agarose gel loaded 
with 20µg total RNA per lane isolated from neurulae. (D) Northern blot hybridising labelled 
oligo d(T)-primed cDNA from RIP material to total RNA from according lanes from (C); EF1a 
serves as a positive control, and size marker. 
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The critical and most important step in the establishment of the protocol for 
this target-screen was to optimize the labelling reaction for sensitivity (Figure 20A). 
As expected, the generated cDNA products are represented by a signal smear and 
not by distinct bands, suggesting that the reverse transcriptase generated first strand 
cDNA products from all mRNA templates of all sizes in the sample. Additionally, the 
co-immunoprecipitated RNA molecules were possibly exposed to partial degradation. 
The radioactivity of the generated cDNA probes due to incorporation of 32p 
dCTP is highest amplified by using only radioactively labelled dCTP without 
unlabelled dCTP and by adding the highest concentration of dNTPs lacking dCTP, 
resulting in a higher signal intensity in the autoradiograph (Figure 20A). cDNAs in a 
wide range from 250bp to 3000bp can be detected as a dark smear.  
The RIP samples of several conditions using different antibodies against 
Seb4, MyoD and β-Cat were efficiently labelled during reverse transcription (as 
described above, 20A lane 1), and analyzed by phosphor-imaging (20B). Control 
reactions from which the reverse transcriptase was omitted, showed explicitly no 
labelled products, indirectly indicating the presence of some RNA in the co-
immunoprecipitated material (20B). After Seb4 RIP, the co-immunoprecipitated RNA 
appears mainly as a smear, with few distinct bands. Unfortunately, all signals derived 
from the RNA-co-immunoprecipiations with different antibodies show the same cDNA 
band pattern probably caused by unspecific binding; no Seb4 specific enrichment of 
RNAs could be found by RIP. 
In the next experiment cDNA probes were generated from oligo-d(T)primed 
and labelled co-immunoprecipitated RNA, and were hybridized against total cellular 
RNA. The pattern of total RNA isolated from neurulae is shown in Figure 20C. Equal 
amounts of RNA were loaded on a denaturing agarose gel visualizing the typical 
rRNA pattern as indicated in Figure 20C. The cellular RNA was blotted on a nylon 
membrane and in the following step hybridized against the RIP probes and analyzed 
by phosphor-imaging (Figure 20D). Elongation factor EF1a (Frydenberg et al, 1991) 
served as a positive control for the experimental procedure (reverse transcription of 
probes, Northern blot hybridization), as well as a size marker (sizes 3kb and 1,5kb; 
20D lane 4). It shows that specific mRNAs, albeit an abundant mRNA, can be 
visualized by this technique. Nevertheless, no enrichment of specific RNAs in the 
Seb4-RIP sample can be detected.  
In spite of RNA-preserving conditions, assuming the coherence of RNP-
complexes, and an efficient RT-labelling-reaction producing cDNAs in a wide range 
of sizes, no selective Seb4-associated RNAs could be enriched.  
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3.5 Localization of Seb4  
As demonstrated in the previous chapters, Seb4 is a highly conserved and 
very abundant protein, but so far no interaction partners of Seb4 could be determined 
by protein-IP, gelfiltration and RNA-IP. Therefore, Seb4 could influence a diverse 
array of global biological processes including cell growth, cell structure and 
differentiation, acting in concert with a broad range of unknown factors to mediate 
important regulatory effects. This leads to the suggestion that Seb4 might function as 
a general regulator in the cell interacting with many targets (e.g. tissue specific 
RNAs). 
Proteins with general, regulatory roles (e.g. splicing factors) are often 
localized to specific cellular compartments, such as the nucleus, nuclear bodies or 
cytoplasmic aggregates. Investigating the specific localization of an unknown factor 
can provide crucial information about the function of the protein. So, I used a different 
approach to gain a better understanding of the function of Seb4 by analyzing its 
localization in vivo by fluorescence microscopy. 
3.5.1 Seb4 is distributed in equal amounts to the cytoplasm and the nucleus  
Subcellular fractionation allows cells to be fractionated into compartment-
enriched fractions, utilizing differential centrifugation. In this case, separating the 
nuclear from the cytoplasmic compartment gives information about in which potential 
regulatory steps of the RNA metabolism Seb4 might be involved. 
In the following experiment, the nuclear compartment was separated from 
the cytoplasmic compartment by isolating the nuclei from neurulae embryos by 
sucrose density centrifugation. Subsequently, the nuclear fraction was further 
separated into a soluble fraction and into an insoluble nuclear pellet. The subcellular 
fractions were analyzed by Western blotting and Commassie staining (Figure 21). In 
the Coomassie stained gel (Figure 21, right panel) the varying protein compositions 
of all three fractions are visualized. The cytoplasm (lane 1) has the highest general 
protein content and a different protein composition than the nuclear fractions. The 
cytoplasmic fraction is characterized by high amounts of α-Tubulin, an abundant 
cytoskeletal protein, whereas Histone H3, a nuclear, DNA bound protein, is solely 
found in the insoluable nuclear fraction. Intriguingly, Seb4 is localized in comparable 
amounts in the cytoplasm and in the soluble portion of the nucleus, but is not bound 
to DNA.  
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Figure 21: Subcellular fractionation of Seb4 protein by preparation of 
tailbud nuclei and cytoplasm. Equivalents of 7 embryos loaded per lane. Antibodies are 
indicated on the right side. Coomassie stained gel serves as loading/separation control. 
 
In conclusion, Seb4 is a soluable protein localized in equal amounts in 
both compartments in the cell — the cytoplasm as well as the nucleus. 
3.5.2 Seb4 is expressed in the Xenopus cell lines A6 and XTC  
Another way to gain more insights into the localization and the linked 
function of Seb4 is to investigate Seb4 in another system. For this approach, two 
Xenopus derived cell lines, A6 Xenopus adult kidney cell line, and XTC Xenopus 
tadpole cell line were analyzed for Seb4 expression. At first, Seb4 expression was 
investigated in A6 and in XTC, on the RNA level by performing RT-PCR utilizing 
primers against seb4, seb4R and histone H4 (Figure 22A), and secondly, on the 
protein level by Western blot analysis (Figure 22B).  
To make sure that the Seb4 primers do not amplify Seb4R, because of the 
high sequence similarity, both primer sets were tested on their own and the other 
target, respectively (Figure 22A lane 5, 6 and 7). Seb4R appears to be strongly 
expressed in both Xenopus cell lines, even more than in a neurula embryo st.18, 
normalized by H4 expression. This might be an add-on effect since the Seb4R 
primers also detect Seb4 to a small extent (22A lane 5). The Seb4 primers, however, 
operate specifically and recognize only Seb4 and not Seb4R (22A lane 7). Seb4 is 
expressed in A6 as well as in XTC cells (upper signal in 22A lane 2 and 3), but with a 
lower expression rate than in a neurula embryo (22A lane 4), as well as lower than 
Seb4R is expressed in both cell lines judged by the H4 expression.  
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Figure 22: Seb4 expression in A6 and XTC Xenopus cell lines. (A) RT-
PCR showing Seb4 and Seb4R mRNA expression in different samples compared to histone 
H4 control. (B) Western blot detecting Seb4 protein in cells and embryos st. 37; Coomassie 
stained gel shows protein extracts used for WB. (C) Seb4 and Seb4R mRNA expression in 
different adult Xenopus tissues shown by RT-PCR. 
 
  
On the protein level, Seb4 behaves differently (Figure 22B). Coomassie 
staining reveals equal loading for the Western blot above. Unexpectedly, Seb4 
protein is expressed to a higher extent in A6 cells than in XTC cells (Figure 22B).  
Even if Seb4 expression is strongest in the embryo (22B lane 3), the A6 
kidney cell line shows Seb4 expression. 
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In the experiment depicted in Figure 22C, the expression levels of Seb4 
and Seb4R are compared in different adult frog organs by RT-PCR. Tissue samples 
of liver, heart, brain, kidney and muscle were analyzed. Similar to the tadpole embryo 
(st. 40), Seb4 is expressed in the adult heart and even stronger in muscle tissue. In 
contrast, Seb4R expression is found weakly in the liver and heart, but mainly in the 
kidney. 
Although Seb4 is neither expressed in the embryonic pronephros nor the 
adult kidney, it is strongly expressed in A6 cells derived from kidney tissue. The 
strong Seb4 expression in the A6 cell line make it a very suitable and easy model to 
study Seb4 localization in detail. 
3.5.3 Subcellular localization of Seb4 in the embryo and in A6 cells 
After determining the protein expression pattern of Seb4 in whole mount 
embryos by ICC (Figure 13B), the following experiments were performed to support 
former results and to learn more about the Seb4 distribution within different 
embryonic tissues and in A6 cells. 
3.5.3.1 Seb4 localization in different embryonic tissues is mainly nuclear 
On paraffin sections of tailbud embryos the tissues known to be Seb4 
positive (chapter 3.2.3) were investigated in detail by immunofluorescence (IF) 
illustrated in Figure 23. The aligned myocytes from the somites (skeletal muscle) 
clearly show Seb4 positive signals (in the sagital sections in panel C and C’), which 
supports the results from Figure 13B and 13C. In myocytes, the Seb4 protein is 
mainly found in the nuclei, rather than in the cytoplasm, as judged by the signal-
overlap (pink) between the red (Seb4) and blue (DNA) channels. The cross sections 
through the somitic myocytes (23D and D’) demonstrate the density and the 
proximity of the myocytes positive for Seb4. The whole myotome consisting of 
stacked myocytes between the epidermis (right) and the notochord (left) express 
Seb4, whereas other cell types, e.g. epidermis and notochord, do not have any Seb4 
protein expression. Interestingly, all cells that express Seb4 show a distinct protein 
distribution inside the nuclei. Within the Seb4 positive nuclei, a circular region devoid 
of Seb4 is surrounded by a high content of Seb4 protein. These Seb4-negative 
structures within the nuclei are also DAPI-free, which were confirmed by later 
experiments to be the nucleoli.  
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Figure 23: Seb4 protein localization in Xenopus embryos by 
immunofluorescence. (A-H) Immunofluorescence using undiluted Seb4 monoclonal 
antibody in sections of st. 27 embryos (40x magnification), (D, D’, F, F’) cross sections, (A-C’, 
E, E’, G-H’) sagital sections. (’) Merge panels. DNA stain shown in blue by DAPI and Seb4 
protein signal in red. (A) Phase contrast of embryo section st. 27 (10x magnification). White 
squares indicate the location of the areas shown enlarged in panel C-H (40x magnification). 
(B) IF anti-rat control without Seb4-ab (40x magnification). (C-D) Detail of myotome; (E-F) 
section through heart, Seb4 signal in the myocardium; (G) otic vesicle; (H) facial placodes. 
 
In panel E and E’ a small detail of a sagital section through the heart is 
shown. Seb4 is expressed solely within the myocardium, the muscular and 
multilayered tissue responsible for the contraction of the heart (23F and F’).  Seb4 is 
co-localizing with the DAPI stained nuclei, suggesting mainly nuclear localization of 
Seb4. The structures surrounding the myocardium contain the epidermis, the 
pericardium, a double-walled sac that contains the heart and the epicardium (not 
distinguishable from another in these sections). These tissues do not show any Seb4 
expression. The endocardium, the innermost layer of tissue lines the chambers of the 
heart is also not visible in these sections (23E and F). The oval single cell layered 
structure surrounded by the myocardium could represent truncated blood vessels, 
which also show no Seb4 expression. In conclusion, Seb4 expression in the heart is 
restricted to the myocardium. 
Another tissue highly expressive for Seb4 is the ectodermal derived ear 
placode (compare Figure 13B). Strikingly, Seb4 protein is exclusively expressed in 
the ventral region of the ear precursor tissue (23G and G’). Accompanied, in the 
ventral part of the otic vesicle Seb4 protein (G and G’) is not co-localizing with the 
DAPI signal in the nuclei. Seb4 protein seems to be localized to the cytoplasm. In 
contrast, the cell layers below the ear (23H and H’), most likely cells belonging to 
other facial placodes like the lateral line primordia, express Seb4 protein within the 
nucleus, overlapping with DAPI stained DNA.  
Since Seb4 is a key regulator of the myogenic programme, the Seb4 
distribution within the myocytes was analyzed in more detail in the following 
experiment. Immunofluorescence of Seb4 can reveal two possible results of the 
Seb4 protein localization in myocytes, most likely due to the IF procedure. 
Depending on unknown technical parameters, the Seb4 protein distribution is 
reproducibly either exclusively nuclear (Figure 24A) and/or strongly cytoplasmic 
(Figure 24B). The distribution of Seb4 inside the nucleus (24A-A’’) appears irregularly 
dotted, with local enrichments and different signal intensities. Per nucleus one to four 
Seb4 free regions are visible, which may be the nucleoli. The cytoplasmic Seb4 
Results  
 
 
90
distribution in B-B’’ is rather diffuse than spotty, although distinct dots can also be 
observed in the nuclei. In the cytoplasm Seb4 is enriched at the termini of the 
myocytes, morphologically easily recognized by the extracellular gap (dark line, Seb4 
negative) between two myocytes in one row. In around 50% (represented by the 
close up shown in B’’), Seb4 co-localizes with striated structures (compared to A’’). 
These regular lines proceed vertically to the longitudinal cell axis. The whole striated 
structure is located parallel between two cells along the nucleus representated in B’’.  
 
 
Figure 24: Nuclear and cytoplasmic localization of Seb4 in myocytes. 
Immunofluorescence on sagital embryo sections with undiluted Seb4 monoclonal antibody 
6E5. Detailed figure of myocyte nuclei (’’). (A) Nuclear Seb4 signal in red; (B) Cytoplasmic 
and nuclear signal in green. DAPI signal in blue. 
 
IF experiments in the embryo confirmed the Seb4 expression in the 
striated musculature, the myocardium and the myotome, and also in cranial 
placodes, like the otic vesicle. In most tissues, apart from the ear, Seb4 is mainly co-
localizing with DAPI. The Seb4 distribution in myocytes is cytoplasmic and nuclear. 
In the nucleus Seb4 is localized in a distinct spotty pattern similar to several nuclear 
bodies (e.g. splicing speckles, etc.). In the contrary, Seb4 distribution in the 
cytoplasm is rather diffuse with local enrichments at the myocyte termini. The 
variable Seb4 protein distribution in different tissues suggests multiple functions for 
Seb4.  
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3.5.3.2 Seb4 knock-down leads to an efficient loss of Seb4 protein in 
embryonic myocytes 
Similar to the Seb4 knock-down experiments in chapter 3.3 (see Figure 
14), here, the specificity of the immunofluorescence signal given by the antibody-
antibody-antigen complex was tested by Seb4 Morpholino injections. This 
experiment should also reveal if the Seb4 distribution in the cell (cytoplasmic and/or 
the nuclear protein population) upon Seb4 depletion was altered. For an internal 
control, the embryos were unilaterally injected with MO (right side of the notochord) 
and cross sections were generated, which were subsequently analyzed by 
immunofluorescence (Figure 25).  
 
 
 
Figure 25: Seb4 depletion by unilateral Morpholino injections leads to 
loss of Seb4 in myocytes. Immunofluorescence using undiluted Seb4 monoclonal 
antibody (red signal) in cross sections of st. 27 embryos. (A, A’) Control embryo injected (right 
side) with 40ng of standard MO; (B, C) Seb4-MO injected embryo (right side). Abbreviations: 
NT neural tube, NC notochord. 
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Injections of high doses of standard control MO had not changed the Seb4 
expression and localization pattern in myocytes (compare injected side in the right 
half of the panel to the uninjected side; Figure 25A and A’): Seb4 is strongly 
expressed in the nuclei (except the nucleoli) of the myocytes adjacent to the 
notochord. Upon Seb4 depletion by injection of 30ng of Seb4 MO, a loss of Seb4 
protein in most cells was achieved (right side) in both compartments, the nuclei (25B 
and B’) and the cytoplasm (25C and C’).  
These evidences confirm, that Seb4 expression is depleted extensively in 
myocytes by Seb4 MO injections. Seb4 knock-down causes equal depletion of both 
Seb4 proteins, the cytoplasmic and the nuclear subpopulations. This result also 
verifies that the signals in both compartments correspond to Seb4 protein.  
3.5.3.3 In A6 cells Seb4 is localized mainly to the cytoplasm 
As shown before in chapter 3.5.2 Seb4 is strongly expressed in Xenopus 
A6 cells. In regard to the varible protein pattern in embryonic myocytes, the next 
puzzling question was how Seb4 is distributed in A6 cells. Analysis of Seb4 
localization in a single cell (of a cell line) by IF is technically easier to analyze and 
could additionally disclose new aspects of the cellular distribution of Seb4 (Figure 
26). 
Interestingly, in A6 cells Seb4 protein is clearly localized to the cytoplasm 
enriched outside the nucleus (26C and C’). The cytoplasmic Seb4 protein appears 
diffusely localized in a very fine dotted pattern. In a few cells, distinct spots of Seb4 
protein are also detectable in the nucleus (26D and D’). Like in the somitic myocytes, 
the nucleoli are devoid of Seb4 (26D and D’).  
The most striking contrast of the cellular distribution of Seb4 protein 
comparing myocytes and A6 cells is that Seb4 is localized in A6 cells mainly to the 
cytoplasm. 
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Figure 26: Seb4 protein localizes mainly to the cytoplasm in A6 
Xenopus cells. Immunofluorescence using undiluted Seb4 monoclonal antibody in A6 cells. 
(A-C’) 40x magnification; (D and D’) 60x magnification with oil. (A) IF control, no Seb4-ab. (B) 
DNA stain by DAPI in blue and Seb4 protein signal in red (C, C’, D, D’). 
 
3.5.4 Co-localization experiments by IF 
The Seb4 distribution pattern alone does not indicate a possible function 
for the Seb4 protein. Since all steps of RNA metabolism are occurring at specific 
subcellular compartments or in dynamic bodies within the cell, the co-localization of 
Seb4 with marker proteins for different cellular regions is one step towards 
elucidating the function of Seb4 from a different angle.  
3.5.4.1 Secondary antibody compatibility tests 
Prior to perform sensitive co-localization experiments it is absolutely 
necessary to titrate the best compatible combination and dilution of secondary 
antibodies to achieve the highest sensitivity. Figure 27 shows the main results from 
the secondary antibody titration and compatibility tests. To minimize cross-reactivity 
among the fluorescently labelled antibodies, the following rules were obeyed.  
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Figure 27: Pretesting of secondary antibodies in A6 cells. (A, B) 
Background controls of secondary antibodies; (C-F) single IF (G, H), co-IF. (A-H) DNA 
staining with DAPI. Secondary antibodies used: Alexa fluor 488 (green), Alexa fluor 594 (red), 
Dianova Cy-2 (green), Dianova RRX (red). (’) Green channel, different secondary antibodies, 
as indicated in the panels. (’’) Red channel, different secondary antibodies, as indicated in the 
panels. (’’’) Merge. (C-H) Primary antibodies used: mouse anti-treacle; rat anti-Seb4. 
 
When two secondary antibodies against two host species (of the primary 
antibodies) were used, they were always chosen from one company as 
recommended (dianova and molecular probes). As primary antibodies, a monoclonal 
mouse antibody against treacle, a nucleolar marker, and the monoclonal rat antibody 
6E5 against Seb4 were used to test the optimal secondary antibody combination. To 
start with, all secondary antibodies were tested for background signals in absence of 
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primary antibodies (Figure 27A-A’’ and B-B’’). In the next step, species specificity and 
minimal cross reaction of the anti-rat secondary antibodies were evaluated by their 
use together with either the rat primary (27C’ and E’’) or the mouse primary (27D’ 
and F’) antibody. But when two secondary antibodies against mouse and rat were 
used together in one experiment with either one (27G-G’’’ and H-H’’’) or two primary 
antibodies (data not shown), the Alexa fluor antibodies from molecular probes cross 
reacted (27G-G’’’, data not shown). The Alexa anti-rat antibody recognizes the other 
secondary Alexa anti-mouse antibody bound to the primary mouse antibody,creating 
false signals (27G’ and G’’). This cross-reaction leads to the illusion that the Alexa 
anti-rat antibody would recognize the primary mouse antibody, which was ruled out 
before (27D’). This combination of Alexa antibodies is therefore inaccurate. In 
contrast, the dianova secondary antibodies do not show any cross reaction with 
another component of the reaction (27H-H’’’, data not shown). 
From theses initital experiments it could be concluded that the Alexa fluor 
secondary antibody against rat (and mouse, data not shown) show cross reaction 
and is therefore inaccurate for the co-immunofluorescence experiments. The dianova 
antibodies, however, are suitable due to their high specificity, lack of cross-reactivity, 
and are therefore chosen for the following experiments. 
3.5.4.2 Markers for co-localization studies 
The proper secondary antibody combination displays only one important 
tool to study co-localization. Just as important is the choice of markers that should 
cover a reasonable range of suborganelles and cellular structures and integrate the 
previous data. The antibodies chosen for the following experiments meet all claims. 
On one hand, they combine a putative function of Seb4 in the RNA metabolism due 
to its RNA-binding motif with the localization data gained by other methods and the 
availability of the antibodies, on the other hand.  
In embryonic myocytes Seb4 expression in the nucleus appears in a 
spotted pattern (see Figure 23). This finding suggests further investigation of nuclear 
suborganelles that are linked to the RNA life cycle.  
Such suborganelles are for example speckles. Speckles are subnuclear 
structures that are enriched in pre-messenger RNA splicing factors and are located 
in the interchromatin regions of the nucleoplasm (see 1.3.2.1). At the fluorescence-
microscope level they appear as punctate structures, which vary in size and shape. 
Speckles are dynamic structures, and both their protein and RNA-protein 
components can cycle continuously between speckles and other nuclear locations, 
including sites of active transcription (Lamond & Spector, 2003). In order to analyze if 
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Seb4 is located in speckles or associated with spliceosomes, two markers for 
speckles, DRSP and SF3b, were analyzed.  
DRS protein (also called Pinin) is associated with desmosomes and co-
localizes with splicing factors in nuclear speckled domains. Nuclear DRSP binds to 
spliced mRNPs and participates in mRNA processing and export via interaction with 
RNPS1 (Li et al, 2003). 
The splicing factor SF3b is a multiprotein complex essential for the 
accurate excision of introns from pre-messenger RNA. As an integral component of 
the U2 small nuclear ribonucleoprotein (snRNP) and the U11/U12 di-snRNP, SF3b is 
involved in the recognition of the pre-messenger RNA's branch site within the major 
and minor spliceosomes (Golas et al, 2003). 
Another interesting nuclear functional structure/complex is at the start of 
the RNA life cycle, the transcription unit. This unit is formed of large multifunctional 
complexes, called transcriptosomes, in which the biosynthesis of mature mRNAs is 
coordinated. The essential key player that builds the platform for these complexes is 
the RNA polymerase II (RNAP II). RNAP II and its associated factors interact with a 
diverse collection of nuclear proteins during the course of precursor messenger RNA 
synthesis. Throughout the transcription cycle the carboxy-terminal domain (CTD) of 
the largest subunit of RNAP II undergoes a variety of covalent and structural 
modifications, which can in turn modulate the interactions and functions of 
processing factors during transcription initiation, elongation and termination. Besides 
the CTD, proteins involved in pre-mRNA processing can interact with general 
transcription factors and transcriptional activators, which associate with polymerases 
at promoters (Howe, 2002). The antibody WGPol II against total RNAP II makes a 
good marker for all sites where either active (phosphorylated CTD) or inactive 
(unphosphorylated CTD) RNAP II is located. Another antibody against active RNAP 
II (phosphorylated CTD at Serin2) was tested in single localization experiments but 
was not found to show any signal overlap with Seb4 (data not shown). 
The most prominent nuclear subcompartment in the nucleus is the 
nucleolus, the site of ribosome biogenesis. The protein Treacle e.g. functions in 
ribosomal DNA gene transcription and is recruited to NOR (nucleolar organizing 
regions) chromatin. Treacle is a phosphoprotein encoded by the TCOF1 gene and 
belongs to the factors involved in linking transcription with pre-rRNA modification 
(Prieto & McStay, 2007).  
Another nucleolar marker, which was used, is NO38 protein. It is an 
abundant nucleolar Histone chaperone and a member of the nucleoplasmin family 
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(Namboodiri et al, 2004). The nucleolar markers can be used as negative controls, 
since Seb4 was shown to be absent from the nucleolus (see  3.5.3.1). 
As a marker for the nucleoplasm an antibody against Xenopus acidic 
nucleoplasmic DNA-binding protein AND-1 was used. AND-1 is a widespread, 
soluable, ubiquitous protein accumulated in the nucleoplasm of oocytes and various 
other cells. AND-1 appears as an oligomer, probably a homodimer, and has been 
localized throughout the entire interchromatic space of the interphase nucleoplasm, 
whereas during mitosis it is transiently dispersed over the cytoplasm (Kohler et al, 
1997).  
Nuclear lamins form a highly insoluble structure, the nuclear lamina, which 
is associated with the nuclear envelope. Lamin A/C belongs to type V intermediate 
filaments and constitutes the nuclear lamina and nuclear matrix, where a variety of 
nuclear activities occur. The antibody against Lamin A marks the nuclear envelope. 
In addition to all these nuclear markers I chose α-Tubulin for the main 
cytoplasmic structure, the cytoskeleton, consisting of microtubules built from basic 
α/β-Tubulin blocks. 
3.5.4.3 Co-IF in embryonic myocytes 
The nuclear portion of Seb4 in embryonic myocytes is localized in a 
spotted pattern. Therefore, it appeared very interesting to test, whether Seb4 co-
localizes with SF3b and DRSP (Figure 28C and D). DRSP as well as SF3b are 
irregularly dispersed over the nucleus, except for the nucleolus, in a rather diffuse 
way with dense areas. Co-localization experiments of the speckles markers with 
Seb4 revealed, that the local areas in which DRSP and SF3b (28C and D) are 
enriched, show partly slight Seb4 localization. Despite suboptimal resolution, Seb4 
protein, however, is predominently located in regions devoid of DRSP and SF3b, 
resulting in no co-localization.  
Next, the nuclear distribution of total RNAP II was analyzed in correlation 
to Seb4 (28E). RNAP II accumulates in distinct spots at many sites dispersed all over 
the nucleoplasm, similar to the Seb4 distibution pattern. Nevertheless, in the merge 
of RNAP II and Seb4 signals it becomes clear, that the sites enriched with either of 
the proteins are not identical; the signal-overlap appears rather random. Seb4 shows 
no co-localization with total RNAP II. 
Finally, the cyotoskeletal marker α-Tubulin was investigated (28F). α-
Tubulin is localized in the cytoplasm, in an irregular manner and not in a filamentous 
network. Seb4 is localized mainly to the nucleus, so no co-localization between α-
Tubulin and Seb4 could be observed. 
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Figure 28: Co-localization of Seb4 protein and selected nuclear and 
cytoplasmic marker proteins in embryonic sections through myocytes. Co-IF of 
Seb4 protein with nuclear (C-G), and cytoplasmic (H-I) proteins. (A-B) Background controls, 
shows secondary antibodies RRX donkey a-rat in red and Cy2 donkey a-mouse in green. (A-
I) DAPI stained DNA, (’) red channel shows Seb4 signal, (’’) green channel shows marker 
signal. (’’’) merge. (’’’’) Detail of (’’’). 
 
3.5.4.4 Co-IF in A6 cells 
In contrast to the embryonic myocytes Seb4 protein is restricted to the 
cytoplasm in A6 cells. Nevertheless, it appeared very interesting to analyze the 
nuclear markers in this cellular background (Figure29).  
Lamin serves as a marker for the nuclear envelope because its boundary 
is more precise than the one from the DAPI counterstain (Figure 29C). The other 
question if Seb4 is perhaps enriched inside or at the periphery around the nuclear 
envelope could be answered by analyzing the co-localization of Seb4 with lamin. The 
lamin dense region, seems devoid of Seb4 or at least of lower concentration.  
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Figure 29: Co-localization of Seb4 protein and selected nuclear and 
cytoplasmic marker proteins in A6 cells. Co-IF of Seb4 protein with nuclear (C-E) and 
cytoplasmic (F) marker proteins. (A-B) Background controls, show secondary antibodies RRX 
donkey a-rat in red and Cy2 donkey a-mouse, and Cy2 donkey a-guinea pig. (A-F) DAPI 
stained DNA; (’) red channel shows Seb4 signal; (’’) green channel shows co-IF signal; (’’’) 
merge; (’’’’) detail of (’’’). 
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Seb4 does not co-localize with lamin at the inside of the nuclear envelope, 
suggesting that Seb4 is localized outside the nucleus.  
The antibodies against SF3b and DRSP mark the position of the splicing 
speckles in the nucleus (29D and E). As shown by the merges, the Seb4 protein 
signal does not overlap with the speckles markers, because it is located in the 
cytoplasmic compartment (29D andE).  
In Figure 29F the nuclearplasm fluoresces via AND-1 detection. 
Additionally to the presence of the nucleus, the signal of AND-1 confirms, that the A6 
cells do not undergo mitosis (see 3.5.4.2). Though the AND-1 signal is very weak, it 
is clear that AND-1 and DAPI overlap, whereas Seb4 is located to the cytoplasm.  
Treacle protein is detected in Figure 29G. It is concentrated in the 
nucleolus as well as in these dotted nuclear entities. There is no Seb4 co-localization 
with Treacle. NO38 shows, besides its nucleolar localization a cytoplasmic 
distribution, where Seb4 is also localized (29H). Upon overlay of both signals, the 
cytoplasmic NO38 protein is located not directly adjacent to the nucleus, resulting in 
a gap of an exclusively Seb4-positive ring around the nucleus. Yet, the structure of 
the cytoplasmic NO38 does not correlate to the diffuse signal of Seb4 in the 
cytoplasm.  
As mentioned above, Seb4 is localized in A6 cells primarily to the 
cytoplasm. So, it was very interesting to see if it co-localized with α-Tubulin (Figure 
29I). In most cells the densities of both Seb4 and α-Tubulin signals are correlated. In 
those cytoplasmic areas where Seb4 is enriched, a more concentrated α-Tubulin 
structure (e.g. both cells at the top right) was detected. This result is confirmed by the 
yellow signal colour in the overlay. Nevertheless, Seb4 does not show the precise 
filamentous protein pattern, like α-Tubulin does. 
 
Concluding from the co-localization experiments, nuclear Seb4 is not 
located to the nucleoli, splicing speckles, or sites of transcription. In regard to its 
cytoplasmic distribution, Seb4 does not appear to be associated with the 
cytoskeleton. 
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4 Discussion 
In the last decades, a large amount of developmental studies have been 
devoted to the identification and characterization of growth factors and transcription 
factors expressed in the early embryo. In the complex series of events involved in 
cellular differentiation and organogenesis, also post-transcriptional mechanisms 
constitute an additional layer of regulatory control over gene expression and are 
employed to modulate differentiation programmes regulated by growth and 
transcription factors. Indeed, a lot of evidence indicates that numerous 
developmental processes are regulated at the level of RNA processing, stability, 
localization, and translation by non-coding RNAs and/or RNA-binding proteins. 
MicroRNAs, a class of non-coding RNA molecules, function in potent inhibition of 
individual key targets or coordinated regulation of target clusters, fine-tuning of target 
activity, and the reversibility of some aspects of microRNA-mediated repression 
(Bushati & Cohen, 2007).  
RBPs coordinate functionally related sets of mRNAs through binding with 
their RNA-binding domains to sequence elements in the mRNA. Considering the 
hundreds of RBPs encoded in eukaryotic genomes, post-transcriptional control may 
be even comparable in its richness and complexity to transcriptional regulatory 
systems. Although they are not generally as well characterized as signalling and 
transcriptional networks yet, the number of RBPs known today to be involved in 
vertebrate development is growing and provides an additional level of coordination.  
The highly conserved, RRM containing protein Seb4 was described first in 
Xenopus laevis by Heinrich Jasper from our laboratory in 1998, as a direct target of 
MyoD (Jasper, 1998), and later by the Bouwmeester labratory (Fetka et al, 2000) as 
a tissue-specific putative RNA-binding protein identified in an RNA in situ screen for 
genes showing time-specific expression patterns. However, the role of Seb4 and its 
biochemical properties have not been published, yet.  
In this study, I have characterized Seb4 in the early development of 
Xenopus laevis by various biological and biochemical approaches. Firstly, I analyzed 
the Seb4 mRNA and protein expression pattern and its subcellular localization. Next, 
I addressed the biological function of Seb4 revealing the skeletal and cardiac muscle 
differentiation pathways, in which Seb4 is involved, and the skeletal muscle and lens 
differentiation pathway, for which Seb4 is required. Thirdly, I attempted to identify 
RNA and protein interaction partners of Seb4 via RIP, IP and gelfiltration. 
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4.1 Molecular tools 
The following chapters serve to discuss and accent the quality of the 
biochemical analyses and the L-o-F approaches employed here. 
4.1.1 Antibodies 
Many applications aiming at the identification of the biochemical properties 
of a special protein take advantage of the antibody-antigen interaction. Thus, a major 
part of protein biochemistry is the use of antibodies.  
Polyclonal sera contain a mixture of antibodies binding to various epitopes 
found on the target protein. Therefore, the avidity of polyclonal sera for the antigen is 
usually high. The polyclonal origin of the antibodies present in the antisera implies 
that they are prone to cross-react with unrelated proteins. By contrast, monoclonal 
antibodies bind only one epitope of the antigen. This results in high specificity and in 
rather low background, but also lower avidity.  
Here, for broader applications, we have generated both monoclonal 
antibodies in rats and polyclonal antibodies in rabbits against the full-length Seb4 
peptide. These were tested individually with regard to their cross-reactivity. 
Regarding their applicability, the monoclonal 6E5 antibody turned out to be an 
excellent tool of very high specificity exclusive of cross-reactions and unspecific 
binding. It was successfully applied in many experimental approaches like Western 
blot, immunocytochemistry, immunofluorescence, and immunoprecipitation, which 
were of fundamental importance for the biochemical characterization of Seb4.  
The monoclonal antibody 6E5 recognizes endogenous and in vitro 
translated full-length Seb4 protein, both in native and SDS-denatured conformation. 
However, the delta C deletion protein (RRM-domain mainly) is recognized only in its 
denatured form, but not as a native peptide. The RRM domains of Seb4 and Seb4R 
are virtually identical in sequence and, consequently, in vitro translated Seb4R is 
recognized by the 6E5 antibody – both in its native and denatured states. 
Endogenous Seb4R protein from embryo lysates, however, is not detected, which 
suggests that the epitope of Seb4R is inaccessible, either by an associated factor or 
by modification. 
These observations indicate that the epitope is located within the 
conserved RRM domain. Though, in some cases, unnatural folding may prevent 
exposure of the epitope to the antibody, which explains, for example, why the delta C 
peptide is not recognized. Also in case of Seb4R, it appears that the epitope of 
endogenous Seb4R is masked, either by complex formation with interacting factors, 
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or it is not accessible due to modifications. Most importantly, endogenous Seb4 and 
Seb4R could be distinguished. 
The polyclonal serum 7600 showed a lower signal/noise ratio in WB and 
ICC, but a higher efficiency in IP than the monoclonal 6E5 did. For future 
experiments this polyclonal serum could be of great value if it was further processed 
by affinity purification to minimize cross-reactions. An additional advantage is the 
different host species against which the polyclonal serum had been generated (anti-
rabbit), as it would allow double-immunofluorescent analysis with rat-antibodies, 
which can be applied to demonstrate co-localization. 
4.1.2 Morpholinos 
Gain-of-function studies (G-o-F) provide useful information about the 
potential function of a protein. However, only the loss-of-function (L-o-F) studies can 
reveal the essential function of a protein. Researchers working on RNA-binding 
proteins with several RRMs have successfully constructed dominant-negative 
versions of RBPs, by generating truncated constructs, missing one or two RRMs 
(Akamatsu et al, 1999; Anderson et al, 2000). However, because Seb4 only contains 
one RRM, I could not use such a strategy. Previously in our laboratory, deletion and 
point mutation constructs were generated, which lacked biological activity and were 
in consequence not dominant-negative. The most successful method used for L-o-F 
experiments in Xenopus is to reduce protein levels by inhibiting mRNA translation by 
microinjection of specific antisense MO oligonucleotides (Heasman et al, 2000). This 
method is well established in Xenopus and offers many advantages like high 
specificity, easy target selection, high biological stability, and high efficiency. Its 
greatest advantage compared to genetic knock-out mutants (in other organisms) is 
that phenotypes can be rapidly observed in the same generation of animals (F0). The 
degree of depletion depends on many parameters, including the abundance and 
stability of the protein that is present at the time of MO introduction, the amount of 
diffusion, the localization of the targeted mRNA, and the amount of de novo 
transcription. The penetrance of the phenotype obtained by a specific MO is quite 
variable ranging from low (e.g. smad5) to high percentages (e.g. no tail) (Heasman, 
2002). Furthermore, the expressivity of a specific phenotype can vary immensly, e.g. 
from only partial protein depletion (may cause only minor defects) to complete lack of 
protein (Heasman, 2002). The severity of the phenotype is dependent on the injected 
dose of MO oligonucleotides and the stability of the MO. Subsequently, the 
concentration of Seb4 MO played an important role for the penetrance and severety 
of the phenotype; the higher the dose of injected Seb4 MO the more efficient was the 
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down-regulation of Seb4 protein, as observed in Western blots, consequently leading 
to an even more severe phenotype (see 3.3.1).  
Another consideration specific to Xenopus laevis is that due to its 
allotetraploidy both gene copies of seb4, seb4a and seb4b, have to be targeted by 
the MO to achieve an efficient knock-down. Therefore, the MO was designed against 
the conserved coding region at the start site of both gene copies. 
Nevertheless, there are limitations to the MO technique. Several authors 
report toxic effects after MO injections in zebrafish. It has not been resolved whether 
these side effects are non-specific or due to the MO being complementary to an 
unknown target. These side effects include widespread cell death, defects in epiboly, 
and neural degeneration (Imai & Talbot, 2001; Karlen & Rebagliati, 2001; Lele et al, 
2001; Nasevicius & Ekker, 2000). None of these phenotypes was observed in 
Xenopus after Seb4 MO injection. The results of the Seb4 MO L-o-F experiments 
complemented and substantiated the presumptions achieved from the previous 
overexpression studies (data not shown, chapter 1.3.4). Notably, rescue experiments 
are left here to mention, which would also demonstrate the specificity of a MO. 
Overall, the antisense morpholino oligonucleotides represent a great tool 
to study many aspects of Seb4 protein function (as shown in Figure 4, 6, 7, and 18). 
Thus, the knock-down experiments using MO against Seb4 emerged as a very 
successful approach leading to profound results concerning the role of Seb4. 
 
4.2 Spatio-temporal expression of Seb4 in Xenopus 
embryos 
4.2.1 Seb4 is an abundant protein expressed in early development 
In this study, Seb4 protein is shown to be expressed throughout early 
larval development from the unfertilized egg to late tailbud stages. Since zygotic 
transcription only starts during the mid-blastula transition, Seb4 protein in the earlier 
stages, from egg to blastula, is either due to the translation of maternal seb4 RNA or 
represents maternally contributed Seb4 protein. Maternal Seb4 was located in the 
animal half of the embryo, which suggests a regulated localization for either Seb4 
mRNA or protein. After zygotic transcription has commenced at MBT, the level of 
zygotic Seb4 remains equally until neurula stage. During neurogenesis, protein 
expression increases strongly, reaching a constant level at st. 19 neurulae until late 
tailbud stages.  
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In order to estimate the Seb4 protein abundance, semi-quantitative 
Western Blot analysis was performed. Assuming that a tailbud embryo contains 106 
cells with roughly 10% expressing Seb4, we calculate an average abundance of 105 
Seb4 protein copies per cell (see calculation in 3.2.1). In comparison, a mammalian 
dividing cell contains up to 107 ribosomes. In the Xenopus oocyte even 1012 
ribosomes accumulate (Cooper, 2000). Histones, for example, are with 3 x 108 
molecules one of the most prevalent proteins in the cell, whereas other protein types 
only exist in up to 1000 copies per cell (Müller-Esterl, 2004). Actually, the abundance 
of different proteins varies widely, from the quite rare cell-surface receptor protein 
that binds the hormone insulin (20,000 molecules) to the abundant structural protein 
actin with 5 x 108 molecules (Lodish et al, 2000). 
Thus, the Seb4 protein content with 105 copies per cell is in a range just 
below the most frequent proteins and is therefore a very abundant protein, 
suggesting broad, perhaps general roles for Seb4. 
Besides the high abundance of Seb4, another interesting feature is that in 
all analyzed stages endogenous Seb4 from embryo extracts migrates as a double 
band at 25kDa. The migration size correlates with the estimated molecular weight of 
24,75kDa, but the origin of the doublet appears puzzling. One explanation is that 
Seb4 exists in two isoforms, as it was shown before in human, mouse and Xenopus, 
where alternative splice variants exist for many proteins. In human, there is evidence 
that the RNPC1 gene, which is the human homologue of Seb4, encodes at least two 
isoforms of an RNA-binding protein through alternate splicing at the C-terminus. Both 
isoforms, RNPC1a with 239aa and RNPC1b with 212aa, are identical in their N-
terminal RRM domain. RNPC1 is induced by the p53 family and by DNA damage in a 
p53-dependent manner, whereby RNPC1a is capable of inducing G1 arrest and 
binds to the 3' UTR of the p21 transcript regulating its stability (Shu et al, 2006). 
By knocking-down Seb4 selectively with MO (seven mismatches to 
Seb4R) it was ruled out that the endogenous ortholog Seb4R is detected by the 
monoclonal 6E5 antibody, concluding that Seb4 exists in two forms. It is possible that 
either both gene copies Seb4a (calculated MW 24,75kDa) and Seb4b (calculated 
MW 24,97kDa), two splice variants of Seb4a/b or two protein forms display different 
migration behaviour due to post-translational modification with the doublet signal 
representing the steady state equilibrium between the two forms. SR proteins, e.g. 
those containing one or two RRMs, are extensively phosphorylated at their SR 
domains and can exist in differentially phosphorylated (hypo- and 
hyperphosphorylated) states. For proper execution of splicing activity, cycles of 
phosphorylation and dephosphorylation of SR proteins are important. 
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Phosphorylation of SR proteins also dictates their nuclear import (Graveley, 2000; 
Lai et al, 2001; Shi et al, 2006).  
The ability of Hu proteins to stabilize their mRNA targets is also regulated 
by post-translational modifications of the Hu proteins themselves. For instance, the 
stabilization of the SIRT1 mRNA appears to be modulated by phosphorylation of 
HuR (Abdelmohsen et al, 2007), whereas the arginine methylation of HuD by 
coactivator-associated arginine methyltransferase 1 (CARM1) affects mRNA turnover 
of p21cip1/waf1 mRNA (Fujiwara et al, 2006). 
Therefore, phosphorylation as the most common post-translational 
modification, as shown above, was experimentally tested here, but turned out not to 
play a role for Seb4 protein migration and doublet recognition indicating that Seb4 
protein is not modified by phosphorylation. As it was shown for HuD, for example, it 
could be tested if arginine methylation, is responsible for the two Seb4 protein states 
detected. 
4.2.2 Seb4 expression in mesodermal and ectodermal derivatives 
In the embryo, Seb4 is expressed in a tissue and stage specific pattern in 
cells belonging to the mesodermal and ectodermal lineages. In gastrula stage 
embryos, Seb4 expression is first induced in the mesoderm in prospective myoblasts 
that also strongly express MyoD and Myf5, but Seb4 is restricted to two small regions 
flanking the organizer. At neurula stage, the expression domains of Seb4 and MyoD 
are identical in the paraxial mesoderm. Additionally to Seb4 expression in other 
tissues (see below), at later stages, Seb4 and MyoD expression overlap in 
differentiating myocytes of the skeletal muscle. The in situ analyses strongly confirm 
the data gained from the in vitro screen, where Seb4 was found as a direct target of 
MyoD protein (Jasper, 1998). Conclusively, endogenous Seb4 expression in the 
mesoderm is directly controlled by MyoD during muscle differentiation in vivo. Thus, 
Seb4 may be involved in the determination phase of the muscle lineage. 
As development proceeds, Seb4 is also expressed in the myocardium 
(heartmuscle) and in neuroectodermal derivatives like the eye (neuronal), the ventral 
part of the otic vesicle, some cranial placodes and developing lateral line primordia. 
All of these tissues lack MyoD expression suggesting that the Seb4 promotor 
receives multiple inputs and Seb4 transcription responds tissue-dependently to other 
transcription factors than MyoD.  
Moreover, in situ expression analyses revealed that the patterns of Seb4 
mRNA and protein expression are identical with the exception of the eye. There, 
Seb4 mRNA expression seems not to correlate with the Seb4 protein localization. 
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Seb4 mRNA can be detected firstly in the in the retina at tailbud stage 23. As 
development proceeds, the retinal Seb4 RNA expression is lost, but found again later 
in the lens. Seb4 protein behaves the other way around. Firstly, Seb4 protein is 
detected in the lens and is later solely found in the retina. This paradoxical 
observation and the poor correlations generally reported in the literature between the 
mRNA and protein can be explained by several reasons, that may not be mutually 
exclusive (Greenbaum et al, 2003).  
First, there are various post-transcriptional mechanisms involved in turning 
mRNA into protein that may disturb protein or mRNA detection. Second, proteins 
may differ substantially in their in vivo half-lives compared to their mRNAs. The 
impression can impose that mRNA and protein are expressed differently, if the 
mRNA is only transiently expressed, whereby the protein is very stable. In the stages 
where Seb4 mRNA is detected, but no Seb4 protein, it could be explained by a 
higher stability of Seb4 mRNA compared to the protein. Since not all continuous 
stages were analyzed, it is possible that the missing stages would show an overlap 
of Seb4 mRNA and protein expression. 
Another explanation for the indirect correlation of Seb4 RNA and protein 
expression in the eye could be due to non-specific cross-reactions of the 6E5 
antibody accompanied with masking of the Seb4 epitope. Since Seb4R harbours the 
same epitope recognized by the 6E5 antibody in vitro, it could become the target 
protein, because it is expressed in the retina (Boy et al, 2004). A conformational 
change or the dissociation of a bound factor, for example, could suddenly make the 
Seb4R epitope accessible.  
The option that Seb4 protein is transported from the retina to the lens and 
later from the lens to the retina is rather unlikely.  
The possibility that Seb4 RNA was not detected despite it was expressed, 
is ruled out by the ISH procedure, which destroys all RNA secondary structures 
leading to free access of all RNAs to the antisense probes.  
Nevertheless, in regard to the eye, the disparate correlation between the 
observed Seb4 mRNA and protein expression remains cryptic and requires further 
investigation. But in all other tissues, muscle, heart, ear, and neural placodes the 
expression of Seb4 mRNA and protein is identical. 
4.3 Nuclear and cytoplasmic localization of Seb4 
Immunolocalization experiments in the embryo have demonstrated that in 
striated muscle Seb4 protein is localized to the nucleus and cytoplasm. Regardless 
of the different volumes of both compartments Seb4 is shown to be distributed in 
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equal amounts (not concentration) between the nucleus and the cytoplasm. Seb4 
contains no classical nuclear localization signal for active transport. Seb4 protein with 
only 25kDa is small enough to enter the nucleus by passive diffusion through the 
nuclear pore complex.   
On the other hand, passive diffusion would imply an equal protein 
concentration in both compartments. Taking in consideration that the volume of the 
nucleus is much smaller than of the cytoplasm, Seb4 concentration in the nucleus is 
much higher (even when the protein amounts are equal in both compartments). This 
supports the hypothesis of an active import mechanism for Seb4. This finding 
suggests a role for Seb4 in the early RNA metabolism, a step between the birth of 
transcripts until they are exported out of the nucleus. In this study however, Seb4 
was shown not to localize to the sites of transcription, where nascent transcripts are 
generated, because no co-localization with total RNA-Polymerase II was found. In 
the nucleus of myocytes Seb4 is concentrated in distinct foci – structures that bear 
similarity to nuclear speckles, in which splicing factors accumulate when they are not 
actively engaged in splicing reactions.  
Seb4 may be involved in polyadenylation or a later step in the RNA 
metabolism implicating a shuttling mechanism. One option to be considered is that 
Seb4 could exit the nucleus by the piggyback style, as part of RNP complexes 
dependent on the association to mRNA. 
SR proteins, for example, piggyback on mRNA to exit the nucleus. Several 
members of this family have been shown to bind to exon sequences and to 
accompany mRNA molecules in transit to the nuclear pores. The association of SR 
proteins with spliced mRNA could therefore serve as a guide for mature RNAs to 
cross the nuclear pores (Manley & Tacke, 1996). 
U2AF65 and U2AF35 are also shown to shuttle continuously between the 
nucleus and the cytoplasm by a mechanism that involves carrier receptors and is 
independent from binding to mRNA. The SR domain of U2AF65 or U2AF35 acts as a 
nuclear localization signal and is sufficient to target the protein complex to the 
nuclear speckles. Although Seb4 is enriched in distinct foci, Seb4 does not co-
localize with markers for speckles. Furthermore, the presence of an SR domain in 
either U2AF subunit is sufficient to trigger the nucleocytoplasmic import (Gama-
Carvalho et al, 2001). Nucleocytoplasmic shuttling of TIAR and TIA-1 is also 
mediated by their RNA-binding capacity. The RRM2 and the first half of the auxiliary 
region were identified as important determinants for TIAR and TIA-1 nuclear 
accumulation. In contrast, the nuclear export of TIAR and TIA-1 is mediated by 
RRM3 (Zhang et al, 2005). 
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Since Seb4 contains no SR domain, possibly an unknown signal patch or 
peptide in the C-terminal half of the protein is used as a localization signal, or Seb4 
transport is dependent on its single RRM, as shown for TIAR and TIA-1 above. 
So far, the foci in which Seb4 is concentrated could not be associated to 
any of the nuclear suborganelles tested here. 
Previous studies have shown that other RRM containing RBPs are also 
present in both the nucleus and cytoplasm. These include the Elav-family, which are 
required for neuronal differentiation (Perron et al, 1997; Perron et al, 1999). 
Furthermore, it has been demonstrated that RBPs can exhibit different functions in 
different cellular compartments. One prominent example is sex lethal, which 
regulates splicing in the nucleus, but is involved in translational repression in the 
cytoplasm (Bashaw & Baker, 1997; Kelley et al., 1997). 
Another example for post-transcriptional regulation by different subcellular 
localization is already shown for myoD. Early in muscle differentiation, the RBP HuR 
is localized to the nucleus of myoblasts by active Transportin 2 (TRN2)-mediated 
import. In differentiated muscle fibers, however, the TRN2-HuR complex is disrupted, 
leading to the cytoplasmic localization of HuR, as well as to the stabilization of myoD 
and myogenin mRNAs (van der Giessen & Gallouzi, 2007).  
 
In embryonic striated muscle the main population of Seb4 protein is shown 
in this study to be enriched in the nucleus, albeit some of the protein accumulates in 
the cytoplasm. Seb4 protein that is expressed in the ventral part of the otic vesicle is 
exclusively localized to the cytoplasm, suggesting a different regulation and 
functional role for Seb4 in the ear. The ventral pole of the otic vesicle is the pars 
inferior, serving as anlage for vestibular and auditory structures. As in most 
vertebrates, inner ear development begins with the invagination of a thickened 
epithelium near the hindbrain, the otic placode that gives rise to a spherically shaped 
otic vesicle. In Xenopus, induction of the otic placode and specification of the otic 
vesicle are complete by neural tube stages, establishing that the ear is one of the 
first organs to be determined during organogenesis (Noramly & Grainger, 2002). The 
otic placode in early Xenopus tailbud embryos starts out as part of a larger 
dorsoventral placodal area that will later also give rise to individual lateral line 
placodes (Schlosser & Northcutt, 2000). It has been proposed that this dorsoventral 
thickening is merely a subset of a much larger primitive ectodermal thickening 
present at earlier stages that gives rise to all neurogenic placodes, of which some 
also express Seb4. These observations suggest that all ectodermal expression of 
Seb4 in different cranial/neurogenic placodes is derived from one origin, the primitive 
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ectodermal thickening. 
 
 In A6 cells, Seb4 is mainly localized to the cytoplasm, distributed diffusely. 
Cytoplasmic accumulation has been shown to occur in many cases in response to 
cellular stress. For example, the shuttling proteins CIRP and TIA-1/TIAR migrate to 
stress granules, which are sites of translational regulation (De Leeuw et al, 2007; 
Zhang et al, 2005). Unfortunately, it could not be tested whether Seb4 migrates to 
stress granules upon stress induction, because the only available antibody against 
TIAR was against human TIAR and did not cross-react with Xenopus TIAR.  
Instead, it could be shown that cytoplasmic Seb4 is not attached to the 
microtubuli of the cytoskeleton, indicating that Seb4 is not involved in RNA transport 
along these microtubuli. Interestingly in myocytes, besides the diffuse cytoplasmic 
distribution, Seb4 is also organized in regular structures perpendicular to the 
longitudinal axis of the cell. These structures may represent Z-lines, which are dense 
protein bands. In a striated muscle fiber, Actin filaments and Titin molecules are 
anchored to myotendinous junctions and attached to Z-lines, marking the boundaries 
between adjacent sarcomeres (Luther et al, 2003). α-Actinin is a major component of 
Z-lines. It cross-links antiparallel Actin filaments from opposite sarcomeres. Z-lines 
are laterally connected to the extra cellular matrix (ECM). Connecting Z-lines with 
each other and to the surrounding connective tissue ensures synchronous, uniform 
muscle contraction (Jani & Schöck, 2007). Seb4 could possibly be attached to Z-
lines playing a structural role by maintaining, for example, α-Actinin anchorage at the 
Z-line. This could be mediated by controlling the localization of α-actinin mRNA to the 
Z-lines.  
 
4.4 Seb4 is found as a monomer with no associated targets 
The protein sequence of Seb4 containing the highly conserved RNA 
recognition motif RRM reveals the potential to bind macromolecules like nucleic 
acids and proteins.  
A single RRM is known to be sufficient to bind RNA (Scherly et al, 1989), 
but better target specificity has been demonstrated when several RRMs are present 
(Kuhn & Pieler, 1996). These data suggest that Seb4 could act through a multi-
protein complex or as an oligomer conferring higher specificity. The two additional 
conserved domains, observed in the C-terminal half of the Seb4 protein sequence, or 
the RRM itself, could be involved in the formation of this protein complex. The 
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structural features of Seb4 raise the question on how such a small protein aquires its 
specificity. 
To test whether Seb4 operates as an oligomer or in concert with other 
cofactors immunoprecipitation assays followed by silver-staining and gelfiltration 
experiments were performed. Despite the high sensitivity of silver-staining no Seb4 
associated proteins were found. Consistent with this result, gelfiltration experiments 
of embryo extracts also revealed that endogenous Seb4 is not stably bound in a 
complex, and elutes as a monomer. But multiple copies of Seb4 protein may be 
binding to a single RNA. In this case, there need to be no physical interaction 
between individual Seb4 proteins, but to RNA instead. 
Ectopic (myc-tagged) Hermes protein, for example, has been shown to 
pull-down RINGO/spy, mos, and xcat2 mRNAs (Song et al, 2007); however, purified 
Hermes protein does not bind to RNAs in vitro in the absence of oocyte extract 
(Gerber et al., 2002). Immunoprecipitation experiments indicate that multiple copies 
of Hermes protein are associated with each other within the cell. The fact that the 
association of Hermes proteins is sensitive to RNase suggests that it is not a simple 
protein/protein interaction. Thus, Seb4 complex-formation may be based on RNA 
association serving as a platform for other protein partners, as shown for Hermes. 
Of particular interest could be a state of “induced fit”, brought about by 
association with RNA. This conformational change may allow association of Seb4 
with other proteins (homo-oligomerization or hetero-oligomerization). Assembly of 
most RNP complexes is accompanied by significant conformational changes in both 
protein and RNA components. In some cases, these conformational changes may 
occur in a progressive fashion such that early interactions in assembly lead to further 
conformational rearrangements that uniformly facilitate later steps (Williamson, 
2000). 
Analysis of the interaction of Seb4 with RNA by immunoprecipitation 
involves three steps: first, the appropriate experimental conditions allowing natural 
Seb4-RNA and protein interactions, second, the association of endogenous Seb4 
protein bound to its partners with the antibody-beads complex, and third, the 
visualization of the associated target. 
The main challenges in the RIP experiment was, on one hand, the RNA 
preserving conditions and, on the other hand, the visualization step, which requires a 
very sensitive and specific technique to detect possible targets and to reduce 
background contaminations. Most laboratories solve this issue by using the PCR 
method after reverse transcription of the co-immunoprecipitated RNA. The 
amplification step facilitates the detection of rare targets. But the major problem is 
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that the cDNA derived from the immunoprecipitated RNA molecules after RIP are of 
unknown sequence and may possibly contain variable ends due to degradation, 
which makes it difficult to design primer sets against these target sequences. 
PCR can be applied when certain candidates are speculated to be targets 
of a specific RBP. For example, in the case of Hermes, knock-down and localization 
experiments indicated a putative interaction of Hermes with RINGO/spy, mos and 
xcat2. This interaction could then be demonstrated by RT-PCR (Song et al, 2007). 
Just recently, after assuming an interaction of maternal Seb4R with VegT by the co-
localization of both factors in the vegetal pole it was also confirmed by RT-PCR. 
Ectopic Seb4R associates with vegT mRNA controlling its stability and translation 
(Souopgui et al, 2008). 
Here, several experiments led to the conclusion that Seb4 is not only a 
direct target of MyoD, but also an upstream regulator of MyoD. Therefore, myoD 
became a putative candidate for an RNA target of Seb4. Despite the efforts of 
generating several primer sets against MyoD, an interaction of Seb4 protein with 
myoD RNA could not be shown in RT-PCR (data not shown). Because of the lack of 
indications on RNA candidates interacting with Seb4, a more general approach was 
chosen. For Northern blotting, the Seb4-co-immunoprecipitated RNA was labelled 
during reverse transcription and hybridized to total RNA from Xenopus neurulae. The 
attempt to accumulate Seb4 targets by this strategy was not possible. Several 
reasons may be responsible for this. On one hand, the sensitivity of the technique 
could be too low to discover rare targets or, on the other hand, endogenous 
interactions without cross-linking may not be stable enough. In most laboratories 
RNA interactions are shown by either in vitro binding assays, like for Fox-1 and HuR 
(Figueroa et al, 2003; Zhou & Lou, 2008) or with an ectopically expressed, tagged 
version of the protein, like Hermes and Seb4R (Song et al, 2007; Souopgui et al, 
2008). Another common method is to fix the RNP with UV-crosslinking (Luo & Reed, 
2003). 
Hermes was shown to bind RNA only in vivo. The possibility that a protein 
co-factor is required for Hermes to bind RNA efficiently may explain why neither 
protein-protein interactions nor protein-RNA interactions are observed by using 
Hermes protein that has been translated in vitro. Therefore the major aim of the 
target screen was to be as close as possible to the physiological conditions in vivo 
and to find an interaction with the endogenous Seb4 in the embryo. The biological 
relevance of in vitro experiments, frequently including artefacts and false-positives, 
has to be confirmed by all means by in vivo data.  
In contrast, the interaction of Seb4 with RNA could also be of transient 
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nature and, therefore, very challenging to identify.  
 
Another explanation for the negative outcome of the RIP experiments 
could be of functional nature. Many RBPs have been reported to interact with 
thousands of RNAs, in a structural and not sequence-specific manner (Halbeisen et 
al, 2008). For example, to address the question of whether the splicing factors 
U2AF65 and PTB associate with mature mRNAs, a genome-wide analysis of 
transcripts that were immunoprecipitated with U2AF65 and PTB was performed. This 
analysis resulted in over 5000 targets for both RBPs. A detection of Seb4 targets by 
RIP and Northern blotting would be impossible if Seb4 associated with many targets, 
like e.g. U2AF65 and PTB, unselectively. Consistent with this view, Seb4 could 
control generally mRNA on the post-transcriptional level. 
 The U2AF65-associated mRNA population is highly enriched in mRNAs 
encoding transcription and cell cycle regulators, whereas PTB-associated mRNAs 
contain a large proportion of transcripts encoding proteins that are involved in 
intracellular transport and vesicle trafficking. An additional group of genes related to 
ubiquitination and signalling through small GTPase molecules exhibits significant 
enrichment in both U2AF65- and PTB-associated mRNA populations. These data 
illustrate, that these RBPs bind subsets of related gene groups (Gama-Carvalho et 
al., 2006). This finding in combination with the results presented her, could suggest 
not only a global function for Seb4 at a particular step in differentiation, but a 
regulatory role for tissue-specific transcripts, possibly even causing enhanced 
differentiation. 
 
4.5 Seb4 functions as a myogenic regulator 
After Seb4 was identified as a direct target of MyoD in our labratory 
(Jasper, 1998), overexpression studies revealed that Seb4 induced ectopic skeletal 
muscle gene expression (Authaler & Rupp, unpublished results). Here in this study, a 
function for Seb4 as a regulator of the myogenic programme was verified. Loss of 
function experiments demonstrated that dose-dependent Seb4 depletion caused a 
very severe muscle phenotype. This included unstructured somites, reduction to loss 
of muscle-specific gene expression, reduced body size, head and tailbud ablations, 
indicating loss of muscle tissue. These data strongly suggest that Seb4 is involved in 
myogenesis controlling the onset of myogenic regulators and perhaps structural 
properties (Z-lines) of myocyte differentiation.  
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Intriguingly, the expression of myoD, one of the upstream regulators of 
Seb4, was decreased immensely upon Seb4 depletion. Several growth factor 
signalling cascades like sonic hedgehog, FGF, Wnt or TGF-β have been implicated 
to be important for the determination of the muscle lineage (Chanoine & Hardy, 
2003). Furthermore, epigenetic mechanisms like histone deacetylase activities have 
been shown to be involved in the induction of MyoD (Steinbach et al, 2000). At the 
mid-blastula transition (MBT), which demarcates the onset of zygotic transcription, 
MyoD is transiently expressed at low levels (Rupp & Weintraub, 1991). This basal 
gene expression is necessary for the — formerly supposed autocatalytic — 
upregulation of the expression in the preinvoluted mesoderm at the early gastrula 
stage (Steinbach et al, 1998). It is important to note that in the case of MyoD the 
induction occurs on an active rather than an inactive locus. Subsequently, during the 
neurula und the following tailbud stage, MyoD expression is maintained in the 
paraxial mesoderm and in myocytes, respectively (Hopwood et al, 1989). The 
competence phase for the upregulation of the myoD transcription occurs in a narrow 
time window of about 90min during the mesodermal competence phase (Steinbach 
et al, 1998). The window of mesodermal and myogenic competence is terminated by 
the replacement of the maternal linker histones B4 by somatic linker histones at the 
end of the gastrulation (Steinbach et al, 1997).  
The results achieved here, demonstrate that Seb4 functions not only 
downstream but also upstream of myoD indicating a feedback loop between both 
factors at the determination step of the myogenic pathway. In situ data revealed, that 
seb4 expression is located within the myoD expression domain, suggesting that after 
MyoD induction by FGF, for example, Seb4 is induced and feeds back on MyoD 
thereby enhancing the myogenic response in a “wave”, starting in the cells that 
involute first and are later found most anterior. After complete involution, Seb4 is 
expressed in the paraxial mesoderm, correlating exactly with the MyoD expression 
domain, suggesting a role for Seb4 in MyoD maintenance expression.  
Seb4 regulation of myoD, operating either directly or indirectly over one or 
several factors, is anticipated to occur post-transcriptionally, implying another mode 
of controlling muscle determination. As mentionend before, one example of post-
transcriptional regulation is already shown for myoD. During determination, the RRM 
containing protein HuR causes the stabilization of myoD and myogenin mRNAs of 
myoblasts in vitro (van der Giessen & Gallouzi, 2007). 
Taking these evidences together, the effect of Seb4 on myoD transcription 
supports the model that at least one role of Seb4 is maintaining MyoD, thereby 
enhancing positive feed back loops, altogether boosting the differentiation process 
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for example via translational activation/stability, like it is shown for VegT regulation by 
Seb4R (Souopgui et al, 2008).  
The early myogenic phenotype of Seb4 depleted embryos has lasting 
consequences, resulting in dose-dependent impairment of late skeletal muscle 
differentiation and reduction of skeletal muscle tissue. In accordance with this loss of 
muscle the body size is greatly reduced. The observed myogenic effects of Seb4 are 
considered cell autonomous, and are not due to secondary effects of diminished 
neurogenesis. 
In addition to the pro-myogenic role, Seb4 is also required for lens 
differentiation. Though Seb4 is also strongly expressed in the myocardium during 
heart development, Seb4 expression is not required (at high levels) for heart 
differentiation. These results demonstrate that Seb4 is involved in various 
differentiation processes in Xenopus including lens and ear (ectodermal) and skeletal 
muscle (mesodermal) formation. These findings suggest that Seb4 is controlled by 
different upstream regulators tissue-specifically, which leads to different outputs, but 
possibly by a general mechanism.  
All these observations suggest a global function for Seb4 operating in fine-
tuning the differentiation programme of multiple cell lineages promoting 
differentiation. 
 
4.6 Conclusions 
Seb4 was identified as a direct transcriptional target of MyoD protein, in 
the early development of Xenopus. In this study, I investigated the function of this 
putative RNA-binding protein Seb4 in Xenopus. Seb4 is a small, single RRM-domain 
protein, which is a member of a subfamily of RNA-binding proteins conserved in 
human, mouse, fish and C.elegans. My results provide evidence that Seb4 is 
essentially required for myogenesis and lens differentiation in Xenopus. 
Unexpectedly, I found that in embryonic cells Seb4 protein is very abundant. 
Consistent with this, RNA-coimmunoprecipitation assays have failed to reveal 
selective RNA-binding of Seb4-specific target RNAs, which could provide information 
on Seb4 functions. Furthermore, this protein, which I found to be localized in both 
cytoplasmic and nuclear compartments, elutes as a monomer from Superose6 
gelfiltration columns, which so far precluded the identification of interacting partner 
proteins. Given its tissue-specific expression pattern, the high protein abundance and 
the fact that no specific targets could be found, I consider Seb4 to have a more 
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general function in the RNA metabolism of differentiating cells, rather than a selective 
function in the myogenic regulatory circuit. 
 
4.7 Outlook 
In the scope of this work, the RBP Seb4, which is involved in few early 
differentiation processes in Xenopus laevis was characterized. By the means of 
various biochemical and biological approaches this unexplored protein was 
examined from many different angles. Besides many successful experiments and 
fruitful observations, the attempt to identify Seb4 target partners turned out to be very 
challenging. 
The currently available data suggest that a multifunctional nature is more 
likely to be the rule than the exception among RBPs (Moore, 2005). Dissecting the 
cellular roles of multifunctional regulators of gene expression through classical 
approaches involving knock-down or mRNA over-expression is not an easy task, 
because the upstream functions of the processes such as transcription and splicing 
cannot be observed. Thus, searching for the functions of Seb4, forces us to integrate 
new approaches in the future like microarray analyses, e.g. RIP-on-Chip. This begins 
with Seb4 specific RNA-immunoprecipitations performed with the monoclonal 6E5 
antibody. The cDNA copies are then fluorescently labelled and hybridized to DNA 
microarrays. Putative Seb4 mRNA targets identified through the microarray analysis 
could be subsequently confirmed by independent RT-PCR analysis, arguing for the 
specificity of the results obtained. Also expression profiles comparing Seb4-depleted 
tissue to wildtype tissue could reveal the consequences downstream of Seb4. 
Another interesting future experiment would be to discover the implications 
within a Seb4 expressing cell, in which the subcellular localization of Seb4 was 
manipulated. Whether a change in its localization behaviour has any functional 
relevance still has to be determined, but could possibly reveal different functions for 
Seb4 in the different compartments. This, for instance, could be achieved by 
mapping the sequence stretch responsible for the right localization and inserting 
deletions or point mutations into it, in case RNA-binding is uncoupled from 
localization. Another option is to study the consequences when several nuclear 
localization signals have been attached to Seb4. Or what happens if Seb4 was 
tethered to the membrane; would other proteins follow? In the course of this study, 
the precise localization of Seb4 could also be further analyzed by testing for co-
localization with additional markers for subcellular structures, like p-bodies, cajal 
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bodies or stress granules, to eventually associate a putative role for Seb4. The main 
challenge here would be the availability of appropriate Xenopus antibodies, and the 
limitations in the cross-reactivity of antibodies from other species. 
Furthermore, it would be of great interest, whether the specificity of Seb4 
and Seb4R, which show a high degree of similarity, arises from their tissue-specific 
expression or from protein-functional differences. To address this question, it was 
shown by overexpression during retinogenesis, that both genes cause the same 
effects in the retina, suggesting that Seb4, at least when overexpressed in the retina, 
can interact with the same targets than Seb4R (Boy et al, 2004). The next question 
to investigate in this context could be if Seb4R when overexpressed in muscle tissue 
caused the same effects as Seb4. Moreover, could overexpression of Seb4R rescue 
the Seb4 depletion phenotype obtained by Seb4-MO injection?  
Another unresolved and very important issue regards the role of Seb4 
during myogenisis. Indeed, several key observations strongly support an active role 
of Seb4 in this process, most notably the fact that Seb4 is trans-activated by MyoD in 
proliferating prospective myoblasts and that muscle differentiation is impaired in the 
absence of Seb4. In addition, I also showed that Seb4 also feeds back on MyoD, 
implicating that Seb4 is involved in the maintenance of MyoD expression. But what 
other steps of myoblast determination does Seb4 control? And how is the putative 
RNA-binding activity linked to myogenesis? 
Recent works, including many examples discussed in this study, indicate 
that the post-transcriptional control of gene expression is much more elaborate and 
extensive than previously thought, with essentially every step of mRNA metabolism 
being subject to regulation in a mRNA-specific manner. Thus, a comprehensive 
understanding of gene expression requires an appreciation for how the lives of 
mRNAs are influenced by a wide array of diverse regulatory mechanisms carried out 
by RBPs. Particularly, in the embryo RBPs gain more and more importance as 
developmental regulators, as gene expression has begun to be regarded as a 
regulatory network rather than a linear progression of single events.  
It will be a future challenge to link developmental programmes with post-
transcriptional regulatory networks mediated by RBPs to fully reveal their 
physiological implications. 
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Abbreviations 
 
aa amino acid 
ab antibody 
bHLH  basic helix-loop-helix 
bp  base pairs 
cDNA  complementary DNA 
co-IP  coimmunoprecipitation  
d  day/days 
DEPC  diethlypryocarbonate 
ddH2O  double-distilled water 
DNA  deoxyribonucleic acid 
e  embryo 
e.g.  exempli gratia, for example 
et al.  et alii, and others 
etc.  et cetera 
g  gram 
GFP  green fluorescent protein 
G-o-F  gain-of-function  
GST  glutathione S-transferase 
h  hour/hours 
HMG high mobility group 
hpf hours post fertilization 
ICC  immunocytochemistry 
IF  immunofluorescence 
IgG immunoglobulin 
IP  immunoprecipitation 
ISH in situ hybridization 
l  liter 
kDa  kilodaltons 
L-o-F  loss-of-function  
min minutes 
M molar 
MBT mid-blastula transition 
ml milliliter 
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mM millimolar 
MO Morpholino 
mRNA messenger ribonucleic acid 
mut mutant 
ng nanogram 
nm  nanometer 
NTPs nucleotide triphosphate mixture containing adenosine, guanidine, 
uridine and cytosine 
OD optical density 
o/N over night 
PAA polyacrylamide 
PCR  polymerase chain reaction 
pmol  picomol 
pol  RNA-polymerase II 
RBP RNA-binding protein 
RBD RNA-binding domain 
RIP RNA-immunoprecipitation 
RNA  ribonucleic acid 
RNP   ribonucleoprotein complexe 
rpm  revolutions per minute 
RRM  RNA-recognition motif 
rt room temperature 
RT  reverse transcription 
RT-PCR reverse transcription polymerase chain reaction 
SDS  sodium dodecyl sulfate 
SDS-PAGE sodium dodecyl sulfate polyacrylamide gelelectrophoresis 
sec  seconds 
st. Xenopus developmental stages according to the normal table of 
staging of Xenopus laevis (Daudin) after (Niewkoop & Faber, 1994) 
std. standard/control 
TNT transcription and translation 
UV  ultraviolet 
WB  Western blot analysis 
WT  wildtype 
µg  microgram 
µl  microliter 
µM  micromolar 
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